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Chapter I 
General introduction 

General introduction 
The integrity of the genetic material is continuously threatened by a variety of 
environmental agents (e.g. UV irradiation, various chemicals), faulty DNA 
metabolism, and chemical instability of the DNA itself. To protect cells from the 
deleterious accumulation of DNA damage, several DNA repair mechanisms have 
evolved (Friedberg, 1985 for a review). One of the most important and intensively 
studied repair processes is the nucleotide excision repair (NER). NER is capable of 
removing many different lesions, among which are UV (and sunlight)-induced 
cyclobutane pyrimidine dimers (CPD), pyrimidine (6-4) pyrimidone photoproducts ((6-
4) photoproducts), and thymine glycols, as well as bulky chemical adducts and DNA 
crosslinks. If unremoved, these lesions will disturb fundamental cellular processes: 
they will inhibit both DNA-transcription and -replication, which might cause cell 
death. Moreover, erroneous replication passed a lesion will lead to mutations. These 
can interfere with the expression or functioning of genes involved in - for instance -
regulation of cell proliferation and differentiation, thereby possibly providing a step 
in the process of carcinogenesis. 
The first experimental evidence for the importance of DNA repair in prevention 
of cancer was obtained in 1968, when Cleaver reported a deficiency of NER in 
patients with the cancer-prone, hereditary disease xeroderma pigmentosum (XP) 
(Cleaver, 1968). XP is a rare, autosomal recessive disease, with a frequency of about 
1 to 10 patients per million individuals. Clinically, patients are characterised by sun 
sensitivity of the skin, pigmentation abnormalities, and a highly elevated risk for 
developing various types of skin tumors. Some patients have, in addition, neurological 
abnormalities and growth disturbances (Cleaver and Kraemer, 1989 for a review on 
XP). Cell fusion experiments have identified 8 complementation groups (cg) among 
cells of different XP patients, 7 of which are NER-deficient (XP-A to -G; De 
Weerd-Kastelein, eta!., 1972; Vermeulen, eta!., 1991). The eighth cg (XP-variant) 
comprises XP patients with an apparently normal NER, but a defect in postreplication 
repair (Lehmann, et al., 1975). Increased susceptibility for DNA damaging agents has 
now been identified as a common denominator for a number of other rare, cancer-
prone (autosomal recessive) genetic disorders, such as ataxia telangiectasia (AT), 
Bloom's syndrome (BS), and Fanconi's anemia (FA). In contrast to patients with these 
cancer-prone repair disorders are individuals suffering from Cockayne's syndrome 
(CS) and some of the cases with trichothiodystrophy (TTD). Cells from both CS and 
a fraction of TTD patients carry defects in the NER process, but the disorders are not 
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associated with an appreciably elevated risk for (skin)tumor formation (Lehmann, 
1987). Both syndromes are, as XP, genetically heterogeneous- two complementation 
groups have been identified among the classical CS patients (Tanaka, et aL, 1981; 
Lehmann, 1982), and at least two inNER-deficient TID (Stefanini, eta!., 1986, and 
W. Vermeulen, personal communication), one of which is overlapping with XP-D -
suggesting mammalian NER to be highly complex. 
The molecular mechanism of NER has been a major subject of interest for 
many years. In E.coli the process has been unravelled to considerable detail (Van 
Houten, 1990); knowledge about the more complex eukaryotic process is now rapidly 
increasing (Huang, eta!., 1992; Shivji, et al., 1992). To understand this intriguing 
repair system in mammalian cells, as well as its relation to carcinogenesis, extensive 
information about the function of the genes and gene products involved is required. 
The NER-deficient cultured cells from XP and CS patients are, evidently, valuable 
tools. XP cells are being exploited to purify XP-correcting factors, which has resulted 
in the isolation of at least one NER protein (Robins, et al., 1991; Sugano, et al., 
1991; Eker, et al., 1992). In another approach, NER-deficient cell lines serve to 
isolate correcting genes by means of DNA-mediated gene transfer. For this purpose, 
the in vitro mutagenised UV -sensitive rodent cell lines with XP-Iike phenotypes have 
proven to be at least as valuable as XP or CS cells. Among these UV -sensitive rodent 
cell lines, 12 complementation groups have been identified (Thompson, et al., 1988b; 
Zdzienicka, et a!., 1988; Busch, et al., 1989; Hata, et a!., 1991; Stefanini, et al., 
1991 and D. Busch, personal communication). Gene transfer to the rodent mutant cell 
lines has resulted 'in the isolation of five NER genes (Westerveld, eta!., 1984; Weber, 
eta!., 1988; Mudgett and Macinnes, 1990; Weeda, eta!., 1990a, and Chapter III), 
at least three of whlch are involved in XP orCS syndromes (Weeda, eta!., 1990b; 
Flejter, eta!., 1992, and Chapter V). DNA transfections to XP cells have resulted in 
the isolation of another two XP-correcting genes (Tanaka, et a!., 1990; Legerski and 
Peterson, 1992). Though far from complete, this collection ofNER genes and proteins 
is a powerful source from which we can begin to assemble our understanding of the 
many different reactions involved in the removal of one single DNA lesion in a 
mammalian cell. 
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Scope of the thesis 
Knowledge on the molecular mechanism of nucleotide excision repair (NER) 
in mammalian cells is rapidly increasing, but far from complete. The aim of the 
experimental work described in this thesis is to enrich our understanding of the NER 
process, through the identification and characterization of gene(s) involved. Hereto, 
the UV-sensitivity of a Chinese hamster ovary (CHO) mutant cell line from rodent 
complementation group 6 (UV61) was restored to normal levels by means of DNA-
mediated gene transfer. The correcting human gene, designated ERCC6, has been 
isolated and characterized -as described in Chapters III to VI. Mutations in the gene 
appeared to be responsible for (the most common form of) the hereditary DNA repair 
disorder Cockayne's syndrome. A brief overview of (mammalian) NER is given in 
Chapter II. Finally, in Chapter VII the current data on the molecular mechanism of 
(mammalian) NER are discussed. 
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Chapter II 
Nucleotide excision repair 

Nucleotide excision repair 
Nucleotide excision repair (NER) is one of the most versatile DNA repair 
mechanisms of the cell. It is capable of removing a broad category of DNA lesions 
having very dissimilar structures such as UV -induced cyclobutane pyrimidine dimers 
(CPD), pyrimidine (6-4) pyrimidone photoproducts ((6-4) photoproducts), and thymine 
glycols, as well as bulky chemical adducts. The importance of this repair pathway is 
apparent from the phenotype of NER-deficient mutants in various organisms. These 
mutants are being extensively utilized in studies aimed at unravelling the NER process. 
Most of our current knowledge on the molecular mechanism comes from the 
bacterium Escherichia coli (VanHouten, 1990). 
NER in Escherichia coli 
NER can be schematically divided into five successive steps, being (1) damage 
recognition, (2) incision of the damaged strand at both sites of the lesion, (3) excision 
of the damaged strand including the adduct, (4) DNA repair synthesis to fill the single 
stranded gap, and (5) ligation of the newly synthesized strand. In E. coli, at least six 
proteins are involved in this repair process: UvrA, -B, -C, -D, DNA polymerase I and 
DNA ligase. The purification of these proteins as well as the isolation of the genes 
encoding them have been key steps towards the current detailed - but still far from 
complete - mechanistic model (Van Houten, 1990 for a review). 
A simplified scheme of this repair reaction is presented in Figure 1. The UvrA 
subunit dimerizes, and associates with UvrB, to form a UvrA2B complex which will 
bind DNA. The UvrA2B complex possesses a DNA helicase activity, by which it is 
able to scan the DNA strand in search for DNA damage (Grossman and Yeung, 
1990). The complex is believed to recognize a general structural alteration of the 
helix, rather than the damaged base(s) itself. This could explain the broad spectrum 
of damage that can be removed. Upon encountering a damaged site, a stable 
preincision complex is formed and UvrA probably dissociates from the DNA (Orren 
and Sancar, 1989). Once the preincision complex is formed UvrC binds. This ensures 
nicking of the 5"' phosphodiester bond 3' to the lesion by UvrB; subsequently UvrC 
will incise the damaged strand at the eighth phosphodiester bond 5' to the damaged 
base (Lin, eta!., 1992; Lin and Sancar, 1992). Both the resulting oligonucleotide, and 
the UvrC protein are released through the action of the helicase activity of UvrD, 
while DNA polymerase I is needed to fill the gap and release the UvrB protein 
(Orren, eta!., 1992). Finally, the newly synthesized strand is ligated to the parental 
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Figure L A model for the nucleotide excision repair mechanism in Escherichia coli. 
DNA by DNA ligase. 
Preferential repair of active genes: a NER subpathway 
To efficiently remove DNA damage from the genome, NER appears to be 
divided into two - partly overlapping - subpathways. The presence of lesions in the 
DNA has important consequences on both DNA replication and transcription, the most 
urgent effect being the inhibition of actively transcribing RNA polymerase complexes. 
To get around the lethal effect of this transcription block, a sophisticated NER-
subpathway has evolved that is primarily directed towards removal oflesions from the 
transcribed strand of active genes (Link Jr., et al., 1991). This ensures fast repair of 
the relatively small - but vital - active fraction of the genome. The second subpathway 
is dedicated to the removal of damage from both inactive chromatin and the non-
transcribed strand of active genes. The rate of this "overall genome" repair is lower 
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than that of repair of the transcribed strand of active genes, and for some lesions 
repair is incomplete (Link Jr., eta!., 1991 for a review). In human cells, repair of the 
nontranscribed strand of active genes is faster than repair of an inactive locus, but not 
as efficient as that of the transcribed strand (Venema, et a!., 1992). The delicate 
subpathway of preferential repair was first recognized in rodent cells (Bohr, et a!., 
1985). These cells have - in contrast to human fibroblasts - almost no detectable 
overall genome repair, whereas they are as UV -resistant as human cells (Zelle, et a!., 
1980; Van Zeeland, eta!., 1981). The rodent cells appear to mainly rely on the repair 
of the active fraction of their genome, whereas human cells have a more extensive 
overall genome repair (Bohr, eta!., 1985; Mellon, eta!., 1986; Mellon, eta!., 1987). 
The existence of preferential repair of the transcribed strand of active genes has been 
documented also in yeast (Smerdon and Thoma, 1990), and E.coli (Mellon and 
Hanawalt, 1989), indicative of its fundamental importance. 
In E. coli, a direct coupling between transcription and preferential NER seems 
to exist. If CPD removal is measured in the lactose operon upon UV -irradiation of 
E. coli cells, preferential repair of the transcribed strand is only found when 
transcription is induced. Repair of the non-transcribed strand is slower, and resembles 
that of both strands in the non-induced operon (Mellon and Hanawalt, 1989). 
Preferential repair (of CPD) of a transcribed gene also occurs in an E. coli in vitro 
repair assay. A defined NER system, consisting of purified UvrABC excinuclease, 
UvrD, DNA polymerase I, and T4 DNA ligase, together with RNA polymerase 
exhibits strand-selective repair only upon addition of a recently purified factor, called 
TRCF (Transcription Repair Coupling Factor; Selby and Sancar, 1991). When the 
factor is omitted, transcription no longer stimulates, but - on the contrary - appears 
to inhibit preferential repair of the transcribed strand in this defined system (Selby and 
Sancar, 1990). Based on these results, a model was proposed explaining the role of 
TRCF in coupling repair to transcription (Selby, eta!., 1991). In this model, TRCF 
recognizes the RNA polymerase complex as soon as it is stalled at a DNA lesion. 
Either alone or together with the RNA polymerase it would then serve as a high 
affinity binding site for the UvrA2B complex, thus ensuring fast repair of the 
transcribed strand. 
An E. coli mutant, mfd (mutation .frequency decline), appears to lack a functional 
TRCF. Cell-free extracts show no enhanced repair of the transcribed strand of an 
active gene in an in vitro repair assay; a phenomenon restored by the addition of 
purified TRCF (Selby, et al., 1991). The mutant itself, however, shows a (practically) 
no increased UV-sensitivity, but is reported to have an elevated (5x) mutation 
frequency (George and Witkin, 1974). This might be explained by the fact that 
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cultured E. coli cells grow - compared to bacteria in non-laboratory conditions -
exceptionally fast. Since DNA replication is much faster than transcription, DNA 
polymerase complexes will frequently encounter and subsequently remove RNA 
polymerase molecules stalled at a DNA lesion. Translesion DNA synthesis will 
thereafter be necessary for replication to continue, resulting in the observed elevated 
mutation frequency. It would, on the other hand, allow fast resumption of RNA 
synthesis (on the duplicated genome), which could account for the unaffected UV-
survival of the mutant cells. 
Human NER-deficient disorders 
The phenotypic consequence of a NER deficiency in human cells is clearly 
illustrated by two different, rare, hereditary disorders: xeroderma pigmentosum (XP) 
and Cockayne's syndrome (CS). Patients suffering from the prototype DNA repair 
syndrome XP are extremely photosensitive, exhibit pigmentation abnormalities in sun-
exposed areas of the skin and have a highly elevated risk for developing skin tumors 
( ""2000x). Some XP patients ( ""20-35%) have, in addition, a progressive 
neurological degeneration. In CS too, patients are photosensitive, but in contrast to XP 
this syndrome is not associated with an elevated risk for developing skin tumors. CS 
is further characterized by cachectic dwarfism, skeletal and retinal abnormalities, as 
well as progressive neurological degeneration (Lehmann, 1987; Nance and Berry, 
1992 for reviews ) . 
XP fibroblasts show enhanced killing by UV light. The UV -dependent DNA 
repair synthesis seen in normal cells after irradiation is (severely) reduced, indicating 
that UV -induced DNA damage is not repaired in XP fibroblasts (Cleaver and 
Kraemer, 1989 for an extensive review on XP). Introduction of the dimer-specific T4-
endonuclease V, isolated from T4-infected E.coli, or the Micrococcus luteus 
endonuclease into XP cells results in near normal levels of DNA repair synthesis 
(Tanaka, et al., 1975; Tanaka, et al., 1977; Hayakawa, eta!., 1981; DeJonge, et al., 
1985). From these experiments it was concluded that XP cells are probably deficient 
in one of the early steps of NER. Cell fusion experiments have identified seven 
excision-deficient XP complementation groups (XP-A to-G, summarized in Table I), 
suggesting a considerable biochemical complexity (De Weerd-Kastelein, et a!., 1972; 
Vermeulen, et al., 1991). 
Complementation group A comprises a large number of patients. Generally, 
NER seems to be blocked completely in XP-A fibroblasts; the residual repair synthesis 
in most cases is less than 5% (and could be derived from base excision repair of e.g. 
UV-induced thymine glycols). Consequently, most group A patients manifest a severe 
clinical phenotype, with clear neurological degeneration (see Table I). Several patients 
18 
Table I. Characteristics of NER-deficient XP and CS complementation groups 
Clinical characteristics Repair 
Group parameters Rodent Correcting Remarks 
Skin Neurol. Relative uv Residual 
equivalent gene 
cancer abnmm. frequency sens. UDS 
XP-A + ++ high +++ <5% ? XPAC 
XP-B +!- +++!+ very rare ++ <10% group 3 ERCCJ combined XP/CS 
XP-C + high + 15-30% ? XPCC overall genome 
repair deficient 
XP-D + ++1- intermediate ++ 15-50% group 2 ERCC2 includes TID and 
XP/CS 
XP-E + rare ± >50% ? ? 
XP-F + rare/ + 15-30% ? ? repair slow but 
intermediate prolonged 
XP-G +I- ++I+ rare ++ <10% ? ? includes XP/CS 
CS-A ++ rare + wild ? ? preferential repair 
type of transcribed 
genes deficient 
CS-B ++ high + wild group 6 ERCC6 preferential repair 
type of transcribed 
genes deficient 
-
"' 
have been described that exhibit a milder form of the disease. The gene correcting the 
repair defect ofXP-A cells (the XP-A correcting or XPAC gene) has been isolated and 
characterized (Tanaka, et al., 1990). Mutation analysis of this gene has been 
performed in some of the patients. The mutations found in the milder form of the 
disease seem to have a less rigorous effect on protein function than those found in 
severely affected patients (Satokata, et al., 1990; Satokata, et al., 1992a; Satokata, et 
al., 1992b). 
In the extremely rare group B, only consisting of 3 patients, all individuals 
exhibit a remarkable combination of clinical characteristics of XP and CS (Robbins, 
et al., 1974; Cleaver and Kraemer, 1989 and Vermeulen, manuscript in preparation). 
Also here, excision repair is severely affected, the residual repair synthesis is < 10%. 
Fibroblasts from complementation group C are less UV -sensitive compared to 
the severely affected group A and B cells; the residual repair synthesis is between 15 
and 30%. Interestingly, these cells harbor a specific deficiency in the repair of the 
"overall genome", whereas the transcribed strand of active genes is repaired at normal 
levels (Kantor, et al., 1990; Venema, et al., l990b; Venema, et al., 1991). This 
implies the defective protein in XP-C to function mainly (if not solely) in repair of 
inactive chromatin and the non-transcribed strand of active genes. Phenotypically, XP-
C patients differ from group A patients in that they seldomly exhibit neurological 
abnormalities (Cleaver and Kraemer, 1989). 
XP group D is, clinically as well as biochemically, very heterogeneous 
(Johnson and Squires, 1992 for a recent review). It encompasses classical XP patients, 
patients suffering from a combined XP/CS phenotype, and patients with 
trichothiodystrophy (TTD). TID is a rare, recessive disorder characterized by 
sulphur-deficient brittle hair, mental and growth retardation, ichthyosis, and - only in 
20% of the cases - photosensitivity (Lehmann, 1989; Stefanini, et al., 1992). In 
several individuals the genetic defect resulting in photosensitivity is demonstrated to 
be similar to the XP-D defect (Stefanini, et al., 1986; Stefanini, et al., 1992). The 
patients do not show the pigmentation abnormalities or elevated incidence of skin 
tumors characteristic for XP. It is possible, though, that the severe ichthyosis masks 
part of the XP-specific skin defects; it might even (partly) protect cells in the skin 
from sun(UV)Iight. Among the XP group D TID patients, the NER deficiency can 
either concern removal of both (6-4) photoproducts and CPD or removal of (6-4) 
photoproducts only (Broughton, eta!., 1990). 
DNA repair in the rare XP group E is only moderately affected, the residual 
repair synthesis being >50%. The skin symptoms of patients in this group are mild, 
and neurological degeneration has not been reported. In 1988, Chu and Chang (Chu 
and Chang, 1988) reported the apparent absence of a DNA binding activity in cells 
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from two (consanguineous) XP-E patients (XP2RO and XP3RO). Recently it was 
reported that in 8 out of 9 other. unrelated, Japanese XP-E patients the binding 
activity was retained (Keeney, et al., 1992). More conclusive results concerning the 
XP-E deficiency should await the isolation and characterization of the XP-E correcting 
gene and protein. 
XP-F patients have very mild clinical symptoms. NER in XP-F fibroblasts is 
very slow but long-lasting, and residual repair levels vary between 15 and 30%. 
XP-G patients are more severely affected. As in group B and group D, also in 
group G patients have been described suffering from the combined XP/CS syndrome 
(Vermeulen, eta!., 1992). The existence of3 complementation groups that encompass 
patients suffering from 2 rare genetic syndromes, XP and CS, suggests both diseases 
to be - at the molecular level - closely related. 
CS is, as XP, heterogeneous (see Table 1): at least two complementation groups 
exist among the "classical" form (i.e. not in combination with XP) of the disease 
(Tanaka, eta!., 1981; Lehmann, 1982). In sharp- and unresolved- contrast to XP, 
patients suffering from CS do not exhibit the pigmentation abnormalities and the 
increase in skin tumors typical for XP. A distinctive characteristic of CS fibroblasts 
is that after UV -irradiation they perform repair synthesis at normal rates, but are - in 
contrast to normal cells - unable to recover their RNA synthesis (Mayne and 
Lehmann, 1982). The precise molecular defect in this rare disorder has been 
mysterious for many years. A model postulated by Mayne and Lehmann in 1982 
(Mayne and Lehmann, 1982) has only recently been confirmed experimentally, when 
Venema and colleagues pinpointed the CS defect to the sophisticated, preferential 
repair of CPD in active genes. Repair of inactive chromatin appears to be unaffected 
in CS cells (Venema, et al., l990a). In cells from a patient in CS group A, thus far 
the smallest of the two complementation groups, strand specificity of repair of active 
genes is demonstrated to be abolished (Venema, 1991). 
Among CS patients (without XP symptoms), three clinical subtypes have been 
described. The clinical groups mainly differ in the time of onset and severity of the 
clinical symptoms (Nance and Berry, 1992). Patients in which the clinical symptoms 
become apparent several months after birth are classified as CS I. These patients are 
reported to exhibit growth failure (after ""1 year), neurodevelopmental and 
neurological dysfunction, cutaneous photosensitivity, progressive pigmentary 
retinopathy with or without cataracts and/or optic disk atrophy, sensorineural hearing 
loss, dental caries, and cachetic dwarfism. This is the largest group, with 
approximately 120 cases described. About 20 patients that had clinical characteristics 
of the disease already at birth have been classified as "severe" or "CS II". The 
patients have low birth weight, severely reduced growth and poor neurological 
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development. Their prognosis is generally much worse than that of the "CS I" patient 
(death occurring at an earlier age). Patients within the third subgroup, referred to as 
"mild CS", only have some of the clinical features (e.g. patients with normal 
intelligence or reproductive capacity) or the symptoms are mild and/or late in onset 
(for a detailed review, see Nance and Berry, 1992). This clinical heterogeneity does 
not coincide with the genetic heterogeneity as defined by the different 
complementation groups. Both group A and group B (Tanaka, et al., 1981; Lehmann, 
1982), encompass patients classified as CS I, thereby group A also includes cells from 
a "mild" patient. Cells from patients clinical! y classified as "severe" have not been 
included in complementation analysis. It is not excluded, however, that some of these 
severe CS cases in fact also have an XP-like NER defect, and would display the 
clinical hallmarks of XP if they would become older. 
NER-deficient rodent mutant cell lines 
Although the existing human NER-deficient XP and CS cell lines are valuable 
and indispensable tools to enrich our knowledge of the mammalian NER mechanism, 
they have technical limitations such as transfectability (Hoeijmakers, et al., 1987). 
Furthermore, it is likely that certain genes involved in NER will remain unnoticed, 
since mutations within these genes might be incompatible with embryonic 
development. Therefore, considerable effort has been devoted to generate, and 
characterize a collection of UV-sensitive rodent mutant cell lines (Thompson, et al., 
!988b; Zdzienicka, et al., 1988; Busch, et al., 1989; Hata, et al., 1991; Stefanini, et 
al., 1991). Three rodent cell lines - Chinese hamster ovary (CHO) cells, Chinese 
hamster cell line V79, and mouse lymphoma cell line L5178Y - have been used for 
this purpose. In CHO cells, partial hemizygosity of the genome has been demonstrated 
(Siciliano, et al., 1983; Thompson, et al., 1989), implying that only one gene copy 
has to be mutated (in these regions) for a recessive phenotype to become apparent. 
An extensive collection of UV-sensitive rodent mutants is currently available. 
Among those, at least twelve complementation groups have been identified (see Table 
TI). Representatives of the first five groups are very UV-sensitive, and are thought to 
be disturbed in the early steps of the NER pathway. Both group I and group 4 are, 
in addition to UV, extremely sensitive to mitomycin C (MMC), a crosslinking agent 
(Busch, et al., 1989). Groups 5 to 10 and 12 represent mutants with only a moderate 
UV-sensitivity (Thompson, et al., 1988b; Zdzienicka, et al., 1988; Busch, et al., 
1989; Stefanini, et al., 1991 and D. Busch, personal communication). UV61, a group 
6 mutant, has a partial deficiency in repair of CPD from the transcribed strand of 
active genes. Repair of the non-transcribed strand, and the genome overall is -
characteristically for rodent cells - low (Lommel and Hanawalt, 1991). The mutant 
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Table II. Characteristics of rodent NER-deficient complementation groups 
Complementation Representative Parental strain Sensitivity•> to Incision XP orCS col'recting 
group mutant uv MMC deficiency equivalent gene cloned 
UV20, 43-3B CHO ++ +++ + not available ERCCJ 
2 UV5, V-H1 CHO, V79 ++ + + XP-D ERCC2 
3 UV24, 27-1 CHO ++ + + XP-B ( =CS-C) ERCC3 
4 UV41 CHO ++ +++ + ? 
5 UVI35, Q31 CHO, L5178Y +(+) ± + ? ERCC5 
6 UV61, US46 CHO, L5178Y + + partial CS-B ERCC6 
7 VBll V79 + ± partial ? 
8 US31 L5178Y + + ? ? 
9 CH07PV CHO + + partial ? 
10 CH04PV CHO + + partial ? 
II UVS1 CHO +(+) + +b) ? 
12 UV140') CHO + ±d) +b) ? 
•) +, 2-Sx wt; ++, 5-10x wt; +++, >lOx wt sensitivity 
b) A. Collins, personal communication 
c) D. Busch, personal communication 
d) M. Zdzienicka, personal communication 
N 
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seems to be completely proficient in repair of (6-4) photoproducts, when determined 
in the genome overall (Thompson, eta!., 1988a). Chapters TII, IV, V, and VI describe 
the isolation and characterization of the human gene complementing the rodent group 
6 repair deficiency. 
UV -induced mutagenesis 
Since the first evidence for the involvement of NER in the prevention of skin 
cancer -the absence of NER in the cancer-prone disorder XP (Cleaver, 1968) - much 
attention has been focussed on UV-induced mutagenesis. The two most prevalent UV-
induced DNA lesions formed upon irradiation with 254 nm UV light are CPD and (6-
4) photoproducts, in a ratio of about 3:1 (Mitchell and Nairn, 1989). "Overall 
genome" repair of the - more helix disturbing- (6-4) photoproduct in mammalian cells 
is faster and more complete than repair of CPD (Mitchell and Nairn, 1989 for a 
review); removal of (6-4) photoproducts from transcribed regions of the genome is 
only slightly more efficient (Link Jr., eta!., 1991; Link Jr., eta!., 1992). Although 
both photoproducts seem to add to the induction of mutations, the relative contribution 
of each of the two lesions is still not completely clear. The influence of CPD is 
suggested by several experiments. For example, the hypermutable (5x) rodent cell line 
UV61 (complementation group 6) is thought to have normal (6-4) photoproduct repair, 
and is partially deficient only in (preferential) repair of CPD (Thompson, et a!., 
1988a; Lamme! and Hanawalt, 1991). Furthermore, removal of CPD from an 
irradiated SV 40-based shuttle vector (by photoreactivation of the vector) before 
transfection to mammalian cells results in a reduction of the mutation frequency 
(Bourre, eta!., 1989). There is, nevertheless, also convincing evidence suggesting an 
important role for (6-4) lesions. A partial revertant, RHl-26, has been isolated from 
rodent mutant cell line V-Hl, complementation group 2 (Zdzienicka, eta!., 1992). V-
H1 is completely deficient in repair of CPD, and partially defective in (6-4) 
photoproduct repair (Mitchell, eta!., 1989). The revertant has a similarly defective 
CPD removal (both from active and inactive chromatin), but regained normal (6-4) 
photoproduct repair. The 7-fold enhanced mutagenicity of V-Hl, in contrast to the 
normal mutagenicity of RHl-26, suggests (6-4) photoproducts to be the main 
mutagenic lesion (Zdzienicka, et al., 1992). Also results obtained with the bacterium 
E. coli suggest (6-4) lesions to be the main - though not sole - mutagenic lesion 
(LeClerc, et a!., 1991). Taken these data together, it seems very unlikely that 
mutagenesis is simply the result of only one of the two major photoproducts. 
The type of mutations introduced by UV-Iight is diverse, with both transitions 
and transversions occurring. Predominance ofGC to AT transitions has been reported, 
however, after UV -irradiation of E. coli (lacl; Schaaper, eta!., 1987), yeast (the !RNA 
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gene SUP4-o; Armstrong and Kunz, 1990), and human cells (the HPRT gene; 
McGregor, et aL, 1991). This observation is thought to result from the preferential 
insertion of an A residue opposite a non-instructive lesion (the "A-rule"; Strauss, 
1991). Data concerning hamster cells are contradictory: in both the endogenous and 
exogenous, stably integrated APRT gene GC to AT transitions predominated 
(Drobetsky, et al., 1987; Drobetsky, et al., 1989), whereas in the HPRT gene of V79 
and AA8, transversions were the predominant type of mutations present (Vrieling, et 
al., 1989; Menichini, et al., 1991). Possibly, the nature of mutations in different target 
genes is influenced by the regional pattern of replication and transcription. 
Preferential repair of the transcribed strand of active genes has a profound 
influence on the strand specificity of UV -induced mutations. In normal human, 
hamster, and E. coli cells, mutations resulting from lesions in the nontranscribed strand 
of active genes prevail (Vrieling, et al., 1989; Koehler, et al., 1991; McGregor, et 
al., 1991; Menichini, et al., 1991; Vrieling, et al., 1991). InNER-deficient E. coli 
cells, this strand bias of mutations is strongly reduced, conform the absence of 
(preferential) repair (Koehler, et al., 1991). In four mammalian NER-deficient cell 
lines, XP12BE (XP group A) and hamster mutants VH-1, UV5 (rodent group 2), and 
UV24 (rodent group 3) mutations in the HPRT gene are mostly targeted by lesions in 
the transcribed strand (Vrieling, et al., 1989; McGregor, et al., 1991; Menichini, et 
al., 1991; Vrieling, et al., 1992). A hypothesis to explain this unexpected reversion 
of strand specificity has been put forward by Vrieling and coworkers (Vrie1ing, et al., 
1989; Vrieling, et al., 1992). They suggested that the bias found in the absence of 
repair might be dependent on the fidelity of replication. Different DNA polymerases 
(polymerase a, o, and E) are involved in synthesis of the lagging and leading strand. 
The ability to bypass a lesion might be different for the different polymerases, a fact 
that could either be intrinsic to the polymerases itself or to the nature of replication 
of the leading (continuous replication) and lagging (discontinuous replication) strand. 
The presence of a sequence in the first HPRT intron, which is able to function as an 
autonomously replicating sequence in yeast and is associated with the nuclear matrix 
(Sykes, et al., 1988), suggests that during replication most of the HPRT transcribed 
strand functions as the template for the leading strand. But whatever might be the 
mechanism for the strand preference in situations where no repair has occurred, it is 
clear that if preferential repair actively operates, most mutations will reside from 
lesions in the nontranscribed strand. 
Yeast genes involved in NER 
The molecular mechanism of NER in eukaryotes is yet far from understood. 
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The isolation and characterization of genes and gene products involved will be an 
important clue to the understanding of this complex DNA repair process. For this 
purpose, the yeast Saccharomyces cerevisiae, amenable to both genetic and molecular 
manipulation, has proven to be a far-reaching tool. Mutant analysis has demonstrated 
a high degree of complexity among DNA repair processes in yeast: at least 30 
different gene products are involved. The different mutants are divided in three 
epistasis groups (an epistasis group contains mutants disturbed in the same DNA repair 
pathway): RAD3, RAD6, andRAD52 (Friedberg, 1988). The RAD6 group is composed 
of mutants disturbed in so called postreplication repair, whereas the RAD52 group 
comprises mutants defective in DNA damage related recombination processes. Mutants 
from the RAD3 epistasis group are UV -sensitive and deficient inNER; at least11 gene 
products are involved (Hoeijmakers and Bootsma, 1990; Friedberg, 1991 for recent 
reviews). Of these, RADl, 2, 3, 4, 10, and 14 are believed to be essential for the 
incision step of NER. RAD 16 is suggested to be important for repair of inactive 
chromatin. Removal of CPD from the two identical, but differentially transcribed 
mating type loci MAT01. and HMLO!. was compared within radl6 mutants. Repair of the 
transcriptionally inactive HML01.locus was completely defective, whereas repair of the 
transcribed MAT01.!ocus did occur, although slower than in normal cells- a phenotype 
resembling that of XP-C cells (Terleth, et a!., 1990). 
A summary of the main properties of genes from the RAD3 epistasis group that 
have been isolated and characterized thus far is shown in Table III. Of these, only the 
RAD2 gene appears to be inducible by DNA damage (Madura and Prakash, 1986). 
Many of the genes- RADI (Reynolds, eta!., 1987), RAD3 (Naumovski, eta!., 1985; 
Reynolds, et al., 1985a), RAD4 (Gietz and Prakash, 1988), RAD7 (Perozzi and 
Prakash, 1986), and SSL2 (other names: ERCC3'" or RAD25; Gulyas and Donahue, 
1992; Park, et al., 1992) - encode proteins with acidic amino acid stretches, which 
could be involved in chromatin binding via electrostatic interactions with the basic 
histones. 
Three of the gene products listed in Table III encode (presumed) helicases. The 
RAD3 gene product is demonstrated to exhibit (5' to 3 ')DNA helicase activity (Sung, 
et al., 1987). The second - in this case putative - DNA helicase is encoded by the 
SSL2 or ERCC3s' gene (Gnlyas and Donahue, 1992; Park, eta!., 1992). Both proteins 
are of vital importance: "complete loss of function" mutations in either of those genes 
are not compatible with yeast life (lliggins, et al., 1983; Naumovski and Friedberg, 
1983; Gulyas and Donahue, 1992). For RAD3, the helicase activity is indispensable 
for its repair function. Mutations eliminating the helicase function, however, do not 
affect viability (Sung, et al., 1988). The third, again presumed, helicase is encoded 
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Table III. Isolated and sequenced yeast genes involved in nucleotide excision repair 
Gene Chromosomal Protein size Human homolog Protein characteristics 
localization (aa) 
RADl XVI 1100 ? acidic C-terminus, involved in recombination, 
can interact with RAD 10 
RAD2 VII 1031 ? transciption inducible by UV 
RAD3 v 778 ERCC2 DNA-binding, 5'->3' DNA.DNA and DNA. RNA 
helicase, acidic C-terminus, vital function 
RAD4 v 754 ? helix-turn-helix motif present, acidic C-terminus 
RAD7 X 565 ? acidic stretches 
RADIO XIII 210 ERCCJ involved in recombination, can interact with 
RAD 1, binds ss-DNA, renaturation of ss-DNA 
RAD14 ? 246 XPAC Zn2+ -finger motifs, no vital function 
RAD16 II 790 ? member of a subfamily of postulated helicases 
(ERCC6 also belongs to this family), Zn'+ -finger 
motifs 
SSL2 IX 843 ERCC3 also designated ERCC3'' or RAD25, helicase 
signatures present, acidic stretches, a mutant 
SSL2 protein (SSL2-J) is able to promote 
translation past a strong hairpin structure, vital 
function 
For references, see text. 
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by the RADI6 gene (Bang, et aL, 1992; Mannhaupt, et al., 1992; Schild, et al., 
1992). This postulated he1icase is a member of a rapidly expanding subfamily of 
putative helicases, which share a high degree of homology over the entire region 
encoding the helicase signatures. Other members of this family are two proteins of 
unknown function (STHl and FUN30), transcription regulators (SNF2, MOTl, brm), 
a protein involved in preservation of chromosome stability (lodestar), and three 
proteins involved in three important DNA repair pathways (RAD54 in recombination 
repair, RAD5 in postreplication repair and ERCC6 in preferential NER) (Bang, et al., 
1992; Clark, et al., 1992; Davis, et al., 1992; Johnson, et al., 1992; Laurent, et al., 
1992, and Chapter V). 
Several proteins contain putative DNA binding domains within their predicted 
amino acid sequence. Four of the RAD3 group genes, RAD3, 4 (Gietz and Prakash, 
1988; Cuoto and Friedberg, 1989), 10 (Reynolds, et al., 1985b) and SSL2 (ERCC3s), 
encode peptides with homology to the "helix-turn-helix" DNA binding motif; RAD14 
(Bankmann, et al., 1992) and RAD16 (Bang, et al., 1992; Mannhaupt, et al., 1992; 
Schild, et al., 1992) contain zinc-finger motifs. So far, experimental evidence actually 
demonstrating DNA binding has only been obtained for RAD3 (Sung, et al., 1987) 
and RADIO (Sung, et al., 1992). The RADI and RADIO proteins appear to have, 
besides their role in NER, a role in mitotic recombination; presumably they are both 
involved in the same recombination process (Schiestl and Prakash, 1988; Schiestl and 
Prakash, 1990). The two proteins appear to be complexed with each other, both in 
vivo and in vitro (Bailly, et al., 1992; Bardwell, et al., 1992). 
Isolation of human genes involved in NER 
The most generally used procedure for isolation of human DNA repair genes 
is transfection of genomic DNA from normal cells to repair-deficient mutants, 
followed by selection of repair-competent transformants. The correcting gene can 
subsequently be isolated via standard techniques. This method has resulted in the 
isolation of several human genes capable of correcting different complementation 
groups of the in vitro mutagenized, UV-sensitive, rodent cell lines (discussed below; 
see Table IV). Genomic DNA transfections to cell lines from patients with DNA 
repair syndromes (i.e. XP, CS) have so far - with one notable exception (Tanaka, et 
al., 1989) - proven unsuccessfuL The difficulty to isolate repair-competent 
transformants after transfection of repair-defective human cells is due to the low 
amount of DNA that will stably integrate in the genome of these cells. Compared to 
rodent cells, approximately 30 - ;:;,: 100 fold less DNA is integrated. This raises the 
number of cells required to be transfected to generate one genomic transformant 
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Table IV. Isolated human genes involved in nucleotide excision repair 
Gene Chromosomal Gene size Protein Yeast homolog Protein characteristicsa> 
localization (kb) size (aa) 
ERCCJ 19ql3.2 -17 297 RADIO DNA binding?, involved in recombination?, 
homology to parts of UvrA aod C in C-terminus 
ERCC2 l9ql3.2 -20 760 RAD3 helicase?, vital function? 
ERCC3 2q2l -45 782 SSL2, RAD25, helicase?, vital function? 
ERCC3" 
ERCC5 !3q32-33 -32 ? ? 
ERCC6 !Oqll-21 -85 1493 ? member of a subfamily of postulated helicases, 
presumably not essential for viability 
XPAC 9q34 -25 273 RAD14 Zn2+ finger, binds toss and UV-irradiated ds DNA 
XPCC ? ? 823 ? (limited) homology to RAD4 in C-terminus 
For references see text. 
o) 7 denotes a putative protein characteristic deduced from the amino acid sequence or from the function of a yeast homolog; 
direct proof is still lacking 
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containing a specific gene to extremely high levels (depending on gene length to more 
than 109 cells (Hoeijmakers, eta!., 1987)). 
DNA-mediated gene transfer to human NER-deficient cell lines 
The one example of successful isolation of a NER gene via large scale genomic 
DNA transfection to a XP cell line is the XPAC gene (Tanaka, eta!., 1989). This 
gene, localized on chromosome 9, is approximately 25 kb in length, and encodes a 
protein of 273 amino acids (aa) (Tanaka, eta!., 1990). The XPAC protein has been 
(partially) purified from HeLa cells and calf thymus, using either microinjection or an 
in vitro repair assay as a test for activity (Robins, et al., 1991; Sugano, et al., 1991; 
Eker, et al., 1992). The encoded protein has a predicted molecular weight of 31 kD, 
but has been found to migrate with an apparent molecular weight of 40 - 45 Kd (SDS-
PAGE) (Miura, et al., 1991; Robins, et al., 1991; Sugano, et al., 1991; Eker, et al., 
1992). The sequence predicts the presence of a zinc-finger, suggestive of DNA-
binding (Tanaka, et al., 1990). In vitro studies with the purified XPAC protein 
confirm the DNA-binding capacity (Robins, et al., 1991; Eker, et al., 1992). Mutation 
analysis among XP-A patients revealed a founder effect in Japan: of the 21 patients 
analyzed, 16 were homozygous and 4 were heterozygous for the G to C transversion 
at the 3' splice acceptor site of intron 3 (Satokata, et al., 1990). The clinical 
heterogeneity among other patients seems to be correlated with the occurrence of 
different mutations (Satokata, et al., 1992b). A XP-A revertant cell line has been 
isolated (Cleaver, eta!., 1987), in which a nonsense codon at aa 207 (originating from 
an arginine) is altered such that it encodes again an aa (Jones, et al., 1992; Satokata, 
et al., 1992a). This revertant is as UV-resistant as normal cells. Repair of (6-4) 
photoproducts is restored to wild type levels, but dimer removal has remained as 
deficient as in the original XP-A (Cleaver, et al., 1987), suggesting the XPAC protein 
to function - directly or indirectly - in damage recognition. 
For XP cells, an alternative gene transfer strategy, the transfection of eDNA 
libraries, has proven successful too (Peterson and Legerski, 1991). The XP-C 
correcting gene has recently been isolated following this method. The gene, which 
seems to be specifically involved in repair of inactive chromatin (Venema, et al., 
1991), encodes a protein of 823 aa. In its C-terrninus, the protein exhibits (limited) 
homology to the yeast NER protein RAD4 (Legerski and Peterson, 1992). Further 
research on the XPCC gene might shed more light on its function in repair of inactive 
chromatin. 
DNA-mediated gene transfer toNER-deficient rodent cells 
DNA-mediated gene transfer to rodent mutants has- so far -led to the isolation 
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of five human genes correcting complementation groups 1, 2, 3, 5, and 6. The first 
human NER gene isolated was the ERCCI (Excision Repair Cross Complementing 
rodent repair deficiency) gene, correcting cells from rodent complementation group 
1 (Westerveld, eta!., 1984). The gene seems not to be involved in one of the XP or 
CS complementation groups (Van Duin, eta!., 1989). ERCCJ, covering a region of 
15- 17 kb on human chromosome 19q13.2 (Van Duin, eta!., 1987; Mohrenweiser, 
et a!., 1989; Smeets, et a!., 1990), encodes a protein of 297 aa. The predicted aa 
sequence contains a putative nuclear location signal (NLS) and a postulated DNA 
binding domain (of the helix-tum-helix type). It shows a significant "overall" aa 
homology to the gene pro<luct of the yeast repair gene RADIO, suggesting both 
proteins might have similar functions in the excision repair process (Van Duin, eta!., 
1986). Currently, studies are in progress to assess whether ERCCI is involved in 
recombination, as has been demonstrated for the RADIO protein (Schiestl and 
Prakash, I990). The participation of ERCCI in recombinational repair might explain 
the extreme sensitivity of rodent group I mutants for the crosslinking agent MMC. To 
completely repair the damage caused by an interstrand crosslink NER alone will 
probably be insufficient, and additional recombination repair necessary. A role of 
ERCCl in recombination is thus an attractive hypothesis. The predicted ERCCl aa 
sequence extends at the C-terrninus beyond the RADIO sequence (RADIO: 210 aa, 
ERCCI: 297 aa), where it exhibits homology to parts of the bacterial proteins UvrA 
and UvrC (Van Duin, eta!., 1988). Mutational analysis has shown the C-terrninus 
(homology to the UvrC terminus) of utmost importance for the repair function of the 
ERCCJ protein (Van Duin, et a!., 1988, P. van der Spek and J. van den Berg, 
personal communication). In E. coli, the UvrC C-terminal half was demonstrated to 
be important for the incision step of NER (Lin and Sancar, 1991). The UvrC protein 
is suggested to introduce an incision 5' to a DNA lesion (Lin and Sancar, 1992). 
Whether the ERCC I protein has a function in mammalian repair that is comparable 
to that of uvrC in prokaryotic NER (incision) remains to be elucidated. The four 
residues demonstrated to be essential for incision by UvrC, however, are outside the 
region of homology with ERCCl. In contrast to the ERCCl C-terrninus, the- much 
less conserved - N-terminus is relatively unimportant for its repair function, since 
deletions up to 93 aa do not affect the functionality of the protein in repair of MMC-
and UV-induced lesions (Van Duin, et a!., 1988, J. van den Berg, personal 
communication). 
ERCC2, the human gene correcting cells from rodent group 2, is like ERCCJ 
located at chromosome 19ql3.2, within 250 kb from ERCCJ (Mohrenweiser, et a!., 
1989; Smeets, et al.,\1990). The gene (about 20 kb in length) encodes a protein of760 
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aa (Weber, et aL, 1990). Within the aa sequence, seven consecutive domains are 
present, which are conserved in two families of determined or presumed DNA and 
RNA helicases. The gene is strongly homologous (approximately 50% identity) to the 
yeast RAD3 gene product (Weber, et al., 1990), which is demonstrated to have both 
5' to 3' DNA-DNA (Sung, et al., 1987) and 5' to 3' DNA-RNA helicase activity 
(Bailly, et aL, 1991; Naegeli, et al., 1992). Recently, the ERCC2 gene was shown to 
correct the repair defect of cells from XP complementation group D (Flejter, et al., 
1992). Mutational analysis on the ERCC2 gene might be able to shed light on the 
molecular background of the diverse phenotypes of patients in this complementation 
group. 
A third NER gene, ERCC3, corrects the UV -sensitivity of rodent group 3 cells. 
The gene is located on chromosome 2q2l (Weeda, et al., 1991), and spans a region 
of approximately 45 kb. The predicted protein is similar in size to ERCC2: 782 aa. 
It contains a putative NLS, several acidic regions that might be involved in chromatin 
binding, a postulated DNA binding domain of the helix-tum-helix type, and as in the 
ERCC2 protein, the seven consecutive "helicase domains" (Weeda, et al., 1990b). 
This makes ERCC3 the second - putative - helicase functioning in mammalian NER. 
A yeast homolog has been isolated, designated SSL2 (also RAD25 or ERccn, 
sharing about 50% identity at the aa level (Gulyas and Donahue, 1992; Park, et al., 
1992). The ERCC3 gene appears to be involved in XP-B, a rare XP complementation 
group containing only patients that show the clinical symptoms of both XP and CS 
(Weeda, et al., 1990b). If ERCC3, as its yeast homolog, has a vital function (Gulyas 
and Donahue, 1992; Park, et al., 1992), this might explain the sporadic occurrence 
of patients in the XP-B group. 
ERCC5 has recently been isolated by virtue of its ability to correct rodent cells 
from complementation group 5. The gene is approximately 32 kb, and is assigned to 
chromosome 13q33 (Mudgett and Macinnes, 1990). Further research concerning 
ERCC5 is in progress. 
The experimental work described in this thesis (Chapters III, IV, V, and VI) 
focusses on the isolation and characterization of the human NER gene ERCC6. The 
gene has been isolated after transfection of genomic DNA to a rodent mutant cell line 
of cg 6. The mutant, UV61, is (partially) deficient in the removal of CPD, whereas 
repair of (6-4) photoproducts is seemingly unaffected (Thompson, et al., l988a). 
Lamme! and Hanawalt recently demonstrated that removal of CPD from the 
transcribed strand of an active gene was reduced (Lommel and Hanawalt, 1991). The 
ERCC6 gene is located on human chromosome lOq 11-21, and encodes a predicted 
helicase of 1493 aa. In addition, the predicted aa sequence contains two possible NLS 
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and an acidic region that could, as postulated for the ERCC3 protein, be involved in 
chromatin binding. The gene belongs to a gene family consisting of several presumed 
helicases, demonstrating an extremely high degree of homology between the helicase 
regions (the yeast NER protein RADI6 also is a member of this family, see above). 
ERCC6 appears to be involved in the human syndrome CS-B (so far, the most 
common form of the disease), and thus in preferential repair of active genes. 
Mutations found in the ERCC6 alleles of a CS-B patient suggest that the gene product 
is specific for this subpathway of excision repair and has - possibly in contrast to 
ERCC2 and ERCC3 - no essential function (see Chapter V). 
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The UV-sensitive, nucleotide excision repair-deficient Chinese hamster mutant cell line UV6I was used to 
identify and clone a correcting human gene, ERCC-6. UV61. belonging to rodent complementation group 6, is 
only moderately UV sensitive in comparison with mutant lines in groups 1 to 5. It harbors a deficiency in the 
repair of UV·induced cyclobutane pyrimidine dimers but permits apparently normal repair of (6-4) 
photoproduets. Genomic (BeLa) DNA transfections of UV61 resulted. with a very low efficiency, in six primary 
and four secondar-y UV-resistant transfonna.nts having regained wild·type UV survival. Southern blot analysis 
revealed that five primary and only one secondary transformant retained human sequences. The latter Une was 
used to clone the entire 115-kb human insert. Coinheritance analysis demonstrated that five of the other 
transformants harbored a l()()..kb segment of the cloned human insert. Since it is extremely unlikely that six 
transformants all retain the same stretch of human DNA by coincidence. we conclude that the ERCC-6 gene 
fCSides within this region and probably covers most of it. The large size of the gene explains the extremely low 
tr.tnsfection frequency and makes the gene one of the Largest cloned by genomic DNA transfection. Four 
transformants did not retain the correcting ERCC-6 gene and presumably have reverted to the UV·resistant 
phenotype. One of these appeared to have amplified an endogenous, mutated CHO ERCC-6 allele, indicating 
that the UV61 mutation is leaky and can be overcome by gene amplification. 
To countemct the deleterious consequences of DNA in-
jury, an intricate network of DNA repair systems has 
evolved (for a review of DNA repair in general, see refer· 
ence 10). One of the major, universal repair processes is the 
nucleotide excision repair pathway. which is molecularly 
best defined in Escherichia coli (10. 13. n. 24). This system 
removes a broad category of DNA lesions having a very 
dissimilar structure, such as UV -induced cyclobutane py-
rimidine dimers and (6-4) photoproducts, as well as bulky 
chemical adducts and DNA CfOSs-links. To elucidate the 
molecular mechanism of the mammalian excision repair 
pathwa.y, several nucleotide excision repair-deficient mu-
tants are available. Cell .lines from patients with the human 
hereditary disease xerodenna pigmentosum (XP) are one 
example (for a review. see reference 5). Extensive genetic 
heterogeneity has been demonstrated among XP Patients. 
Cell fusion experiments have identified at least seven exci· 
sion-deficient XP complementation groups (2. 9, 17). In 
addition to XP cells. a set of UV ·sensitive. nucleotide 
excision repair-deficient rodent (mainly Chinese hamster) 
mutant cell lines have been generated in the laboratory. 
Eight genetic complementation groups have been described 
(32. 37, 45~ for recent reviews. see references 3. 6. and 30). 
The cell fusion experiments perfonned between some of the 
CHO mutants and XP fibroblasts did not reveal any overlap 
between these two classes of repair mutants (28. 35). This 
suggests that a considerable biochemical complexity under· 
lies the nucleotide excision repair process in mammalian 
~Corresponding author. 
cells. for which the molecular mechanism is largely un-
known. 
CHO mutants of various complementation groups have 
been successfully used to isolate the correcting human 
ERCC (excision repair cross-complementing rodent repair 
deficiency) genes, ERCC-1. ERCC-2. and ERCC-3, comple-
menting the excision defects of mutants of groups 1 (44), 2 
(41). and 3 (43), respectively. The first five groups display a 
similar. high degree ofUV sensitivity and are deficient in the 
incision step of the excision repair process (31-33). In 
contrnst, the two mutants making up group 6. CHO mutant 
UV61 (3) and mouse lymphoma mutant US46 (27. 37). are 
only moderately sensitive to UV exposure. and UV61 is 
partially deficient in the incision of damaged DNA (27, 36). 
Funhermore. mutant UV61 is remarkable in harboring a 
specific deficiency in the repair of cyclobutane pyrimidine 
dimers and bulky chemical adducts, but permitting appar-
ently normal repair of (6-4) photoproducts (34). This pheno-
type suggests that the gene product affected in this mutant is 
involved in the repair of cyclobutane dimers and bulky 
adducts but not in the repair of (6-4) lesions. Alternatively. 
it is possible that the mutation in the UV61 protein alters the 
affinity of the repair complex for different types of damage. 
The alteration would then be such that the rate of removal of 
cyclobutane dimers and bulky adducts was notably dimin-
ished, whereas repair of (6-4) photoproducts was not signif· 
icantly affected. In both hYPOtheses the UV61 (ERCC-6) 
polypeptide plays an important role in repair of specific 
types of DNA injury. 
To obtain insight into the function of this particular protein 
in the DNA excision repair process. we have cloned and 
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partially characterized the human gene correcting the muta-
tion in UV61. 
MATElUALS AJI<'D METHODS 
Cell culture. The CHO mutant cell line UV61 used in this 
study was isolated by Busch et al. (3) and assigned to 
complementation group 6 (36). Its repair-competent, paren-
tal cell line is the CHOline AA8 (3). All cells were grown in 
1:1 F10-Dulbecco minimal essential medium supplemented 
with antibiotics and 8% fetal calf serum. 
DNA transfeetion. High-molecular-size HeLa DNA {ca. 
200 to 300 kb). isolated as described previously (16), was 
either partially cleaved to an ;:,.verage fragment size of 50 to 
60 kb and ligated tO :J dominant marker molecule before 
transfection or directly used for cotr..msfection with a dom-
inant marker. For transfection of ligated DNA. HeLa DNA 
partially digested with Pstl or Mbol was ligated to ?sri-
digested pSV3gptH (44) or BamHI·digested pMCS (14). 
respectively, in a molar ratio of 1:3, by using T4 DNA ligase 
(GlBCO/Bethesda Research Laboratories. Gaithersburg. 
Md.). Ligations were tested on agarose gels. 
For transfections. 5 X lOs UV61 cells were seeded in 
100-mm Petri dishes 1 day before DNA transfection. The 
high-molecular-size DNA. together with one of the two 
domin;:,.nt marker molecules mentioned. was transfected into 
UV61 cells by a modification of the calcium phosphate 
precipitation technique of Graham and Van der Eb (12). A 
20-~J..g sample of DNA (20 IJ..S of ligated DNA or 15 ~J,.g of 
BeLa DNA plus 5 ~J,.g of circular pSV3gptH DNA) was 
applied to each petri dish. Following a 16-h exposure to the 
DNA. cells were treated for 30 min with 10% dimethyl 
sulfoxide and grown for 24 h on nonselective medium to 
allow expression of the transfected marker. Thereafter. the 
medium was changed to selective medium. When selecting 
for expression of the pMCS dominant marker. G418 {GIBCO 
Ltd .• Paisley, Scotland) was added to the F10-Dulbecco 
minimal essential medium described above (concentration. 
750 IJ,.g/ml during the first 3 days of selection a.nd 800 !J..g/ml 
thereafter). Selection for pSV3gptH was done by adding 
aminopterin (0.2 f.l.g/ml). thymldine (5 !J..g/ml), xanthine (10 
!J..g/ml), hypox::mthine (15 ~J,.g/ml). mycophenolic acid (20 
!J..g/ml), and deoxycytidine (2.3 )J.fdml) to FlO-Dulbecco 
minimal essential medium. The selection medium was re-
freshed every 3 to 4 days. 
The same procedure was followed for secondary tr.:Lnsfec· 
tions. DNA of a primary transformant (PT) was used with or 
without addition of dominant m:u-ker pRSVneo (ll) (20 f.l.g of 
PT DNA plus 2 ).l.g of pRSVneo in cotransfection). 
UV selection and UV surviv.al. After the appearance of 
G418- or mycophenolic acid-resistant colonies (within 10 to 
12 days after tr.msfection), the cells were trypsinized. UV 
selection was started 16 to 20 h after trypsiniZation. Cells 
were exposed three times to 8.4 Jim~ (Philips TUV low· 
pressure mercury tube. 15 W. 0.6 J/m~/s; predominantly 254 
nm), with 24-h intervals. UV-resisbnt colonies were iso-
lated. grown in selective medium, and characterized with 
respect to UV resisbnce and human DNA content by 
Southern blot hybridization. 
For determina.tion of UV sensitivity. cells were plated at 
densities varying from 2 x 10: to 2 x 104 cells per 60-mm 
petri dish. depending on the cell line and the UV dose. Cells 
were irradiated 1 day after plating. A series of dishes was 
irradiated for each cell line. each dish receiving a single dose 
(three dishes per UV dose). Clones were counted 6 to 7 days 
after UV irradiation, and relative cloning efficiencies were 
determined. 
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TABLE 1. Repair charncteristics of mutant UV61 
Sensitivity to DNA-damaging agents" 
Result for 
UV61" 
UV.............. ............................ . ..... ca. 2.7x< 
7-BrMcBA"'....... . ........ ca.. 3xc 
Rate of incision ... ....... .. ...... ... .... .... .. .. .. .. ... . .. .Normal,. 
Removal of (6-4) photoproducts ....... . .............. Normal 
Removal of d.imers ................................................... Deficient 
Removal of bulky adducts .......................... . ... Defieient 
UDS' •.• •.•.••••••.•.••••••..•..•.•••• . ...• ca. 709</ 
UV-induced mutagenesis...... . ..... ca. Sx' 
Postreplication recovery. . .......... Normal 
a Data from refen:nec 33. 
bAtDw 
' Comp:m:d wlth thnt of the wild type. 
"'7-BrMeBA, 7-Brom<.>mcthylbenz(a)nnthrncene. 
~ Meo..,ured fin;! at~ h W:ter UV irradi:l.t;on. 
f Own unpublished results. 
Southern bJot hybridization. Digestion of DNA with re· 
striction enzymes. gel electrOphoresis, and hybridizations 
were performed by using routine procedures as described by 
Maniatis et al. (19). Southern blotting to Zeta probe blotting 
membranes (Bio-Rad. Richmond. Calif.) was performed by 
using alkaline transfer (22). as described by the manufac-
turec. 
Library construction and screenin~;. High~molecular-size 
DNA was partially digested with Mboi and size fractionated 
on a sucrose gradient. The 15· to 25-kb fraction was ligated 
to the BamHI sites of lambda EMBL-3 phage arms (Strata· 
gene. La Jolla. Calif.). packaged as described previously 
(25), and then used to infect E. coli LE392 cells. A total of 3 
x 106 phage were plated. and replica filters were prepared as 
described previously (19). 
The filters were hybridized with rn.dioactively labeled 
hum::m Cot-1 DNA. Hybridizing plaques were pl:lted again 
for a second round of screening. Single plaques were grown 
in liquid culture. and DNA w::ts purified ::..s described previ-
ously (19). 
Overlapping phages were identified by using restriction 
enzyme site mapping and the restriction fingerprinting tech-
nique as described by Coulson et ;:,.1. '(7). Enzymes used in 
the latter procedure were Sau3A and Hindlll. 
RESULTS 
Generation of repair-proficient PTs. The main characteris-
tics of mutant UV61 are summarized in Table l. In view of 
the moderate UV sensitivity of UV61 cells. it was necessary 
to develop an o:;>timal selection protocol for repair-proficient 
tro.nsformants. In reconstruction experiments wild-type and 
UV61 cells were mixed in various ratios and different 
selection protocols were tested. The deduced UV selection 
procedure is described in Materials .and Methods. 
Two strategies were followed simultaneously to generate 
PTs. One approach. transfection of ligated DNA (partially 
digested BeLa DNA ligated in vitro to dominant marker 
molecules). increases the chance that a domlnant marker 
copy is near the repair gene. This permits secondary tranS· 
fection of the gene linked to a dominant marker copy Md 
facilitates gene identification and cloning. The cotransfec-
tion. on the other hand. is more efficient for large genes. 
Transfection of ligated DNA to more than 3.6 x lot' cells 
resulted in two PTs that survived the UV selection {PT-3 Md 
PT-4). Cotransfection of high-molecular~size BeLa DNA 
TROELSTRA ET AL. 
TABLE 2. Transfcetion efficiencies of UV-resistant 
PTs and srs of UV61 
No. of Tnnsfection Tmnsfection Approach~ UV' trans-
efficiency" forman~b 
Primary Ligation 2 (0) 1:150,000 
Prim"'Y Cot:ransfection 4(4) 1:100.000 (1:100,000) 
Secondary Linking 0 (0) 
Secondary Cot:ransfecrion 4 (2) 1:20.000 (1:40.000) 
~ For a detailed des<;ription of procedures. see Materials and MethoW;. 
b Number of UV ·resistant, dominant marker-containing trans!ormants iso-
lated; the number afto:r $Ubtraction of reverttlllts is given in parentlteses. 
~ Transfe<::tion clliciencies g~ven as UV-resistant trans!onnants per domi· 
nant marker-expres$ing tr:~m;formant.. Effieiencie& after correction for tlte 
presence of revertants are given in parentheses. 
and pSV3gptH yielded four PTs (PT-1. PT-2, PT-5, and 
PT -6) in experiments involving 6 x 10M UV61 cells. The 
transfection frequencies (i.e .. number of UV-surviving 
transformants per dominant marker-containing transfor-
mants) were extremely low (Table 2). 
Cb.aracterization of PTs. To assess the degree of repair 
proficiency of the transformants, we· determined their UV 
survival. PT-1 had regained wild-tyPe (AA8) UV resistance. 
and the other PTs were in the wild-type range too (Fig. 1}. 
The PTs were analyzed for the presence of human se-
quences by using human Cot-1 DNA or a cloned human Alu 
repeat (8) as probes. As expected for PTs. Southern blot 
analysis (Fig. 2) revealed the presence of considerable 
amounts of human DNA in PT-1, PT-2. PT-3.PT-5, and PT-6 
(results for PT-5 and PT -6 not shown). Surprisingly. PT -4 did 
not contain any detectable human sequences. This could 
mean that PT -4 does not contain a human gene. but is in fact 
a dominant marker-containing revertant. In view of the large 
scale of the genomic DNA transfections, this possibility 
cannot be ruled out. 
0., 
' 
' 
' 
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FIG. 1. UV survival curves of wild-type cell line AA8 (0). 
mutant UV61 (C). and UV61 transformants PT-1 (OJ and ST-1 (A). 
D!l/, 
.... 
C~T-) 
[oo'-1 
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FIG. ::?.. Southern blot analysis of Pstl- (left} or EcoRI (right)-
digested DNA (::?.0 IJ.g) from mutant UV61 and from UV61 PTs and 
STs after hybridization with nP-Iabeled human Cot-1 DNA as the 
probe. 62-56 {lane 9, left panell is a secondary transfommnt ofCHO 
mutant 27-l.containingthe humanERCC-3 gene {43), and served as 
a positive control. 
In our selection protocol each petri dish with colonies of 
dominant marker-containing UV61 transformants (>100 
cells per colony) was trypsinized prior to UV irradiation. 
When a transformant colony stably retains the correcting 
human ERCC-6 gene. one expects that respreading the cells 
will result in many (>10 to 50) UV-resistant clones. assum-
ing normal cloning efficiency and growth rate. For a rever-
tant arising during dominant marker selection or, more 
likely. during UV selection. this number is expected to be 
much smaller. Table 3 summarizes our findings with respect 
to the number ofUV -resistant clones after trypsinization and 
UV irradiation. It is striking that PT-4 falls in the second 
class (i.e., only one or a few UV-surviving colonies). This 
funher suggests that PT -4 is a UV -resistant revertant. 
Generation of repair-proficient STs. In secondary transfec-
tion experiments with DNA of PTs without addition of extra 
dominant-marker molecules. no clones with combined MP A 
and UV resistance or G418 and UV resistance were isolated 
from a total of about 9 x 108 transfected UV61 cells. This 
TABLE 3. Ch=cteristics of UV-resist:.mt transfonnants 
ofUV61 
Transfonnant No. ofUV' Presence of 
clones/dish human DNA 
PT-1 10-50 ++ 
PT-2 <3 ++++ 
PT-3 10-50 ++ 
PT-4 <3 
PT-5 10-50 ++ 
PT-0 10-50 ++++ 
ST-1 10-50 + 
sr-:za. <3 
Sf-2b <3 
ST·5 5-10 
'"The minus ~•gn indiC.?.tes that no human DNA is detectable on Southern 
blots. with humao repeat (Cot·l. Alu) as the probe. 
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FIG. 3. Physical map of the human insen cloned from ST-1. FroE:tDents of <300 bp have not been mapped. lndicated below the map are 
various overlapping lambd:. clones i~olated from the library by screening with hum:m Cot-1 DNA {for the sake of simplicity, only part of the 
lambda clones isol:ued and mapped are indicated). Symbols: ~.repeat-containing fragments: J.. EcoRI; B. Bam HI; S. Sail:-. human insen; 
-. flanking UV61 DNA: - - -, phages isolated ;rlter chromosomal walking. 
result suggests that the distance between an integrated 
dominant-marker copy and the human gene conferring UV 
resistance, in the DNA of the PTs tested, is too large to be 
transferred simultaneously. Therefore. new dominant-
marker molecules (pRSVneo) were added to PT DNAs for 
subsequent secondary transfection. This approach yielded 
four UV-resistant secondary transformants (STs) (after 
transfection of 4.0 x 10~ UV61 cells). designated ST-L 
ST-2a, ST-2b, and ST-5 (the numbers refer to the parental 
PTs: ST-2a and ST-2b were isolated from two independent 
dishes in one experiment with PT-2 as the donor DNA). 
Again. transfection efficiencies were very low (Table 2). 
Characterization of STs. The UV survival of all STs was 
determined. ST-1 wn.s corrected up to wild-type (AA8) and 
PT-1 UV resistance (Fig. 1). Similar results were obtained 
for the other STs. 
Southern blot analysis with human Cot-1 DNA as the 
probe reve::Ued the presence of human sequences only in the 
DNA of ST-1 (Fig. 2). For ST-2a and ST-2b (and ST-5 [not 
shown]) we were unable to detect any human repetitive 
DNA. 
The absence of detectable human DNA in three of the four 
STs and in PT-4 can be explained in several ways. The 
transfected repair gene may contain two few repetitive 
sequences to be visualized by Southern blot hybridization 
with human Cot-1 DNA as the probe. Alternatively, the 
three empty STs (ST-2a, ST·2b. and ST-5) may simply be 
dominant marker-containing revenants. Two of these three 
STs (ST-2a and ST-2b) were from dishes with one or a few 
UV-resistant clones after trypsinization and UV selection 
(Table 3), as was PT-4 (see above). These results further 
suggest that ST-2a and ST-2b may be revertants. 
Molecular cloning of the human insert. ST-1. which con-
tains detectable human material, is from a dish w1th multiple 
UV-resistant clones after trypsinization and UV selection. 
Furthermore. ST-1 is derived from aPT (PT-1). also belong-
ing to this category (Table 3). This information suggests that 
ST-1 is a bona fide transformant. Therefore. ST-1 DNA was 
chosen to construct a genomic library in lambda EMBL-3. 
The library (2.5 x 106 plaques: total complexity. 16 times the 
haploid genome) was screened with human Cot-1 DNA as 
the probe. Two hundred plaques containing human DNA 
sequences were identified; after a second round of screening 
pure cultures were grown from 50 plaques. DNA of these 
lambda recombinants was isolated and characterized by 
restriction mapping. The human n.nd hamster parts were 
identified by hybridization with species·specific repeat 
probes. 
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Overlapping lambda clones were identified as described in 
Materials and Methods. A restriction site ma.p of the inserts 
resulted in the identification of two nonoverlapping seg-
ments. Both segments harbored UV61 sequences at one end. 
Chromosomal walking was performed by using unique se-
quences from the human termini of both segments. Subse-
quently. phages were isolated that joined all contipwus 
parts. yielding a human insert with a total size of approxi-
mately 115 kb. A physical map is shown in Fig. 3. The 
phages isolated via chromosomal walking are indicatea. 
These cover a part which contains very few repetitive 
sequences. explaining why these lambda recombinants had 
escaped detection in the first Cot-1 screening. In fact. the 
cloned region overall has relatively few repeats (Fig. 3). 
Coinheritance analysis of independent transformants. A 
systematic se:a:ch for coinheritn.nce of the same human DNA 
segment in independent UV61 transformants was per-
formed. This search was based on the notion that the human 
gene specificolly conferring UV resistance to UV61 should 
be present in each genuine trn.nsfonnant. To this aim. 14 
unique probes spread over the entire cloned human region 
were isolated and hybridized to genomic DNA digests of all 
UV-resistant PTs and STs obtained. The results are shown 
in Fig. 4A and summarized in Fig. 4B. Probe IV. for 
instance. does recognize the expected 6.4-kb EcoRl frag-
ment in ST-1. from which the library was made. In addition. 
it hybridizes to a band of the same size in PT-1. PT-2. PT-5, 
PT-6, ST-5. and HeLa DNA. PT-3. PT-4. ST-2::1., and ST-2b 
do not contain this human fragment. The s:une holds true for 
probes III through XIV. with the exception of probe VIII 
(Fig. 4). This indicates that the same contiguous region of at 
least 100 kb is present in 6 of 10 UV61 transformants. 
Probes I and il are near the left UV61 border in ST-1 (Fig. 
4). Probe I recognizes a rearranged EcoRI fragment in DNA 
of ST-1 compared with HeLa DNA. or. in the case ofPT<?.. 
PT-6, and ST-5. no fragment at all (Fig. 4). Probe il 
recognizes a 1.8-kb EcoRl fragment in ST-1 DNA. as in 
HeLa DNA; a rearranged fragment is detected in PT-2 (F1g. 
4B). At the right-hand end the DNA of ST-1 is the first to 
diverge from the human genomic sequence and that of the 
other transfonn:uns (Fig. 4B). From these results. we de-
duce that the length of the human segment common tO all 
transformants is approximately 100 kb. 
The signals in the laneS with PT-1 and ST-1 are stronger 
than those in the other lanes (Fig. 4A and 5). Because both 
probe VII (Fig. 4A) and probe XV (Fig. 5) weakly cross-
hybridize with hamster sequences, the endogenous bands 
(2.5 kb for probe VII in Fig. 4A [arrowhead]: the lower two 
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FIG. 4. Coinheritance analysis of ::ill tronsfonnants for the retention of human sequences present in ST-L (A) The same Southern blot of 
EcoRI-digested DNA from all primary and secondary UV61 transfonnants, mutant UV61, and HeL:l. cells w:c; hybridized with different 
probes from the human region present in ST-1. Probes arc indicated below the map in panel B. (B) Summary of coinheritance analysis. 
Symbols: +. same fragment hybridizing as in HeL:l. DNA; -. no fragment hybridizing; r, hybridizing fragment re:.ur.mged compared with 
HeL:l. DNA; +'\endogenous UV61 fragment hybridixing more strOngly than in other transfonnants and UV61; ND, not determined. See the 
legend to Fig. 3 for explanations of other symbols. 
hybridizing bands for probe XV in Fig. 5) serve as a 
convenient internal control for the amount of DNA loaded. 
Apparently, both PT-1 and ST-1 have a 5~ to 10-.fold ampli-
fication of the transfected. human region. 
The amplification of this region in ST-1 is probably the 
reason that we were able to detect it by using human Cot-1 
DNA as the probe on Southern blots of genomic DNA. ST-5, 
on the other hand, has only one copy {Fig. 4A and 5), which 
w:15 not visible on our blots. Since this region cont:l.ins 
relatively few repeats, the Southern blot hybridizations were 
clearly not sensitive enough to detect it as a single copy. 
Presence of UV6I revertants. The coinheritance analysis 
revealed thatPT-3, PT-4, ST-2a. and ST-2b all lack the entire 
human locus (Fig. 4B). which strongly suggests that these 
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FIG. 5. Southern blot an.a.lysis of Hindill-<ligestc:d DNA (20 14g) 
from HeLa cells, mutant UV61, and all. PTs and STs with 32P-Jabeled 
unique sequences from the region between probes Vll and Vlli on 
the map in Fig. 4B (probe XV). 
are revenants. This agrees well with the fact that three of 
them (PT-4, ST-2a. and ST-2b) lack detectable human se-
quences (Fig. 2) and originated from a dish with a small 
number of UV-resistant clones after UV selection (Table 3). 
(One additional transformant, PT-2. also yielded a small 
number ofUV-resistant clones, but nevertheless appeared to 
contain the common human segment (compare Table 3 and 
Fig. 4). This may be explained by initial instability of the 
transfected sequences. low cloning efficiency, and/or slow 
growth of this transformant.) 
Various human genomic probes contained conserved se-
quences and cross-hybridized under normal stringency to 
Chinese hamster genomic sequences representing the ham· 
ster ERCC-6 homolog (for example, probe VII in Fig. 4A 
[arrowhead} and probe XV in Fig. 5). The cross-hybridiza-
tion to Chinese hamster DNA in the lane ofPT-3 is consid-
erably stronger than that in the other lanes, irrespective of 
the probe or digest. This indicates thatPT-3 has amplified an 
endogenous. mutated allele at the CHO ERCC-6 locus. 
DISCUSSION 
The evidence that we have indeed cloned ERCC-6 is based 
on the coinheritance analysis of independent transformants 
for the retention of human sequences present in ST-1. This 
study showed that six transfonnants harbored the same 
human segment of 100 kb. The chance that this is due to 
coincidence is extremely small. When one assumes that 
every transformant integrates on the average 104 kb of 
exogenous sequences. as we have shown for several CHO 
lines (15). the likelihood that four independent PTs contain 
the same human fragment by coincidence is approximately 
10-10• Taking into account that two STs also possessed this 
region. this chance becomes vanishingly small. Two addi-
tional findings also strengthen the significance of the corre-
lation between the cloned human integrate and the repair-
proficient phenotype of the UV61 transformants: (i) the 
exceptionally large size of the common genomic fragment for 
transfection experiments and (ii) the observation that one of 
the transformants (PT-3) appeared to have amplified the 
CHO sequence cross-hybridizing to the human integrate. 
Although the gene is spread over too many lambda recom-
binants to permit direct transfection (of pooled clones) to 
UV61 cells. we conclude, on the basis of the arguments 
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FIG. 6. Relationship between primary transfection efficiencies 
and gene size of ERCC-1. ERCC-3, and ERCC~. Trnnsfection 
efficiency is given as UV-rcsistant tronsformants per dominant 
marker-containing transformants. For ERCC·l. ligated genomic 
DNA (50 to 60 kb in size) was used. 
summarized above. that ERCC-6 must be retained on the 
100-kb common region. Hence this gene was cloned notwith-
standing the moderate sensitivity of the mutant to UV, the 
extremely low transfection frequency. the low content of 
repetitive elements in the gene. and the occurrence of 
revertants. 
The ERCC-6 gene probably spans most of the cloned 
common area because during transfection double-strand 
breaks have been shown to occur on the average every 5 to 
15 kb in various cell lines (15). Preliminary mapping of 
panial ERCC-6 eDNA clones on the isolated genomic region 
confirms this proposition. A eDNA clone representing ap-
proximately 75% of the smallest ERCC-6 mRNA already 
covers 80 kb of the cloned locus. As far as we know. 
ERCC-6 is the largest gene to be cloned by using the genomic 
transfection approach. The frequent occurrence of double-
strand breaks in transfected DNA molecules during the 
transformation process (15) strongly selects against large 
genes. This observation -provides a reasonable explanation 
for the extremely low transfection efficiency encountered in 
the cloning of ERCC-6 (Table 2). which is even more 
pronounced when we correct for the revenants among the 
UV61 transformants isolated. The transfection frequency 
(primary cotransfections) for ERCC-6 is 1 in 100.000 domi-
nant marker-containing UV61 transfonru:tnts. This is 40-fold 
lower than the frequency of ERCC-1 transfonnants (44) 
(gene size. 15 to 17 kb [39]) and 7-fold below that of the 
ERCC-3 gene (approximate size. 45 kb [43}). These genes 
were isolated by us under comparable conditions. Hence a 
relationship exists between gene size and transfection fre-
quency in the CHO lines used for these experiments (Fig. 6). 
An interesting aspect concerns the identification of rever-
tants. The occurrence of revertants has been described 
before in attempts to clone other repair genes (see. e.g .• 
references 1, 4. 18, 23, and 26). For two simian virus 
40-transformed fibroblasts isolated from XP patients and 
belonging to complementation group A. which have been 
used extensively as recipients for genomic DNA transfec-
tions. the recovery of partial and complete revertants.has 
been reported by several groups (1. 23). One partial rever-
tant has been characterized in detail and found to be profi-
cient in (6-4) photoproduct excision, but affected in dimer 
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removal (4), a remarkable phenotype that resembles UV61 
and a Chinese hamster mutant. VH-1. belonging to comple-
mentation group 2 (20. 46). The frequency of revenants 
seems to be enhanced when long-lasting UV s-election pro-
tocols are used. This is one of the reasons why we have tried 
to minimize the number of UV exposures of UV61. 
In none of the instances mentioned above has the nature of 
reversion been elucidated. The analysis ofPT-3 in this study 
revealed that amplification of an endogenous. mutated Chi-
nese hamster ERCC-6 allele underlies the acquired UV 
resistance in this UV61 revenant. We have found recently 
that the amplification is also reflected at the mR..t"'A level. 
These data suggest that the mutation in UV61 is leaky and 
that its effect can be overcome by increasing the copy 
number of the gene and mRNA. thereby raising the amount 
of (partly functional) gene product. This explanation would 
be compatible with a model in which the affinity of the 
ERCC-6 protein for dimer lesions is lowered by the UV61 
mutation and can be compens:ned for by larger quantities of 
the defective polypeptide. The molecular basis of the rever-
sion in the other three UV61 revertants is unknown. but 
must involve other mechanisms than gene amplification. 
ERCC-6 is the fourth of a set of human repair genes that 
have been cloned by using UV -sensitive. laboratory-induced 
CHO mutants. One of the most interesting features to 
emerge from the analysis of these genes is their high inter-
species sequence conservation. The ERCC-1 protein is ho-
mologous to the yeast RADIO excision repair gene product 
and to parts of the£. coli UvrA :llld UvrC proteins (38. 40). 
The protein encoded by the ERCC-2 gene. cloned by Weber 
et aL (41). possesses a high level of identity with the yeast 
RAD3 protein (42), which was shown by Sung et al. to 
specify a 5'-to-3' DNA helicase (29). Finally. the ERCC-3 
gene also is very strongly conserved, and a homologous 
yeast gene has been identified (M. H. M. Koken. G. Weeda. 
and J. H. J. Hoeijmakers. unpublished data). This gene was 
recently found to be involved in the human repair diseases 
XP and Cockayne's syndrome (G. Weeda. R. C. A. van 
Ham, W. Venneulen. D. Bootsma. A. J. van der Eb. and J. 
H. J. Hoeijmakers. Cell. in press). Future analysis of 
ERCC-6 should reveal the level of sequence conservation of 
this gene. its specific role in d.imer repair, and whether it is 
implicated in one of the human repair disorders. 
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We have cloned the human DNA excision repair gene 
ERCC6 by virtue oi' its ability to correct the uv sensitivity of 
Chinese hamster ovary cell muta.nt UV61. This muta.nt is a 
member of complementntion group 6 of the nucleotide e:s:ci· 
sion repai:r~deficient rodent muta.nts. By means of in situ hy· 
bridization and Southern blot anulysis of mouse X humnn SO· 
matic cell hybrids, the gene was localized to human chromo· 
some 1 Oqll-<~,21. An RFLP detected within the ERCC6 locus 
can be helpful in linkage anulysis. •O ul\Y.!: ~~· ~>r-. .u. •• 
INTRODUCTION 
To protect DNA from deleterious accumulation of 
damage and permanent mutations, an intricate network 
of DNA repair systems has evolved (reviewed by Fried· 
berg, 1985). One of the major DNA repair processes is 
the nucleotide excision repair pathway. This system re· 
moves a broad range ofDNAlesions, such as uv-induced 
cyclobutane pyrimidine dimers and (k) photoprod· 
ucts, bulky chemical adducts, and DNA crosslinks. 
Two human genetic diseases in which the excision re· 
pair mechanism is defective are known: xeroderma pig-
mentosum (XP) and Cockayne syndrome (CS). The au· 
tosomal, recessive disorder XP is clinically character-
ized by extreme sensitivity of the skin to sunlight {uv). 
pigmentation abnormalities. predisposition to skin 
cancer. and frequently neurological complications 
(Cleaver and Kraemer, 1989). Cell fusion experiments 
have identified at least seven excision-deficient XP 
complementation groups (De Weerd-Kastelein et aL, 
1972: Vermeulen et aL, 1991. and references therein). CS 
patients exhibit sun sensitivity, dwarfism, microceph-
aly, wizened appearance, deafness, and severe mental 
retardation. CS is. unlike XP, not associated with an 
1 Present address: Depnrtmentoflnterno.l Medicine. AZU. Utre<::ht. 
The Netherlands. 
"To whom correspondence should be addressed. 
elevated risk for skin tumor formation (reviewed by 
Lehmann. 1987). Recently. CS cells were found to be 
disturbed in a subpathway of the nucleotide excision re-
pair: the preferential repair of actively transcribed genes 
(Venema et aL. 1990). Also. CS is genetically heteroge-
neous; at least three complementation groups have been 
identified (Lehmann. 1982). 
A second class of mammalian excision repair-defi-
cient cell lines consists of laboratory-induced, uv~sensi· 
tive, rodent cell lines. Eight complementation groups 
have been identified (reviewed by Collins and .Johnson, 
1987: Busch et aL, 1989). So far, only one overlap be-
tween these two classes has been detected: the gene 
correcting XP complementation group B is identical to 
the gene correcting complementation group 3 of the ro-
dent mutant cell lines (Weed.a et aL, 1990). 
Recently. we have cloned the human ERCC6 gene (ex-
cision repair cross complementing rodent repair defi· 
ciency). This gene is capable of correcting a uv-sensitive 
CHO mutant belonging to group 6: UV61 (Troelstra et 
aL, 1990). Mutant UV61 is remarkable in harboring a 
specific deficiency in the repair of cyclobutane pyrimi· 
dine dimers and buLlcy chemical adducts, but permitting 
apparently normal repair of (6-4) photoproducts 
(Thompson et aL. 1988). This suggests that the gene 
product affected in UV61 is, directly or indirectly, in· 
volved in damage recognition. Whether ERCC6 is impli-
cated in one of the XP or CS complementation groups 
remains to be elucidated. 
Here we report the chromosomal localization of the 
ERCC6 gene by in situ hybridization with biotinylated 
eDNA probes and Southern blot hybridization of 
ERCC6 probes to DNA of somatic cell hybrids. Further-
more, an RFLP that can be used for linkage analysis has 
been identified within the ERCC6 locus. 
MATERIALS AND METHODS 
In. situ hybridi:;a.til:m. Treatment of human lymphocyte metaphase 
spreads prior to hybridization was as des<:ribed by W ecda. i't aL ( 1991). 
088$.-7543/92 $3.00 
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FIG. 1. Re~triction mnp of th<J human ERCCS locus. The eDNA probe used for in. sicu hybridizv.tionR und tho;- :;enomic probo;- VII (~""" 
Troolstrn ec aL, 1990) used on Southern blots are shown. Exon contnini.n~ frar::ments r~or::nizo;-d. by the eDNA probe are indicated. Shon bun; 
repreao;.>nt EcoRl restriction site><. SymboL'<: B, BamHI; S, Sell; *, repo;.>at contuiniDI': fro.pno;.>nt:; VII, ~nomic probe VII. 
In sicu hybridizv.tion experiments using the ERCC6 eDNA frnf:Illent 
shown in Fig. 1 or cDNAs extending more 5', a chromosome 8-Rpeci.fic 
m.urker (thyroglobulin ~n<J}, and the co;.>ntrom~-~pecific mark<-r 
Dl0Z1 as biotin-l.nbded probes wo;.>re performed 1m descnOed elsewhere 
(Pinkel et aL. 1986). Both probe and target DNA were denatured at 
sooc for 5 min. Hybridization was 16 b at37°C in 50% fonna.mide, 2x 
SSC. 40 mM sodium phosphate {pH 7.0). 10% dextran sulfate, 100 ng 
sonicated salmon sperm DNA, 100 nt: yo;-ast tRNA. and 20 ng !a.OOled 
probe. The slides were wnshl'd with 50% formamide, 2X SSC,pH 7,nt 
45°C followtld by 4X SSC p!UB 0.05% Tween 20 nt room temperature. 
Slides were incubated with 5 "'g/ml nvidin D-FITC (Vector. U.S.A.), 
and the fluorem:ent signal was IUJlplifi<-d with biotinylnted gent anti-
avidin D. washed, dehycirnted with c-thnnol, and air-dried. The ali de~ 
were either counterstnined with propidi um iodlde in antifade medium 
or banded with 4',6'-dia.m.i.d.ino-2-phenylindole (DAPI) and actinomy-
cin D. 
CeU /i:n,es. Somatic cell hybrids CYlS and CYS are mouse--bu= 
hybrid cell lines containing a single human chromosome 16 and a der 
10t(l0;16)(q26;q22) translocation chromosome-, respectiwly, as their 
only human mnterial (Callen, 1986). The original mouse C<"ll]ine used 
for fusion was GM346A. a HPRT- nnd APRT-deficient moWie L·cell. 
Southern. b!Qt analysis. Digestion of DNA with the indicated re-
striction enzymes, ~:el i.'\ectrophoresis, labeling of DNA probes, and 
hybridizv.tions were performl'd ll>ling routine procl'dures as described 
(Mn.niatis et aL, 1982). Southern blotting to Zeta probe blotting me-m-
branes was performed by a..lkoline transfer, as described by the manu· 
facturer (Bio-Rad.. Richmond, CAl. 
RESULTS 
In Situ Hybridization 
To map the ERCC6 locus, in situ hybridization was 
carried out using biotinylated ERCC6 eDNA probes. 
The 3.6-kb probe (Fig. 1) represents the 3' half of the 
smallest of the twoERCC6transcripts ofabout5 and 7.5 
kb detectable on Northern blots (unpublished results). 
This 3.6-kb eDNA fragment covers 75 kb of the ERCC6 
locus. Also, longer eDNA probes. extending more 5', 
have been used in in situ hybridizations. Two representa-
tive in situ hybridizations are shown in Fig. 2. Although 
the chromosome banding is not as detailed as that in a 
routine G-banding procedure, the hybridizing chromo-
some can be identified as human chromoSome 8 or 10. in 
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the area close to the centromere. In situ hybridization. 
simultaneously using the ERCC6 eDNA probe and a 
probe specific for either chromosome 8 (a single-copy 
probe from the thyroglobulin gene) or chromosome 10 
(an alpha satellite DNA probe. D10Zl). clearly demon-
strated the ERCC6 locus to be on chromosome 10qll-
q21 (results not shown). 
Hybridization to DNA from Somatic Cell Hybrids 
To confirm the assignment of the ERCC6 gene to 
chromosome 10, two human X mouse somatic cell hy-
brids (CYS and CY18) were used. Hybrid CYS contains 
almost the complete chromosome 10 and part of chro-
mosome 16 as the only human chromosomes; in hybrid 
CY18 only human chromosome 16 is present (Callen. 
1986). The probe used in these e:xperim.ents was a unique 
2.2-kb human genomic DNA fragment (probe VII. see 
Fig. 1) that recognizes a Taqi fragment of 3.2 kb in He La 
DNA (Fig. 3). In DNAs of both hybrids and mouse cells, 
a cross-hybridizing fragment (4.3 kb) from the mouse 
ERCC6 homo1ogue is detected. indicating that the probe 
contains a conserved sequence. In CY5 the human 
ERCC6 Taqi fragment (3.2 kb) is present (Fig. 3). In 
hybrid CY18 no human fragment is detected. meaning 
that the ERCC6 locus segregates with human chromo-
some 10. completely in accordance with the results from 
the in situ hybridization. 
Restriction Fragment Length Polymorphism in the 
ERCC6Gene 
The genetic defect in multiple endocrine neoplasia 
type 2 (MEN2) has been mapped to the pericentromeric 
region of chromosome 10 (Mathew et aL, 1987: Simpson 
etaL, 1987: Narum et aL. 1990; Wu etaL, 1990: Lairmore 
et aL, 1991). The ERCC6 gene might therefore reside in 
the vicinity of the MEN2 locus. This prompted us to 
look for RFLPs within the ERCC6 region. DNAs of 30 
MA.PPINC OF THE HUMAN DNA EXCISION REPAIR G&"ffi ERCC6 
FIG. 2. Loculization of ERCC6 by in situ hybridization. (A. CJ Knryotypes ofbuma.n lymphocyte metaphase spreo.ds, stained with DAPI; 
nnowheuds indicate chromosome 10. (B. D) Pbotog:raph.s showing the correspondin.,; fluorescent in. situ. hybridimtion with the human ERCC6 
eDNA frll.glllent Ill\ a probe. Arrowheads indico.te the ftuorescent label on chromosome 10. 
unrelated European Caucasians were digested with 
Bani.Bglii, EcoRI, Hind!II. Mspi. Psti, Taqi. andXbal. 
Southern blots were hybridized to various ERCC6 
probes and checked for the presence of polymorphisms. 
Using probe 4J.ES3 (probe VII in Fig.·l. results shown 
from analysis of a family) Taqi identified a two-allele 
polymorphism (Al = 10.3 kb, • .1.2 "" 3.2 kb) without a 
constant band (Fig. 4, individuals homozygous for Al 
not shown). Based on the analysis ofDNAfrom these 30 
unrelated European Caucasians. an allelic frequency of 
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FIG. 3. Locafu:ntion of ERCC6 by hybridization to somatic ~ll 
hybrids. South<':rn blot an.olysis of genomic DNA (20 ,.g) from He Ln. 
somatic cell hybrids CY18 and CY5. and mouse cell line GM346A. 
digested with Taqi and hybridized with genomic probe VIi (Fig.l). 
0.42 for A1 and 0.58 for A2 can be calculated. No RFLPs 
were detected with this probe in the other digests tested. 
DISCUSSION 
By means of in situ hybridization and analysis of so-
matic cell hybrids, we have assigned the ERCC6Iocus to 
human chromosome 10, region qll-q21. The ERCC6 
gene product participates in the nucleotide excision re-
pair pathway, which removes a wide range of potentially 
mutagenic and carcinogenic lesions in the DNA. As 
such. the ERCC6 protein is involved in the prevention of 
carcinogenesis. Whether mutations or deletions in the 
ERCC6 locus are of any importance for development of 
specific tumors is unknown. It is, however, interesting to 
A 
IV.> 
note that during progression from astrocytoma to glio-
blastoma (part of) chromosome 10 is frequently found to 
be lost (James et aL, 1988). 
Several other human DNA repair genes have been as-
signed to various chromosomes (Mohrenweiser et al., 
1989; Smeets et al., 1990; Weeda et al., 1991; Siciliano et 
al., 1986: Thompson et aL, 1987; Kaur and Athwal, 1989: 
Ishizaki et al., 1990). A remarkable clustering of repair 
genes occurs on chromosome 19, in the q13.2-q13.3 area. 
This chromosome contains ERCCI, ERCC2, XRCCI 
(X-ray-repair crass complementing rodent repair defi-
ciency gene) and ligase I. ERCCI andERCC2 have been 
shown to be separated by less than 250 kb (Mohren-
weiser et al., 1989; Smeets et al., 1990). ERCC6 is the 
second DNA repair gene assigned to chromosome 10, the 
other being a gene encoding a human methyltransferase 
(Rydberg et aL, 1990). / 
Previous reports have;fnapped the genetic defect in 
the MEN2 syndrome to the pericentromeric region of 
chromosome 10, possibly in :the vicinity of the ERCC6 
locus. Two clinical types of MEN2 exist: MEN2A and 
MEN2B. By linkage analysis, both have been located 
more precisely: to a small region ( -11 eM) around the 
centromere, bordered by FNRB (at 10p11.2) and RBP3 
(at 10q1L2). ~ightly linked to D10Z1 (Narum etal., 1990: 
Wu et aL, !'990. Lairmore et al., 1991). Polymorphic 
DNA markers that are closely linked to the gene for a 
genetic disease have proved to be of great value for de-
termining the genotypes at the disease locus of members 
of affiicted families. In addition, such markers are a valu-
able tool in the molecular cloning of the disease gene. 
Although it remains to be determined how closely linked 
the Taqi RFLP reported here and the MEN2 locus 
are, the RFLP might be of importance in future MEN2 
studies. 
1 2 3 4 s 6 7 s 9 10 11 12 13 
kl::l 10.3-
FIG. 4. Detection of an RFLP within the ERCC6 gene. (A) pbd,;groo of the MEN2A family used in B. (B) Southern blot anaiyl!is of genomic 
DNA (20 .ttg) of 13 family members digested with Taqi and hybri.dized witb. tb.e genoll'lie pro\x> vn (Fig. 1) detecting the Al and A2. alleles 
indicated. Lane 1. ILl; la.ne 2. Il.2; lnne3, IILl; lane 4, III.2; la.ne 5, III.3; lnne 6. Ill.4: lane 7,II.3: lan<.J 8.ll.4; lane9, ll.S; lane 10. III.6; lnne 11. 
III.5; lane 12, IV.l; lane 13. III.7. 
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344) pn>senting a Cockayne syndl'Ome patient with an interstitial <fu. 
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indications that one copy of the ERCC6 gene is missing in DNA of thil:l 
patient. Thi:l makes ERCC6 a candidate gene for the excision repair 
disorder Cockayne syndrome. 
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Summary 
Cells from patients with the UV-sensitlve nucleotide 
excision repair disorder Cockayne's syndrome (CS) 
have a specific defect in preferential repair of lesions 
from the transcribed strand of act[ve genes. This sys-
tem permits quick resumption of transcription after 
UV exposure. Here we report the characterization of 
ERCC6, a gene involved in preferential repair ln eu-
karyotes. ERCC6 corrects the repair defect of CS com-
plementation group B (CS-6). It encodes a protein of 
1493 amino acids, containing seven consecutive do-
mains conserved between DNA and RNA helicases. 
The entire helicase region bears striking homology to 
segments in recently discovered proteins involved in 
transcription regulation, chromosome stability, and 
DNA repair. Mutation analysis of a CS.B patient indi-
cates that the gene is not essential for cell viability 
and is specific for preferential repair of transcribed 
sequences. 
Introduction 
The genetic information of an organism is continually sub-
jected to the damagirig effects of environmental and inter-
nal genotoxic agents. chemical instability, and the inher-
ent imperfection of DNA metabolizing processes. If 
unrepaired, such DNA injury will lead to mutations, carci-
nogenesis. general deterioration of cell functioning, 
and cell death. To counteract these deleterious conse-
quences. an intricate network of DNA repair systems has 
evolved (for review see Friedberg, 1985). Among the most 
important and best-studied repair mechanisms, both in 
prokaryotes and eukaryotes, is the nucleotide excision re-
pair (NER) pathway. This system eliminates a remarkably 
broad spectrum of structurally unrelated lesions, such as 
ultraviolet (UV)-induced cyclobutane pyrimidine dimers 
(CPO) and (6-4) photoproducts. bulky chemical adducts. 
and DNA cross-links. Removal of these lesions proceeds 
via a multistep reaction. which is resolved to considerable 
detail in the bacterium Escherichia coli (van Houten. 
1990): a UvrA:!B helicasecomplexscansthe DNA for struc-
tural distortions by locally unwinding the two strands (Oh 
and Grossman. 1987) and delivers the UvrB subunit to the 
lesion (Orren and Sancar, 1989). UvrC interacts with the 
damage-specific UvrS-DNA complex and catalyzes inci-
sion of the damaged strand on both sides of the injury. 
Release of the lesion-containing 12-13 nt oligomer. as 
well as the bound UvrC. is performed by UvrD (helicase 
JJ), after which DNA polymerase I turns over UvrB and 
fills the resulting single-stranded gap (Orren et al .• 1992). 
Finally, the newly synthesized repair patch is ligated to the 
parental DNA. Knowledge of the molecular mechanism of 
NER in eukaryotes is rapidly accumulating. Recently, a 
dual incision has been demonstrated {Huang et al., 1992), 
and several proteins required for pre- or postincislon steps 
were identified (Shivji et al.. 1992). 
The prototype repair disorder xeroderma pigmentosum 
(XP) illustrates the phenotypic consequences of defective 
NER. Patients suffering from this rare recessive inherited 
disease characteristically exhibit extreme sun (UV) sensi-
tivity, p'1gmentation abnormalities, pred'1sposition to skin 
cancer. and frequently progressive neurological degener-
ation (Cleaver and Kraemer, 1989). Extensive genetic het-
erogeneity was disclosed by cell hybridization with the 
identification of at least seven excision-deficient comple-
mentation groups {XP-A to XP-G) (de Weerd~Kastelein et 
al., 1972: Vermeulen et al., 1991). The biochemical basis 
forthe XP NER defect probably resides in undefined early 
steps of the pathway preceding incision and repair synthe-
sis {Shivji et al.. 1 992). 
An immediate and urgent effect of the presence of le-
sions in DNA is interruption of the vital process of tran-
scription (Mayne and Lehmann, 1982). To release this 
otherwise lethal block, a sophisticated NER subpathway 
appears to operate that pr"1marilyfocusesonthe rapid and 
preferential removal of certain lesions {from the transcribed 
strand of) active genes. This NER process was first discov-
ered in mammalian cells {Bohr et al., 1985) and found to 
explain the apparent paradox that rodent cells perform 
only a fraction of CPD removal compared with human cell 
lines, yet they exhibit the same degree of UV resistance 
(Zelle et aL. 1980: van Zeeland et al., 1981 ). It appeared 
that rodent lines mainly rely on the strand-selective repair 
of active genes and are largely deficient in the NER sub-
pathway that is responsible for the slower and incomplete 
removal of CPO from the genome overall (including the 
nontranscribed strand) (Bohr et al., 1985; Mellon et al., 
1987). Human cells are proficient for both processes (Mel-
lon et al., 1986,1987: Venema et al .• 1990b). This demon-
strates the importance for cell survival of preferential re-
pair of the small but vital active compartment of the 
genome. Recent analysis of mutations in various genes 
has provided evidence that strand-selective repair also 
contributes significantly to prevention of mutagenesis orig-
inating from this strand in cultured cells (Vrieling et al.. 
1991). The universality of preferential repair "1s demon-
strated by the recent discovery that in yeast and E. coli 
also the transcribed strand is more rapidly cleared from 
CPD lesions than the nontranscribed strand (Mellon and 
Hanawalt, 1989; Smerdon and Thoma. 1990). These ob-
servations suggest that a direct coupling or a feedback 
mechanism exists between transcription and NER. 
The notion that this important process constitutes a dis-
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tinct subpathway of NER came from the finding that pa-
tients suffering from Cockayne'ssyndrome (CS) carry spe-
cific defects in this system. CS is a rare genetic disorder 
that manifests UV hypersensitivity (but no other cutaneous 
abnormalities). retarded growth, and severe progressive 
neurological degeneration. Remarkably, in striking con· 
trast w"lth XP, nosignif1cantincrease in skin cancer is noted 
(Lehmann, 1987: Nance and Berry, 1992). Cell fusion ex-
periments have revealed the presence of at least two com-
plementation groups, group A (CS-A) and group B (C$-8), 
within the classical form of the disease (Tanaka et al., 
1981; Lehmann, 1982). A characteristic hallmark of the 
disease is the observation that CS fibroblasts perform 
rates of repairsynthes·ts in the normal range yet. in contrast 
with repair-competent cells. are unable to recover their 
RNA synthesis after UV irradiation (Mayne and Lehmann, 
1 982). The early suggestion put forward by Mayne and 
Lehmann (1982) that the CS defect resides in the repair 
of transcribed genes was only borne out by the recent 
finding of Venema et al. (1990a) that CS fibroblasts have 
lost the preferenf1al repair of active genes but are proficient 
in overall genome repair. For Cs-A, it was demonstrated 
that the absence of preferential repair correlates with a 
complete deficiency of selective repair of the transcribed 
strand (Venema. 1991). 
Here we report a key step toward defining this system 
at the molecular level by the analysis of a gene implicated 
in the preferential repair pathway. This human gene, 
termed ERCC6. was cloned by virtue of its ability to correct 
the NER defect of a UV-sensitive Chinese hamster ovary 
(CHO) mutant (Troelstra eta!., 1990). The mutant, UV61, 
is a representative of complementation group 6 of the 
laboratory-generated, excision-deficient rodent cell lines 
(Busch et al., 1989). We show that the ERCC6 gene at the 
same time corrects the repair defect of CS-8, the most 
common form of the disease, and that the gene encodes 
a protein with a presumed DNA unwinding function. The 
helicase segment bears striking resemblance to similar 
domains in transcription regulators and proteins involved 
in various repair processes and chromosome stability re-
cently identified in yeast and Drosophila. 
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Figure 1. Construction ol a Functional ERCC5 
eDNA 
The inserts of HTL 1 Band HTL 1C (human testis 
eDNA library) were Isolated from the phage 
arms via PCA and joined by ligation (Vertical 
arrows) at tho uniqwe Bglll site (B). The frag-
ment HTL1J(0.8E} Is added through homolo-
gows recombmation (X). and fmally PL 14 (hw-
man placentn eDNA library} IS added to the 
reswl!lng molecule by 11gatton at the PtiMI (P) 
sit(!. The parts obtwned v'1a PCR or homolo-
gous recombination were chocked by so-
quoncc analysis. The th1ck line 1n HTL 1C cor-
responds to tne probe wsM ior Southern blot 
<malysism Figure 69. Other symbols: E, EcoRI; 
N. Nsii; dotted line. soqwenco not representing 
ERCC5 (artiiicially ligated to ERCC6); stippled 
region, th(! ORF. See Exper~mental Proce-
dwros tor detailS. 
Isolation of the ERCC6 eDNA 
The human excision repair gene ERCC6 was recently iso-
lated. after large-scale transfection experiments of human 
(Hela) genomic DNA to UV-sensitive CHO mutant UV61 
(rodent complementation group 6 [CG~6J) and rescue of 
the correcting human sequences from a secondary trans-
formant (Troelstra et al., 1990). The gene appeared to 
have a respectable size (for transfection cloning) of close 
to 100 kb. Unique conserved genomic ERCC6 sequences 
were identified and used as probes to hybridize to a human 
testis eDNA library. This resulted in the isolation of anum-
ber of overlapping eDNA clones. together having an insert 
size of 3 kb with a polyadenylation signal 20 nt from the 
3' end. Northern blot analysis w'1th part of this 3 kb eDNA 
as a probe revealed the presence of two messenger RNAs 
(mRNAs) of about 5 kb and 7-7.5 kb in length. Sequence 
analysis and restriction mapping indicated that the differ-
ence in size is due to alternative polyadenylation (unpub-
lished data). Both mRNAs are very Jowly expressed, an 
observation upheld by the recovery of very low numbers 
of ERCC6 eDNA clones from various eDNA libraries. After 
screening of several eDNA libraries, an almost full-length 
molecule of 4.7 kb could be constructed (see Figure 1 for 
details). 
Correction of UV61 by the ERCC6 eDNA 
The 4.7 kb eDNA molecule was inserted in mammalian 
expression vector pSLM (see Exper'lmental Procedures) 
under the control of the SV40 late promoter. Cotransfec-
tion of this plasmid with pSV2neo to UV61 cells yielded 
UV-resistant clones with ver).r high efficiency (transfection 
frequency of UV and G418 resistance was similar to that 
of G418 resistance alone). UV survival of these trans-
formants appeared within the wild-type range (Figure 2A). 
To verify whether other DNA repair endpoints were cor-
rected by EACC6, we examined the recovery of RNA syn-
thesis after UV exposure. In normal cells, transcription 
drops rapidly after UV irradiation (owing to the appearance 
of blocking lesions in the DNA template) but resumes 
A 100 ·-.·--~:~~:!·-·------.:~ Figure 2. Correction of the UV61 Aopalr De-fect by ERCC6 eDNA 
(A) UV survivaJ curves of wild-typo CHO cell 
line AAB (closed boxes), mutant UV61 (closed 
circles), and ERCCScDNA transtormant61 E6a 
{closed triangles). 10 
l 
" 
"' 
* 
0.1 
··, 
(B) Recovery of RNA synthesis in wild-type coli 
line AA8, mutant UV61, and ERCC6 eDNA 
transtormant 61 E6a. Cells unlrradiatod or UV 
Irradiated with 6 J/m2 wore pulse labeled with 
['H]undir'IC at different times after irradiation; 
the incorporated radioactivity was determined 
by liquid scintillation counting (soo Expenmon· 
tal Procedures tor details on the procedure). 
For symbols seo (A). The standard error of tho 
mean (three duplicate plates) tails Wlthm tho 
s1::::e of tho symbOls. 
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within several hours as the result of preferential (strand-
specific) repair. In excision...(jeficient cells such as XP and 
CS, recovery of RNA synthesis does not occur (Mayne and 
Lehmann, 1982). Since this repair parameter has never 
been investigated for rodent mutants, we decided to as-
sess the behavior of RNA synthesis in CHO wild-type AAS. 
mutant UV61, and eDNA transformant 61 E6a upon UV 
irradiation. As shown in Figure 28, RNA synthesis (ex-
pressed as the ratio of [3H]uridine incorporation in UV-
irradiated cells to that in unirradiated cells) initially de-
creases within 1 hr to 70%-80% but quickly resumes in 
AAS, whereas it remains low in UV61. Recovery of RNA 
synthesis, as in wild type. is observed in ERCC6 trans-
formant 61 E6a, indicating that the human gene also cor~ 
rects this repair endpoint. 
To investigate the specificity of correction by ERCC6, 
the gene was transfected to mutaf!tS from rodent CG-4, 
CG-5, and CG~7 and to two other members of group 6 
(CG-1, CG-2, and CG-3 were not tested since the correct~ 
12 
ing genes for these mutants have been cloned [van Duin 
et aL, 1986; Weber et al., 1990; Weeda et al.. 1990a. 
1 990bl). No UV-resistant transformants were obtained in 
the heterologous CG, whereas numerous UV-surviving 
colonies were observed in the other representatives of 
CHO group 6, demonstrating the specificity of ERCC6 cor~ 
rection and validating the complementation studies. 
Nucleotide and Amino Acid Sequence 
of ERCC6 eDNA 
The nucleotide sequence of the ERCC6 eDNA is shown in 
Figure 3A The first ATG codon (nucleotide 80), preceded 
by two in-frame stop codons, starts an open reading frame 
(OAF) of 4479 bp. The purine often found at the important 
-3 position before a start codon (Kozak, 1991) is present, 
as is the G at +4. The other nucleotides within the start 
site. however, deviate from the optimal initiation start site 
GCC(A/G)CCATGG (Kozak, 1991 ). All otherORFs present 
encode much smaller polypeptides. Therefore, we con· 
69 
., ..... ~~---­
, 0 I 0 0 0 > 0 T 0 < 0 0 < > 0 > 0 T Y 0 0 0 < < 0 0 I< 0 0 
"'~-~ 
......... ' " • ' ••• 0 ' 9 • y •••••• " • ' 0 • 
-::~~~
···-~---..-~, >'' 9 C v 0 Y < 0 0 0 0 o v > 0 0 !. ~ o < T 0 o C 0 0 j o ' l l 
Yl.......,_.,.,~ OM"""""""' 
, .... ' •• 0 •• ' ••• ' •••••• v •• 0.' ••• '9 
... -~ 
,,., 0 A 0 9 0 <' 0 0 0 0 0 0 0 0 < 0 0 0 0 0 0 0 A 0 0 0 Y T 0 
::~ ••••••••••••••••••••• i""'::"":"" 
, ... ~~-~-··"' .~;~::: ;~<:::::::::::::: 
,,,,..,.,~.,.,~-----'-''" 
, •• ' •• '.'.' ••••••••• ' •••• y. v 0', •• 
>::::.' •••••••••••••••••••••.• '.' .• 
>:,;~~~,..~~ •• ~""
•••• ~--;;;o..,._~.....,~-·6>· 
... • • . ' .••• ''' ••• '.'.'' ..• ''' 0.'. 
,.,..,..,_ .... .....:.~""""..,. .. :;;J,, 
... ' ••••••• < 9 0 ••• , •••••••••• , 0 ' l • 
"''~~''"" 
... T 0 0 0 j. 0 0 0 0 j 0 T 0 0 0 0 0 0 0 0 0 CO 0 T 0 j V < 0 
~~:~:.·.~~~~ .... 
"''~'"""""-,..,.,..~-=----... -- •••• 
..,, •••••• ' • '.~ • ' < •• ' ' ' ' • ' • ' ' • \. • ' •• 
:::«:~~~ . ::::.~~: 
-· ' • " ••• ' ' •••••• 0 •• ' •• ' •••••• , •• 
·~:;~";:"']"~"';'~~~·­
'::;~·~~~·~~~··,. 
>;;:~~~~~·;~~~,.,. 
·:~:~"";"""~~:"'~'''' 
,_........ .. --..., 
''''~"'~_.._....~,, .. 
.. , ... '.' .. ' •. " .. '"''. " ..•. \.., '' v. 
'"'"=~''"'"'·~---~~-.-....,,.........;;;.: ,,,, 
,._ 0 0 0 0 0 0 0 o!. 0' 0 oTT T l 0 > '0 > C t T 0 0 0 < > 
, . ,~~~~''"' 
., •••••• , • , 0 ••••••• , ' ••• 0 •• " •• ' •• 
,.,,_,...,................,,..,. ·'""~-'"' 
... • • ' ' ••• , ' •• 9 ' •• 0 •• , •• ' ' •••• 0 " • 
·~:"77'::'":"'::~'"":"i:"7~~~~"': '"' 
~;;;~~~~~"':~'"" 
;~;~ ••• o":"'T''i'"!~"':~~~~:: .~.~~~~~ ""' 
,,.,.,..., ... __ ~ .. ..,....,-.... _-- .. , 
"" ...... ' .. " ....... ' .... ' ... , .. ' 
;;;:·~;-r~-.-.~· .• ~":'~·;"'";"'"::'"?: "" 
li!i~f"':""'~"':"'['"';""~~;•ooo 
.. ., ........ ,~~ .. ~· ~·~· 
,.., ' .. ' ' .. ' .... ' . ' ' . ' ' ' . ' ' .. ' .... 
\~'""':'~'7~'"';~::":"~~~-:"<o ,., 
""'~-,~~-'''''"'"'"'"'"'"''~"'~''"' 
"" ~ ••••• ' ••• 9 •• ' ' ' ' ••••••• ' v '-· •• 
~:::"'!"':"':'~~;"'~~ ... ;'"'~~~:"'.:"':: .... 
'"''""'"'""""~""""'"'"'-·~--· 
"" •• ' •••• 0 • < ' ' •••••• , •••••• ' ' ••• 
.... _._...,. ... ,_, ............. ~""'"""'""'·~·>•• 
"" ••••••• ' ••••••••• 0.'. '-' •••• <. 
''''""'-'"'~--~,.,.,..,...,...-~""""'«<"<" ,,,, 
"" 0. ' ••• '.' •• '.' ••• ' ••• 0."' •••• ' 
~;:-:.~~":"'::-:"":.:'~~~···· 
;;~:~~~~"70-'' 
,,,,~,...,...........,..._~,...,.t<Aa<oT<'''"'"''''<T•<<o><>o•<>•'"''......,......,. ,,,_ 
·~· •• ' • ' ' '" ••• ' ...... ' 0 • < •••• ' .... '-' 
... ,~~--~""""'~~-=·· .. 
,., ' ••• , ••• '.' •• ' •• ' .. <. 
elude that the OAF of 4479 bp, depicted in Figure 3A, 
defines the ERCC6 protein. 
The deduced amino acid sequence specifies a protein 
of 1493 amino acids (see Figures 3A and 3B), with a pre-
dicted molecular size of 168 kd. Although a systematic 
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Figure 3- Nucle<Jtlde and Pre-dicted Amino Acid sequence of the 
£RCC5cDNA 
{A) ERCC$ nucleotide and predicted amino acid sequence. The se-
quence of 4714 nt has been Obtained from the eDNA fragments, as 
depicted In Flgure 1, together with a eDNA clone from an adenov·lrus-
transformed retina cell library (the first 16 nt). Putativetur"lctiona! units 
are overllned: CKII phos, caseir"l kinase II phosphorylation site; NLS, 
nuclear location signal (basic regions are double overllned); NTB, nu· 
clootide binding fold; numbers I, lA, and II-VI relertothe corresponding 
hellcaso motifs. Tho AATTAAA potyader"lylatton signal os underlined . 
Arrows Indicate the mutations In patient CS1AN; CSD moans the cryp-
tic splice donor, while putat. SA indicates the putative splice acceptor~ 
the putative branch point. the pyrimidine stretch, and theAG dlnucleo-
tides are underlined; the third AG represents the normal axon 13 
border . 
(6) Schematlcal representation of predicted functional domains In the 
ERCCS protein. The truncated ERCCS proteins encoded by the 
CS1AN alleles are indicated. A, acidic amino acid stretch; G, glycine-
rich region; S, serine phosphorylation site preceded by a nuclear loca-
tion signal; N, nucleotide binding fold; arrow, nonsense sequence due 
to a frameshlft In allele b of patient CS1AN. 
computer search did not identify any protein with overall 
homology to EACC6, a close inspection of the sequence 
did reveal several regions of interest and similarity to other 
polypeptides . 
F1rst, there was an acidic part from res'1due 356-394 
harboring close to 60% glutamic or aspartic acids includ-
ing a stretch of 10 acidic residues. Acidic regions have 
been found in a number of nuclear prote"ms that associate 
with chromatin or histones (Lapeyre eta!., 1987; Ptashne, 
1988; Sung et aL, 1988; Wen eta!., 1989). This part is 
followed by a stretCh of glycin res'1dues (amino acids 442-
446) and a very hydrophilic segment (from residue 447-
495) containing >60% charged amino acids. 
Second. two regions with the hallmarks of a bipartite 
nuclear location signal (amino acids 466-481 and 1038-
1055; Robbins eta!., 1991) were found in close vicinity to 
potential casein kinase II phosphorylation sites (Kemp and 
Pearson, 1990, amino acids 483-490 and 1068-1074). 
Recently, it was noticed that putative casein kinase II phos-
phorylafJon sites are located nearby many nuclear location 
signal sequences (Aihs et a!., 1991 ). 
Third, the region from amino acid 527 to amino acid 
950 contains seven sequences (starting with a nucleotide 
binding fold) matching seven consecutive motifs recog-
nized by several investigators to be conserved between 
two superlamilies of ANA and DNA helicases (Gorbalenya 
et at, 1989). This region (amino acids 527-1 007) exhibits, 
in addition, a very high overall homology with parts of eight 
other proteins containing the same seven moflfs: RAD16 
(Bang et aJ.. 1992; Schild eta!., 1992), RAD54. SNF2 
(SWI2). STH1 (Laurent et al., 1992), MOT1 (Davis et aL. 
1992), FUN30 (Clark et al.. 1992). brm (famkun et al.. 
1992), and lodestar (Girdham and Glover. 1991) (Figure 
48). The similarity is confined to this particular segment 
(Figure 4A) and is far higher than the motif-restricted ho-
mology normally detected between different helicases 
(see Figure 48 for the consensus sequence of the seven 
helicase motifs). 
Fourth, a second putative nucleotide binding domain 
(Saraste et al., 1990) is found in the C terminus (amino 
acids 1134-1138). 
Involvement of ERCC6 in CS 
The ERCC6 gene. correcting a CHO mutant. could possi-
bly also be implicated in one of the forms of XP orCS. The 
first clue concerning this possibility was presented by a 
patient with symptoms of late onset CS. being heterozy-
gous for an interstitial 1 Oq211 deletion in all cells (Fryns 
et al., 1991), i.e .• a chromosomal region to which we have 
assigned ERCC6 (froelstra et al.. 1 992). Southern blot 
analysis of DNA from the patient suggested that ERCC6 
resides within the deleted segment (data not shown). 
Since no cells of this patient were available and the com-
plementation group to which he belonged was unknown, 
we decided to transfectthe ERCC6 eDNA expression plas-
mid together with the dominant selectable marker 
pSV2neo into CS38E.S3.G1 and C$1AN.S3.G2. immor-
talized cell lines representing CS CG-A and CG-8, respec-
tively (Mayne et al., 1986). G41S.resistant transformants 
of each ce!lline were grown in mass culture. In view of the 
poor transfectability of many SV40-immortalized human 
fibroblasts, Southern blot analysis was performed to verify 
whether a significant fraction of the G41 S.resistant trans-
formants had indeed incorporated the cotransfected 
ERCC6 eDNA For CS3BE.S3.G1, this fraction was very low. 
but detectable, on Southern blot (average incorporation of 
<0.1 intact ERCC6 eDNA copy per cell). CS1AN.S3.G2 
cells had an average integration of one to two copies per 
transformant (data not shown). To test whether ERCC6 
restores the DNA repair capacity of one of the CS comple-
mentation groups, the G418-resistant mass populations 
(consisting of ± 100 and 800-1000 independent clones 
for CG-A and CG-8, respectively) were subjected to a UV 
dose lethal to the parental CS cells (8 or 6 J/m2 , which 
gives a 0.25% survival for CS-A and cs-s. respectively, 
and 15% or 25% survival for wild-type cells; the treatment 
was repeated after 48 hr). For CS3BE.S3.G1, none of the 
G418-resistantcellssurvived the UV selection. and neither 
did the transfected mass population show enhanced sur~ 
viva! (at different doses). This suggests that ERCC6 is un· 
able to correct the repair defect of CS·A (although it should 
be kept in mind that less than 10% of the transformants 
had incorporated an intact copy of the EACC6 eDNA). 
ERCC6 did confer UV resistance to CS1AN.S3.G2 cells; 
the transfected mass population efficiently survived the 
UV selection. The UV survival of two independent trans-
formants (E61ANa and E61 ANd) is depicted in Figure SA 
and shows that both have regained _a wild~type UV resis-
tance. To establish the specificity of correction further, 
ERCC6 eDNA was introduced (either by DNA transfection 
or by microinjection) into representative cell Jines of XP-C 
and XP-E to XP-G; the correcting genes for XP-A (Tanaka 
et aL, 1990). XP-B (Weeda etaL, 1990b), and XP-D (Fiejter 
et al., 1992) have already been isolated and are different 
from ERCC6. Because XP-E cells are only slightly UV sen-
sitive. it was not possible to derive definite conclusions 
from thetransfection experiments to this complementation 
group. The ERCC6 gene was unable to correct the repair 
defect of the otherXP groups tested. These results confirm 
the complementation data and demonstrate that no over-
lap exists between CS-B and any of the known XP groups 
(with the possible exception of XP-E), in contrast with 
CS-C. which is identical to XP-8. 
RNA Synthesis Recovery in ERCC6 eDNA 
Transformants of CS1AN.S3.G2 
As mentioned above. CS cells are, in contrast with repair-
proficient human cells, unable to recover their RNA syn-
thesis after UV exposure (Mayne and Lehmann, 1982). 
To see whether ERCC6 also complements this CS-typical 
repair parameter, RNA synthesis was measured after 
UV irradiation in SV40-transformed norma! fibroblasts, 
CS1AN.S3.G2, and eDNA transformants E61ANa and 
E61ANd. As shown in Figure 58. transcription initially 
drops to ::::::60% within '1 hr after irradiation. The RNA syn-
thesis quickly recovers in normal cells, whereas it remains 
repressed in CS1AN.S3.G2cells. The eDNA transformant 
E61ANd resumes transcription with almost wild-type kinet-
ics; E61ANa. on the other hand. recovers more slowly, 
being retarded at early times after UV but reaching wild-
type levels at 16 hr. In Figure5C the level of transcription 
16 hr after UV irradiation is tested at different UV fluences. 
ln both eDNA transformants. RNA synthesis is similar to 
that in repair~proficient cells tor all UV doses, whereas 
transcription in CS1AN.S3.G2 is consistently lower. The 
slow (but after 16 hr complete) recovery of E61ANa, in 
contrast with the fast recovery of E61ANd (Figure 58), 
might be auributed to the slow growth rate of E61ANa. 
Alternatively, expression levels of the eDNA, influenced 
by, e.g., the integration site, could have an effect on the 
kinetics. 
To demonstrate the universality of C&B correction, pri-
mary fibroblasts of another CS-8 patient, C$1 BE, were 
microinjected with ERCC6. Recovery of UV-induced tran-
scription inhibition was, as in the CS1AN eDNA trans-
fomiants, restored to levels within wild-type range (data 
not shown). Preliminary data suggesting that microinjec-
tion of ERCC6 into primary fibroblasts of C8-A did not re-
store ANA synthesis recovery after UV irradiation confirm 
the complementation data. 
The ERCC6 Mutation in CS1AN Cells 
The previous experiments showed that EACC6 specifically 
corrects the UV survival and ANA synthesis recovery after 
UV exposure of C$-B. To obtain direct proof that ERCC6 
is responsible for the C8-B repair defect, we searched 
for mutations in the gene. The polymerase chain reaction 
(PCR) was used to amplify ERCC6 eDNA selectively from 
ANA of the SV40-transformed C8-B cell line CS1AN.-
S3.G2. For both eDNA synthesis and PCR, the ERCC6 
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Flgure 4. Homology of the EACC6 Hellcase Region to tho Similar Region 
of RA054, RA016, lodestar, SNF2. STH1, brm, MOT1, and FUN30 
(A) Schematlcal representation of ERCCS, RA054, RA016, lodestar, and 
SNF2 to indicate the locatiOn of the homologous segment In the proteins • 
Stippled boxes represent homology: hell case motifs are indicated by closed 
boxes. 
(6) Alignment of conserved regions of the ERCCS, RA054, AADt 6, lodestar, 
SNF2, STH1. brm, MOTt, and FUN30 amino acid sequences. Sequences 
that correspond to the seven consensus motifs Identified among two super-
fam!lles of DNA and ANA hel!cas&sareover11ned. The consensus {consens) 
sequences given below the corresponding domains are from Gorbalenya et 
al. {19S9); hydrophobic (l,l. V. M, F. Y. W) and charged or polar residues 
(S, T, D. E. N. 0. K. R) are Indicated by plus and 0, respectively. Shaded 
amino acids are slmllar In at least five of the proteins compared; residues 
belonging to one of the followJng groups are considered to be similar: L.. V, 
I, M; F, Y, W; S, T, A, P, G; K, A. H; and E, 0, Q, N. The AA054-sequence 
Is taken from Emery at al. (1991) and the $NF2 sequence from l.aurent et 
al. (1991); other references are given In the text A small change has bOOn 
introduced in the published sequence of the lodestar gene (Girdham and 
Glover, 1991), since we noticed that this results 11'1 the presence of all seven 
hellcase domains, Instead of the reported thr&e. By introducing a loop of 61 
amino acids between domains !II and IV In the FUN30amil'toacld sequence. 
we ware able to perfectly align domains 1-JII. In addition to domains IV-VI 
that ware Identified by Clark at al. (1992). 
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Figure 5. Correction of the C$1AN.S3.G2 Re-
pair Defect by ERCCS eDNA 
(A) UV survival curves of an SV40-transformed 
wild-type cell line (solld line). mutant C$1AN.-
S3.G2 (dashed and dotted line). and £ACCS 
eDNA trans!ormants E6tANa (dashed line) 
and E61ANd (dotted line). 
(6) Recovery of ANA synthesis at different 
times after UV Irradiation. Cells unlrradlated or 
UV irradiated with 4 Jim' were pulse labeled 
with rHJurldlrtO at different times after lrradia· 
tlon; the Incorporated radioactivity was deter-
mined by liquid SCII'ltil!atlon counting. FQr sym-
bols see (A); the average (open circle) and the 
standard error of the mean {vertical line) are 
given (within one experiment). 
{C) ANA synthesis 16 hr after UV lrradlatJon 
with increasing dose. Colis unirradlated or UV 
irradiated with different dose were pulse la-
beled with PH] undine 1 6 hr aft or irradiation: the 
incorporated radioactivity was determined by 
liquid scintillation counting. For symbols see 
(A) and (8). 
73 
GATC ... , GATC 3, GATC 3' G' 
-.._A ./~ ]A i llll-}~ }"" "'""' A "" 1=.... A 
--~ G ]-, ~ J K/•m -~ - A ]><, A/T 
-
-y 
..: - ~ J o,. ·\~ 
·=- n o, ="~ J a~ 5' 5' 5' 
HeLa CS1AN(SV) CS1AN 
> 
~ 
~ ~ B 
~ < " E ~ 5 u 
" 
10.5 kb 
---
ERCC-6 probe 
4.4 kb control probe (EFD75) 
Flgure 6. ERCC6 Mutation in CS1AN.S3.G2 and Allele a of Patient CS1AN 
(A) Part of the ERCC6 nucleotide sequence of total PCA product (from eDNA) from He La, CS1AN.S3.G2 (CS1AN(SV)). and the primary fibroblasts 
of patient CS1AN. The A toT transvorsJon, resulting In a premature stop codon (the mutation in allele a), Is Indicated by an arrowhead. 
(B) Southern blot anaJysls of CS1AN.S3.G2 and two control cell lines. The same Southern blot was hybridized with two probes. Tho ERCC6 probe 
1sa 350 bp EcoAI eDNA fragment (see Figure 1), and EFD7Sisacontrol probe derived from thetelomericend of chromosome 10q {10q26) (Simpson 
and Cann, 1990). The contrOl probe recognizes two polymorphic bands In DNA of CS1AN.S3.G2, each having an Intensity half ofthattrom the single 
band of botil controls. This indicates that at least thiS telomerlc part of chromosome 10 is diploid In CS1AN.S3.G2. For the two controls, the ERCCS 
signal is comparable with that of EFD75. In CS1AN.S3.G2, however, the intensity of the ERCC6 signal is similar to that of only one of tile two 
polymorphic EFD75 bands. suggesting that only one copy of ERCCO is present. 
mRNA was divided into six overlapping segments of ap-
proximately 1 kb each. Single-stranded DNA for direct se-
quence analysis of the PCR product was prepared by 
asymmetric PCR, using amplified eDNA as a template. 
Sequencing revealed an A toT transversion at nucleotide 
1088, resulting in a premature stop at amino acid position 
337 (Figure SA). Only one type of allele was detected, both 
at the level of RNA and in genomic DNA, implying that 
CS1AN.S3.G2 is either homozygous or hemizygous for 
the A •oaa to T transversion. Jn the family history of patient 
CS1AN, consanguinity has not been reported. Southern 
blot analysis of DNA from CS1AN.S3.G2 confirmed that at 
least part of one ERCC6 allele was deleted (Figure SB). 
Since SV4Q-transformed fibroblasts are chromosomally 
unstable, sequence analysis of the ERCC6 gene and 
eDNA was verified in the primary fibroblasts of patient 
CS1AN, GM00739. The A toT transversion at nucleotide 
1088 was confirmed, but unexpectedly the primary line 
appeared to possess a second allele with the wild-type A 
residue at nucleotide position 1088 (Figure SA). Further 
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sequence analysis of the total PCR product derived from 
RNA of GM00739 revealed the appearance of a double 
sequence ladder when entering from exon 14 backward 
into exon 13 (Figure ?A). When the normal nucleotide se-
quence of exon 13 is subtracted, a perfect match is found 
with a sequence 100 bp upstream in exon 13. The resulting 
100 bp deletion is not present in RNA from the SV40-
transformed CS1AN.S3.G2 cell line (Figure ?A). thus prov-
ing that it is der'1ved from the second allele (allele b) of 
GM00739. The 3' end of the deletion coincides exactly with 
the end of exon 13, whereas the 5' end occurs in a 
sequence (GG/GTACT; see Figure 3A, nucleotides2576-
2582) matching the splice donor consensus (AG/GTPuAG; 
Pu =A or G) (Senapathyeta!., 1990). This suggests that, 
in allele b. a cryptic donor is utilized instead of the normal 
exon 13 spnce donor. Therefore. a mutation in the splice 
donor of exon 13 of allele b was expected. At the level of 
DNA. however, neither the normal nor the cryptic splice 
donor was mutated (Figure ?B). The only detectable muta-
tion was a C264ato T transition 30 nt upstream of the normal 
GATC 
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Figure 7. ERCC6 Mutation In Allele b of Patient CS1AN 
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(A) ERCC6 nucleotide sequence from the exon 14/exon 13 border of both C$1 AN.S3.G2 (CS1AN(SV)) and the primary fibroblasts CS1AN. Sequanco 
analysiS was performed on total PCR product obtained after amplification of RNA. The start of the double sequenco ladder In CS1AN, resulting 
from a deletion of 100 bp (allele b. schematically depleted underneath the sequencos), Is Indicated by an arrowhead. The sequence obtained with 
CS1AN.S3.G2 Is identical to that using HeLa RNA. 
(B) Nucleotide sequence of part of axon 13 at the level of the genome of CS1AN.S3.G2 (CS1AN(SV)) and the primary fibroblasts CS1AN. The C 
toT trat~sltlon In CStAN, responsible for the 100 nt deletion at the mANA level, is Indicated by an arrowhead. The asterisk next to the CS1AN 
sequence indicates a sequence artifact that was also detected In CS1AN(SV) (and HaLa) on longer exposures. 
(C) SchamaticaJ representation. of the two possible splicing reactions that could result In the 100 nt delation In the mANA of CS1AN. 
splice donor of exon 13. How could a single point mutation 
at this position have such a profound influen-::e on the 
apparent functioning of the still normal splice donor se-
quence30 nt downstream? A search for dramatic changes 
in secondary structure caused by the C to T transition 
failed to reveal any clues to explain this effect. Close in-
spection of the sequence revealed that the C to Ttransition 
might create a putative branch point sequence (Ruskin et 
al., 1984: Senapathy et ar., 1990) at position 2645-2651, 
which, together with a coincidently present pyrimidine 
stretch and one of the three subsequentAG dinucleotides, 
completes a possible splice acceptor site (see Figures 3A 
and 76). This newly created acceptor, together with the 
cryptic splice donor in exon 13, may generate anew intron. 
The 100 nt deletion could thus be tbe result of an extra 
splice event if the third (C)AG is used. The normal splice 
donor site of exon 13 should then have a dual role: splice 
donor in the normal splicing of intron 13 and splice ac-
ceptor in a subsequent erroneous splice event. removing 
the last 100 nt of exon 13 (see Possibility 1 in Figure ?C). 
Alternatively, use of the first AG dinucleotide, which in in 
vitro and in vivo studies is demonstrated to be strongly 
preferred above any secondAG (Smith etaL. 1989; Weeda 
et al.. 1990a). would define a very small exon of 9 nt at 
the end of exon 13. It is known from studies of several 
investigators that such small exons may be skipped (both 
in vitro and in vivo) when the surrounding splice sites are 
nonoptimal (Black. 1991; Dominski and Kale. 1991, 1992). 
This would result in the ligation of the cryptic splice donor 
within exon 13 to exon 14 (see Possibility 2 in Figure 7C). 
For the ERCC6 gene product. the resulting 1 00 nt deletion 
has profound consequences. The protein will only be 857 
amino acids long and consequently lacks half of the heli-
case region (see Figure 36). Presumably, as with allele a. 
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Table 1. Comparison o1 Repair Characteristics of UV61 and CS Cells 
Repair Characteristics UV61" cs 
UV sensitivity {at o,,) ==2.7x• =3-3.Sx' 
RNA synthesis recovery 
afteruv 
Repair synthesis (percent· ::::70%' Wild-type range" 
age of wild type) 
Pre1erential repair of CPDs 37%" 
In active genes 
Overall g~nome repalr 
--
+' 
Repair of (6-4) photo- +' +' 
products 
UV-Inducod mutagenesis Elevated" Elevated'·"' 
• Mutant, probably leaky (Troolstra et al., 19g0). 
"Thompson et al. (198Sa). 
< CS1AN.S3.G2 (unpublished data). 
"This study. 
• Mayne and Lehmann (1982). 
' Unpublished data. 
o Andrews et al. (1978). 
"Lommel and Hanawalt (1991). 
'Venema et al. (1990a). 
J Characteristic of rodent cells. 
'Barrett et al. (1991). 
'Henderson and Long (1981). 
"'Arlett and Harcourt (1982). 
allole b in CS1AN cells will produce a nonfunctional 
ERCC6 protein. 
Discussion 
A Rodent Equivalent of CS-B 
The ERCC6 gene was previously isolated by virtue of its 
ability to correct the repair deficiency of UV61, a NEA-
deficient rodent mutant cell line from complementation 
group 6 (Troelstra et al., 1990). In this paper, we report 
the isolation of a functional ERCC6 eDNA molecule that 
efficiently and specifically corrects both the UV sensitivity 
of UV61 (and other representatives of rodent group 6) and 
its inability to restore ANA synthesis after UV exposure. 
Introduction ofthiscDNA into cells of several XP, CS, and 
rodent complementation groups by transfection or micro-
needle injection demonstrates a specific correction of the 
repair deficiency of CS-8 fibroblasts: both UV survival as 
wei! as ANA synthesis recovery are restored to a level 
within wild-type range. This result implies UV61 and other 
members of rodent complementation group 6 (Thompson 
eta!., 1988b; Busch et al., 1989) to be the rodent equiva-
lents of the human repair disorderCS-B, the most common 
fonn of the disease. In retrospect we note that the repair 
phenotypes of UV61 and CS-8 can be reconciled with 
each other (Table 1), taking into account the fact that ro-
dent and human excision repair display some principal 
differences (Zelle et al., 1980; van Zeeland et al., 1981; 
Mellon et al., 1987) and the notion that UV61 is very likely 
a leaky mutant (Troelstra et al., 1990). 
The ERCC6 Mutations in Patient CS1AN 
Sequence analysis of the ERCC6 gene in patient CS1AN 
revealed deleterious mutations in both alleles. Allele a, 
76 
which is the only allele present in CS1AN.S3.G2 cells (see 
below), carries an A 'ooa toT transversion leading to a pre-
mature stop at amino acid 337. The encoded protein of 
336 amino acids lacks all postulated domains (Figure 38). 
Allele b contains a C'-"6411 to T transition that triggers an 
erroneous splice event and thereby results in a frameshift. 
As depkted ·In Figure 7C, two splice mechanisms can be 
envisaged that could give rise to the deletion of 100 bp. 
Although undetected in CS1AN mANA, we cannot exclude 
the presence of trace amounts of the partially spliced inter· 
mediate depicted in Figure 7C (Possibility 1). Similarly, 
undetectable amounts of mANA including the newly de-
fined 9 nt exo-n (depicted in Figure 7C, Possibility 2) might 
be produced. However, none of these transcr"1pts w·111 en-
code a protein longer then 860 amino acids. Presumably, 
these severely truncated ERCC6 proteins will be nonfunc-
tional. Nevertheless, cells from patient CS1AN seem to 
be affected in preferential DNA repair only, implying that 
ERCC6 is specific for this NEA subpathway. In addition, 
these findings suggest ERCC6 to be a nonvital protein, in 
contrast with the ERCC2 and ERCC3 gene products, of 
which at least the yeast homologs AAD3 and EACC3.sc 
(SSL2) are shown to be indispensable for cell survival (Hig-
gins et al., 1983: Naumovski and Friedberg, 1983; Gulyas 
and Donahue, 1992: J. H. J. H., S. Prakash, and L. Pra-
kash, unpublished data). 
The immortalized CS1AN derivative CS1AN.S3.G2 only 
retained allele a and lacked allele b. Presumably, this ·Is 
not due to loss of one total copy of chromosome 10, since 
CS1AN.S3.G2 is polymorphic for at least one locus on 
1 Oq26 (EFD75; see Figure 68). A similar case was re-
ported recently with another repair disorder resulting from 
mutations in the ligase! gene. The primary fibroblasts of 
the patient, designated 468R, carried different mutations 
·1n each ligase I gene copy, whereas the SV40-transformed 
derivative 46BR.1G1 only retained one of the two (mu-
tated) alleles (Sames et al., 1992). Although the genomic 
instability of SV40-transtormed cell lines is generally 
known, these findings further emphasize the importance 
of including primary cell lines as controls in this type of 
study. 
ERCC6, Member of a Recently Identified Family 
of Putative Helicases 
The predicted amino acid sequence suggests the EACC6 
gene product to be a nuclear DNA (or ANA) unwinding 
protein. ERCC2 and ERCC3 have also been postulated to 
encode DNA helicases, as deduced from the"~r am'mo acid 
sequence (Weber et a!., 1990; Weeda et al., 1990b), and 
for ERCC2, in addition, based on the demonstrated DNA 
helicase activity of its yeast homolog AAD3 (Sung eta!., 
1987). Therefore, the ERCC6 gene may encode the third 
DNA unwinding function in mammalian NER. In E. coli 
both the Uvr~B complex and the UvrD protein have been 
shown to exhibit DNA unwinding acf1vity (Oh and Gross-
man, 1987: Orren et al., 1992, and references therein). 
Similarly, several DNA helicases might be expected to 
function in mammalian excision repair. The gene product 
of ERCC6, however, certainly differs from the E. coli 
UvrA2B and UvrD proteins in that it is specific for preferen-
tial repair of active genes. 
The entire helicase region of the EACC6 protein appears 
to be highly homologous to a similar region in proteins 
from a recently identified. rapidly expanding family of pos-
tulated helicases {Bang et al .• 1992; Clark et al .• 1992; 
Davis et al., 1992; Johnson eta!., 1992; Laurent eta!., 
1992: Schild et al., 1992; Tamkun eta!.. 1992}. This nove! 
subgroup encompasses proteins implicated in transcrip-
tion regulation (SNF2. MOT1, and brm), preservation of 
chromosome stability (lodestar), and DNA repair (AAD16, 
AAD54, and the very recently identified AAD5 protein). 
The group also includes two proteins of unknown function 
(STH1 and FUN30). The degree ot homology (around 30% 
identity and up to 57% similarity) by far exceeds the resem-
blance normally present among helicases. This suggests 
a specific type ofhelicase function common to all members 
of this gene famlly. 
The transcription regulators SNF2 {Laurent et al .• 1991) 
and brm (Tamkun eta!., 1992) are thought to be engaged in 
transcription activation, SNF2 as a component of a larger 
functional complex involving SWI1. SW13. SNF5, and 
SNF6 (Laurent et al., 1991; Peterson and Herskowitz. 
1992). The gene product MOT1. on the other hand, is 
supposed to be a negative regulator of transcription {Davis 
eta! .• 1992}. One of the proposed activities for the MOT1 
protein is that it strips resident DNA-binding proteins 
(which would otherwise activate transcription} from their 
cognate binding sites by melting the DNA helix (Davis et 
al.. 1992}. 
Mutations in the maternal-effect gene fodestar result in 
chromatin bridges at anaphase. The precise molecular 
pathway in which this protein functions is unknown. but 
one of the processes suggested is completion of incom-
plete DNA repair or replication pr'10r to mitos'1s (Girdham 
and Glover, 1991). 
It is of interest to note that the three major DNA repair 
pathways in yeast are all equipped with at least one mem-
ber of this subfamily: AAD16 in NEA of the inactive HMLa 
locus, i.e., opposite from the function of ERCC6 (Terleth 
et al., 1990}; AAD54 in recombination repair (Saeki et al.. 
1981; Budd and Mortimer, 1982}; and AAD5 in postreplica-
tion repair (Johnson et al.. 1992}. Our results demonstrate 
that preferential repair of active genes alSO involves a 
member of this he!icase subfamily (£RCC6). Common de-
nominators of all proteins comprising this gene family 
could be complex formation (as described for SNF2 
[Laurent et al., 1991; Peterson and Herskowitz, 1992]), 
complex delivery at the desired site in DNA. and release 
of DNA-bound proteins (as proposed for MOT1 [Davis et 
al.. 1992]). although other options can be envisaged as 
well. 
Hypothetical Models for ERCCS Function 
The predicted amino acid sequence of EACC6 advocates 
the protein to be a nuclear DNA helicase, with strong se-
quence homology to the subfamily described above. The 
ability of the ERCC6 eDNA to correct the repair defect of 
C8-B fibroblasts and the severe mutations in CS1AN cells 
provides evidence for a specific ro!e of EACC6 in preferen-
tial repair of active genes. Preferential repair has been 
documented in mammals (Bohr eta!., 1985; Mellon et al .• 
1986, 1987), yeast (Terleth et al., 1989; Smerdon and 
Thoma, 1990), and E. coli (Mellon and Hanawalt. 1989). 
The molecular mechanism of the process itself is, never-
theless, completely unknown. A major step toward defin-
ing this NER sub pathway in E. coli is the recent purification 
of the transcription repair coupling factor (TACF) (Selby 
and Sancar, 1991). This polypeptide, identified as the mfd 
gene product (Selby eta!., 1991), specifically enhances 
repair of the template strand of an actively transcribed 
gene in an in vitro repair system. It is speculated that the 
protein recognizes a ANA polymerase complex that is 
stalled at a DNA lesion and forms together with this com-
plex a high affinity binding site for other repair proteins 
(the UvrABC complex) (Selby et al., 1991). With respect to 
the biochemical reaction that the EACC6 protein might 
catalyze within the mammalian preferential repair pro-
cess. we can envisage several models. First, a transcrip-
tion complex stalled at a lesion will probably sterically hin-
der access to the damage by the NEA machinery and 
should somehow be displaced. A possibility would be that 
the presumed helicase activity of EACC6 serves to dissoci-
ate the RNA polymerase complex from the DNA, e.g., by 
locally melting the nascent ANA-DNA hybrid region, or 
that the protein forces the polymerase complex either past 
the injury or backward (see MOT1 [Davis eta!., 1992]). 
Extrapolating from this idea, it may be that an important 
function of this subfamily of putative he!icases is to strip 
bound proteins from specific DNA regions either in the 
context of repair or in transcription regulation. Dissociation 
of protein complexes from nucleic acids by helicases has 
already been suggested in the process of splicing (Ruby 
and Abelson, 1991). Second. or in addition, the EACCS 
helicase could, as part of a repair complex, be 'mvolved in 
scanning the transcribed strand of active genes for a 
stalled ANA polymerase, thus efficiently guiding the NEA 
machinery to lesions that thwart transcription (see TACF 
[Selby eta!., 1991 ]). Which of the presented or other possi-
ble hypotheses concerning ERCC6 function corresponds 
to the actual role of the protein in the preferential repair 
subpathway remains to be elucidated. 
Experimental Procedures 
General Procedures 
Purification 01 nucleic acids, restriction enzyme digests. gel electro-
phoresis. DNA ligation. synthesis of radlolabeled probes using random 
oligonucleotide primers, and filter hybridization were performed ac· 
cording to established procodures (5ambrook et al.. 1969). 
Isolation of eDNA Clones and Sequence Analysis 
Unique genomic fragments were used as a probe to hybridize a Agt1 1 
human testis eDNA library(Cionetech). eDNA fragments isolated were 
subsequently used as probes to screen eDNA libraries from human 
testis. placenta (Ye et al.. 1987), brain (cortex), amygdala. ovary 
(Cionetech), adenovlrus-translormed retina cells. or pre-S cell line 
Nalm-6 (provided by Dr. A. Bernards). and a eDNA library provided by 
Dr. H. Okayama Soquence analysis was performed on denatured 
double-stranded plasmid by the dideoxy chain termination method 
(Sanger et al., 1977) using T7 DNA polymerase (Pharmacla). Se-
quences were determined on both strands either by construction o1 
plasmlds containing progressive unidirectional deletions with the 
Erase-a-Base System (Pro mega) or by sequence-specific primers. Se-
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quences have been compared with the protein and nucleotide data 
bases using TFASTA and BLAST (Altschul at al., 1990). 
Plasm ids 
Construction of the eDNA expression plasmid was dono as follows (see 
Flguro 1): HTL1B and HTL1C (nucleotldos 1462-3746 and :2700-
4714), contalnmg several internal EcoAI sJtes, wore isolated from the 
A vector (cloning site EcoAI) via PCR and joined at the unique Bglll 
site (nucleotide 2991). The 3.2 kb eDNA thus obtained was cloned into 
the Sail site of pTZ19R containing a more 5'but overlapping fragment 
{HTL 1J(O.SE)) of 700 bp. with 205 bp overlap In the following orienta-
tion: EcoRI-700 bpfragment5'to 3'-EcoRI-$all). Transformation Into 
E. coli strain DHSo.F' resulted In a plasmid that had recombined the 
two ERCC6 fragments somewhere In tho 205 bp overlapping region. 
The ERCCS sequence of this plasmid was verified, and one mistake 
originating from the PCR was removed by exchanging the Nsil frag-
ment contalningthe error with tho original Ns!l fragment. The total OAF 
was then obtained by ligation of the most 5' fragment to the PfJMI 
site at position 1381. This almost full-length eDNA moleCtJie was then 
ligated Into a modified pSVL eukaryotic expression vector {Pharmacla; 
M. van Du'1n, unpublished data), yielding pSLME6[+). 
Cell Lines, Transfee\lon Experiments, UV Selection, 
and UV survival 
The CHO cell lines used wore wild-type AAS, mutants UV41. UV135. 
UV61, and VB1 1 from CG-4. CG-5, CG--6. and CG·7, respectively 
(Zdzienicka et al., 1988: Busch at al., 1989), and two new and unpub-
lished mutants from group 6 provided by Dr. D. Busch. The immortal-
Ized human fibroblasts are SV40-A'dam (Wild type), CW12 {XP.C from 
XP7CA}, CW3 {XP-E from XP2RO) (Wood at aL, 1987), XP2YOSV 
()<P·F) (Yagl and Takebe, 1983}. CS3BE.S3.G1 {Cs-A) {Mayne et al., 
1986), and CS1AN.S3.G2 (CS-B} (Mayne et aJ., 1986). Primary fibro-
blasts used are XP1 Bl {XP-G) (Keijzer et al., 1979). CS3BE (CS-A), 
CS1AN (CS.B), and CS1BE (CS-B) (Lehmann. 1982). All CHO cells 
and Immortalized human fibroblasts used were grown in 1;1 F10-
0ulbecco's minimal essential medium supplemented with antibiotics 
and S%-10% fetal calf serum (F10-0MEM). Primary fibroblastS were 
cultured in F1 0 supplemented wtlh antibiotics and 1 0%-1SOJo fetal calf 
serum. Transformed OOis harboring the E. con neo dominant marker 
gene (plasmid pSV2noo} were selected and cultured in medium con-
taining (3418 (concentration 300-850 J,~glml. depending on the cell 
line). 
Transfect:Jon of CHO cells and immortalized fibroblasts was per-
formed using lipofectln (Bethesda Research laboratories). essentially 
as described by tho manufacturer. All cells were transfect:ed at approxi· 
mately 80% confluence (on 60 mm petri dishes). with 2 1-1g of p$V2neo 
and 5 1-1g of pSLME6(+). DNA (a total of 7 11g) and 14 11g of Ilpofectln 
were separately added to Opti-MEM (Bethesda Research labora· 
torles); thereafter, the two were mixed and lett at room temperature 
for 15 min. Cell~ were washed with phoc.phata-buHered saline (PBS) 
before addition of the Opti·MEM-ONA-IIpofectin mixture. CHO cells 
wore Incubated for ~7 hr; thereafter 10% fetal calf serum was added. 
Medium was refreshed with F10-DMEM af!.er approximately 16 hr. 
Immortalized human fibroblasts were inCtJbated for a slmllar period, 
but medium was subsequently refreshed with F10-DMEM. Cells were 
trypsin !zed (and. depending on cell density, divided over more dishes) 
and placed on selection medium 48 hr attertransfection. Select:lon for 
repair-proficient transformants was started after the appearance of 
G418-res!stant colonies. Cells were trypsinized, and UV select:lon was 
started 1~20 hr attertrypsinJ;::atlon for CHO cells. 20-48 hr after tryp-
sinization for Immortalized human fibroblasts. cells were irradiated 
three times, CHO cells at 1 day Intervals and the SV40-Immortalized 
fibroblasts at 2 day Intervals. The UV dose given (Philips TUV low 
pressure mercury tube, 15 W, 0.45 Jlm'ts; predominantly 254 nm) 
var'1ed with the cell line; 2 Jim' (UV135); 4 J/rrt' (UV41, XP2YOSV): 6 
J/m2 (CW12, CS1AN.S3.G2); 8Jfrrt' (CS3BE.S3.G1); 8.4J/m2 (UV61): 
and 11 Jlm2 (VB11). 
For determination of UV sensitivity of G41 a-resistant mass populations 
(CS3BE.S3.G1 and CS1AN.S3.G2 translormants), G418-rosistant plus 
UV-rosistant mass popu!atlons (61 E6a), or isolated UV-rosJstant colonies 
(E61ANa and E61ANd), cells ware plated at densities varying from 2 x 
10"10 5 x 10"cellsper 60 mm petri dlsh, depending on cell line and UV 
dose. Cells were rinsed with PBS and exposed to UV light about 1 day 
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attar plating. A series of dishes was Irradiated for ooch cell line, each 
receMng a single UV dose (throodishes per UV dose). Clones were fixed 
and stained with Coomassie brilliant blue &-1 o days after UV Irradiation, 
and relative cloning efficiencies were determined. 
RNA Synthesis Reeovery 
The r.~ethod used was as described by Mayne and Lehmann (1982). 
wtth several modifications. Cells ·.vere seeded in 30 mm petri dishes 
In 1.5 ml of medium. One day after seeding, the medium was changed 
for F10. supplemented with antibiotics. 15% fetal calf serum • .20 mM 
HEPES. and 0.0.25 J,~CI/ml [,.C]thymldlne (50 mCi/mmol). The cells 
were grown for 16 hr, and then the medium was removed; cells were 
rinsed with PBS and UV Irradiated (at 254 nm. fluence rate 0.7 Jim'ts, 
three petri dishes for each time point or UV dose). At various times 
af!.er UV irradiation, the medium was replaced by medium containing 
S 1-1Cilml ['H]urldino (45 Ci/mmol), and the cells were Incubated for 1 
hr. At the end of the labeling penod, cells were washed once with 
leo-cold PBS containing >1 mM uridine and once with lee-cold PBS. 
Cells were scraped from the dishes and spotted onto GF/C Whatman 
glass filters soaked in 10% trichloroacetic acid. These were then 
washed once in 10% trichloroacetic acid and 960/o ethanol, dried, and 
counted In a liquid scintillation counter. "C counts served as an Internal 
control for the number of cells present. 
Microln]ectlon 
ERCC6 construct p$LME6(+) was Injected Into nuclei of XP or CS 
homopolykaryons as described by van Duln et al. (1989). Cells were 
incubated 24-4S hr to allow expression of the injected DNA. To deter-
mine the Influence of the ERCC6 gene on DNA repair ,Injected XP cells 
were subjected to UV-Induced repair synthesis (unscheduled DNA 
synthesis), which was measured by autoradiography as described pre-
viously (Vermeulen etal., 1986).1njected CSflbrotllastswere UV lrradl· 
ated and subsequently lncubaled with fH]uridlne to measure recovery 
from uV-Induced RNA synthesis Inhibition. 
DNA Amplification and Mutation Determination 
Total RNA (10 1-1g) was used for preparation of eDNA with £RCC6-
speciflc primers. RNA was dissolved in 5 111 of water. heated tor 3 min 
at 85°C, and cooled on Ice. Subsequently, the RNA was added to 15 
111 containing so pmol ot3'primer, 18 U of RNAguard (Boehringer), 12.5 
U of avian myeloblastO'"..ls virus reverse transcriPtase (Boehringer), 1 
mM dNTPs, 50 mM KCi, .20 mM Tr1s HCI (pH 8.4 at .20°C), 2.5 mM 
MgCI,. and 100 11g/ml bovine serum albumin; incubation was for 1 hr 
at 37oc. The eDNA (4 ~I of tho above reaction mixture) was added to 
961-11 containing 10 pmol of 5' primer, 0.2 mM dNTPs, 50 mM KCI, 20 
mM TrisHCI {pH 8Aat20°C),2.5 mM MgO,, 100 ~J.g/miBSA. and2.5 
u of Taq polymerase {Bethesda Research laboratones); the mixture 
was overlayed with oil. In some expenments, Taq polymerase was 
added only af!.er the samples reached the denaturing temperature of 
94°C (hot start). Amplification was done 1n 35 cycles: 1 (or 2) cycles 
of 5 min denaturation at 94°C, 5 min annealing (temperature de-
pending on primer combination used). and 5 min extension at 72°C, 
followed by 34 (Or 33) cycles of 2 min at 94°C, 2 min annealing, and 
3 min at 72°C. Chromosomal DNA was amplified as above, startmg 
from 200 ng. in 25 cycles. Asymmetric PCR was performed on 1 1-11 of 
PCR product, using the conditions mentioned above (35 cycles), with 
a primer ratio of 1:100 (0.5 pmol ofoneandSO pmol oftheo!herpr"1mer). 
If available.lnt&rnal primers were used. Products were extracted once 
with phenol-chJoroform-isoamyjalcohoJ and once with chloroform, 
separated from oligonucleotides and dNTPs on a Centrlcon-1 00 col· 
umn (Amicon), and dried under vacuum in a SpeedVac concentrator 
{New Brunswick Scientific). Pellets were dissolved in 15 1-11, 7 1-11 of 
which was used for each sequencing reaction. 
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SUMMARY 
The human repair gene ERCC6- a presumed DNA (or RNA) helicase - has 
recently been found to function specifically in preferential nucleotide excision 
repair (NER). This NER subpathway is primarily directed towards repair of (the 
transcribed strand of) active genes. Mutations in the ERCC6 gene are responsible 
for the human hereditary repair disorder Cockayne's syndrome complementation 
group B, the most common form of the disease. In this report, the genomic 
organization and expression of this gene are described. It consists of at least 21 
exons, together with the promoter covering a region of 82 - 90 kb on the genome. 
Postulated functional domains deduced from the predicted amino acid sequence, 
including 7 distinct helicase signatures, are - with one exception - encoded on 
separate exons. Consensus splice donor and acceptor sequences are present at all 
exon borders with the exception of the unusual splice donor at the eud of exon 
VII. The "invariable" GT dinucleotide in the consensus (C,A)AG I GTPuAGT is 
replaced by the exceptional GC. Based on 42 GC splice donor sequences identified 
by an extensive literature search we found a statistically highly significant better 
"overall" match of the surrounding nucleotides to the consensus sequence 
compared to normal GT-sites. This confmns and extends the observation made 
recently by Jackson (Nucl. Acids Res., 19,3795-3798 (1991)) derived from analysis 
of 26 cases. Analysis of ERCC6 eDNA clones revealed the occurrence of 
alternative polyadenylation, resulting in the (differential) expression of two mRNA 
molecules (which are barely detectable on Northern blots) of 5 and 7 kb in length. 
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INTRODUCTION 
Nucleotide excision repair (NER) is one of the major DNA repair systems 
functioning in mammalian cells (Friedberg, 1985). It is able to remove a broad variety 
of DNA lesions, such as UV -induced pyrimidine dimers and (6-4) photoproducts, as 
well as bulky chemical lesions and DNA cross links. After induction of DNA damage, 
the NER machinery appears to be directed first primarily towards the transcribed 
regions in the genome. This enables the cells to rapidly resume the vital process of 
transcription, that otherwise would remain blocked by lesions in the DNA template 
(Bohr, et al., 1985). This preferential repair of active genes is even specific for the 
transcribed strand (Mellon, eta!., 1987). Removal oflesions from the non-transcribed 
strand, as well as from inactive chromatin proceeds more slowly and appears to be 
incomplete for several lesions (Link Jr., et al., 1991 for a recent review). In human 
cells, repair of the non-transcribed strand is more rapid than that of inactive genes 
(Venema, et al., 1992). 
In the rare hereditary disorders xeroderma pigmentosum (XP) and Cockayne's 
syndrome (CS), deficiencies in NER are thought to underlie the clinical symptoms. 
XP patients are clinically characterized by severe sun(UV)sensitivity of the skin, 
pigmentation abnormalities, a highly elevated risk for developing skin tumors, and 
often neurological degeneration (Cleaver and Kraemer, 1989). Cell fusion experiments 
with cells from these patients have distinguished 7 NER-deficient complementation 
groups (cg; XP-A to XP-G) (De Weerd-Kastelein, eta!., 1972; Vermeulen, et al., 
1991). The biochemical basis for the XP NER-defect probably resides in undefined 
early steps of the pathway preceding incision and repair (Shivji, et al., 1992). For XP-
C cells the defect appears to be specific for repair of inactive chromatin; these cells 
have retained the ability to remove damage from the transcribed strand of active genes 
(Kantor, et al., 1990; Venema, et al., 1990b; Venema, et al., 1991). CS patients 
have, in sharp contrast to XP, no pigmentation abnormalities and no elevated risk for 
skin tumor formation. They are clinically characterised by skeletal and retinal 
abnormalities, growth retardation, progressive neurological degeneration, and a 
sunsensitive skin (Lehmann, 1987; Nance and Berry, 1992 for reviews). Like XP, CS 
is heterogeneous: 2 cg have been identified (CS-A, -B; Tanaka, et al., 1981; 
Lehmann, 1982). The molecular defect in CS-A and -B was shown to affect 
preferential repair of active genes only, whereas repair of the inactive chromatin 
regions proceeds normally (Venema, et al., 1990a). A third complementation group 
was defined (CS-C), containing one patient that exhibited a combination of 
characteristics of XP and CS. This patient is also classified as XP-B (Robbins, et al., 
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1974; Lehmann, 1982). Several patients exhibiting this combined XP/CS phenotype 
are reported; one of these has been assigned to XP group D \Vermeulen, et a!., 1991). 
Another class of mammalian NER-deficient mutants consists of laboratory-
induced, UV-sensitive, rodent (mainly chinese hamster) mutant cell lines. Among 
these, at least 10 cg have been defined (Thompson, et al., 1988; Zdzienicka, et aL, 
1988; Busch, et aL, 1989; Stefanini, et al., 1991). A number of rodent mutants have 
been successfully used for isolation of human genes capable of correcting the rodent 
repair deficiency (Hoeijmakers and Bootsma, 1990 for a recent review). Subsequent 
introduction of these genes into XP and CS cells has demonstrated an overlap between 
the hamster and human cg: rodent cg 2 and 3, corrected by ERCC2 and -3, are the 
rodent equivalents of XP-D and XP-B, respectively (Weeda, et al., 1990; Flejter, et 
al., 1992). Recently, we have isolated the human repair gene ERCC6 by virtue of its 
ability to correct the UV -sensitivity of the Chinese hamster ovary (CHO) mutant cell 
line UV61, cg 6 (Troelstra, et al., 1990). The gene encodes a protein of 1493 amino 
acids; the predicted amino acid sequence suggests that the ERCC6 gene product is a 
nuclear DNA helicase. Mutations in the ERCC6 gene appear to be responsible for the 
repair deficiency of CS-B cells, implying that the ERCC6 gene product is specifically 
involved in the process of preferential repair (Troelstra, et a!., 1992b). This paper 
describes the genomic architecture and expression of the ERCC6 gene. 
MATERIALS AND METHODS 
General procedures 
Purification of nucleic acids, restriction enzyme digests, gel electrophoresis, 
DNA ligation, synthesis of radiolabeled probes using random oligonucleotide primers, 
the polymerase chain reaction (per), sequence analysis (dideoxy-mediated chain-
termination), and filter hybridization were performed according to established 
procedures (Sambrook, eta!., 1989). 
Construction of the eDNA plasmid 
Construction of the (almost) full length ERCC6 eDNA was as described 
(Troelstra, et al., 1992b). The eDNA insert was subcloned into both the vector 
pTZ!9R (Pharmacia) yielding pTZE6total, and the mammalian expression vector 
pSLM, a derivative of pSVL (Pharmacia; Van Duin, unpublished results). In the 
mammalian expression vector the ERCC6 eDNA is under the control of the SV 40 late 
promoter, whereas in pTZE6total the eDNA is not preceded by a eukaryotic promoter. 
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Cell culture, transfection, and selection 
UV-sensitive CHO cell line UV61 and wt CHO cell line AA8 were grown in 
1:1 FlO-Dulbecco minimal essential medium supplemented with antibiotics and 8% 
fetal calf serum. The ERCC6 eDNA construct pTZE6total (3 p.g) was cotransfected 
with 2 1-'g pSV2neo and 20 1-'g lambda phage 6B (see Figure l) to UV6l cells. In 
order to release the lambda arms and plasmid vector from the inserts prior to 
transfection, both pTZE6total and lambda phage 6B were digested with Sal I; an 
enzyme which does not cut within the insert. Transfection and selection were 
performed as described before (Troelstra, et al., 1992b). 
Identification of intron-exon borders 
All genomic fragments hybridizing to the ERCC6 eDNA were subcloned in 
pTZ19R (Pharmacia) or pBluescript II KS (Stratagene), and sequenced with ERCC6-
specific primers. All sequence reactions were performed on double-stranded templates 
by the dideoxy chain termination method, using T7 DNA polymerase (Pharmacia). 
Intron length was determined either by restriction enzyme digestions and subsequent 
Southern blot analysis or by per with exon-specific primers on subcloned genomic 
fragments. 
Northern blot analysis 
RNA samples were separated on an agarose gel and transferred to a nylon 
membrane (Zeta probe from Bio-Rad) as described by Fourney et al. (Fourney, et al., 
1988). The filters were hybridized at 65°C, in 3xSSC, 10xDenhardt's reagent, 0.1% 
SDS, 90 J-Lglml dextran sulfate, and 50 J-Lg/ml denatured salm sperm DNA. Filters 
were washed 2 times (10 min.) in 3 x sse, 0.1% SDS and once (10 min.) in 1 x 
sse, 0.1% SDS, at 65°e. 
Synthesis of strand-specific probes 
Strand-specific probes were synthesized according to the method described by 
Espelund et al. (Espelund, et al., 1990), with several modifications. The template was 
generated by per, with one normal and one biotinylated primer. The biotinylated 
product was then bound to streptavidin-coated magnetic beads (Dynabeads M-280, 
Dynal) through a 30 min. incubation at 37oe in 5xSSPE (20xSSPE: 3.6M NaCI, 
200mM NaH2P04 pH7.4, 20mM EDTA pH7.4). The beads were washed 4x with a 
solution containing 0.17% (w/v) Triton X-100, 100 mM Nael, 10 mM Tris.Hel 
pH7.5, and 1 mM EDTA; subsequently the non-biotinylated strand was removed by 
2 cycles (7 min. each) of denaturation in 125 mM NaOH, 100 mM NaeL After 
washing twice with 100 mM Tris.Hel pH7 .6, 150 mM NaC!, the biotinylated strand 
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is radioactively labelled via primer extension. The beads were washed 3x, and the 
DNA was denatured by two incubations (7 min. each) in 125 mM NaOH, 100 mM 
NaCL The supernatant was neutralized with an equal volume of 1M Tris.HCl (pH? .5), 
and used in hybridizations. 
RESULTS 
Architecture of the ERCC6 gene 
ERCC6 promoter region 
The ERCC6 gene was isolated from a lambda EMBL3 library originating from 
a repair-proficient secondary UV61 transformant. The genomic region coinherited by 
independent, repair-proficient primary and secondary UV61 transformants, as judged 
by Southern blot analysis, was approximately 100 kb, and consequently separated over 
several lambda clones (Troelstra, eta!., 1990). A physical map of this region is shown 
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Figure L Genomic organization of ERCC6. A physical map of the ERCC6 locus is shown. Exons 
(I to XXI) are indicated by boxes on the bar underneath the map. cDNAs from the two encoded, 
differentially poly-adenylated mRNAs are shown; white and hatched areas represent untranslated 
regions, the black area represents the ORF. Exon borders in the eDNA are indicated by vertical lines 
on top of the shortest eDNA. Phage 6B: a A-phage containing the promoter region of the ERCC6 
gene. Symbols: fJ, a CpG-island encompassing a Bss HI. Not I, and a Sac II restriction enzyme site 
located just 3' of exon I; S, Sa! I; B, Bam HI; short bars in the map representEco RI restriction sites. 
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in Figure 1. The size of the ERCC6 locus was determined by hybridization of an 
(almost) full length, functional eDNA of 4.7 kb, encoding at least the total open 
reading frame and the 3' end (of the shortest mRNA, see below), to the different 
lambda clones. The eDNA, previously localized on chromosome 1 Oqll-21 (Troelstra, 
et al., 1992a), was shown to encompass 82 kb at the genome level (Figure 1) and to 
reside on a 430 kb Not I fragment (data not shown). One of the Not I sites is part of 
a CpG-island present in the 5' region of the ERCC6 gene (Figure 1). To pinpoint the 
region containing the promoter and the 5' untranslated end of the mRNA (part of 
which might be lacking in the eDNA), a promoterless eDNA construct (pTZE6total, 
see Materials and Methods) was cotransfected with lambda clone 6B, containing the 
first 4 exons present in the eDNA, and approximately 8 kb more upstream sequences 
(Figure 1). To be expressed, the promoterless eDNA should recombine within the cell 
with the cotransfected lambda phage, thus producing a "mini gene". After transfection 
of the two DNAs together UV -resistant clones were obtained, with an efficiency that 
was =lOx lower than after transfection of a eukaryotic expression vector carrying the 
ERCC6 eDNA behind the SV 40 late promoter. The UV -sensitivity was corrected to 
a level within wt range (Figure 2), as determined by survival experiments with pooled 
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Figure 2. Correction of the UV-
sensitivity of mutant UV61 by the 
ERCC6 gene. UV survival curves of wild 
type CHO cell line AA8 (E--E), 
mutant UV61 (e .. -.. e), and UV61 cells 
cotransformed with A-phage 6B (see 
Fig.!) and a promoterless ERCC6 eDNA 
( ........ ). 
clones. To rule out the possibility that the UV -resistant transformants obtained in the 
cotransfection experiments were caused by fortuitous integration behind an endogenous 
promoter, instead of reconstitution of a functional gene by recombination between the 
5' ERCC6 gene part with the rest of the eDNA, we also transfected the eDNA without 
a functional promoter at its 5' end. In this experiment, in which the eDNA was placed 
in the inverted orientation in vector pSLM, no UV -resistant clones were obtained. 
These findings strongly suggest that a functional gene has indeed been generated via 
homologous recombination (between the lambda and eDNA clones) within the cell. 
The promoter should then be situated within the ± 8 kb genomic region 5' of the first 
exon present in the eDNA clone. The ERCC6 locus thus covers a region of 82 - 90 
kb. 
Intron exon structure 
Appropriate fragments were subcloned into plasmid vectors in order to 
determine intron-exon borders. Sequence analysis demonstrated the ERCC6 eDNA to 
be dispersed over 21 exons (Figure 1 and 3). The CpG-is1and present in the 5' region 
of the ERCC6 gene is situated within the first intron of ERCC6 (Figure 1). The first 
exon present in the eDNA does not contain any coding information, analogous to the 
' first exon in another repair gene, ERCCi (Van Duin, et al., 1987). Since we have not 
determined the transcriptional start site, we cannot exclude the presence of an 
additional exon more 5' on the genome, which is absent in the eDNA. The presence 
of a CpG-island in the first intron, however, argues against the existence of an 
additional 5' exon located far upstream. The tentatively identified functional domains 
are - with the exception of helicase signature VI - encoded by separate exons (Figure 
4). 
As shown in Figure 3, all sequences around intron-exon and exon-intron 
borders are consistent with the consensus splice acceptor and donor signals 
(Senapathy, et al., 1990), with the exception of the splice donor of the intron VII. The 
canonical GT dinucleotide at the beginning of the intron is replaced by GC (see 
below). In all introns, the weakly defined branchpoint sequence (PyNPyTFuAPy) 
could be tentatively identified at the appropriate distance (10 -50 nt) from the splice 
acceptor site (underlined in Figure 3; Ruskin, et al., 1984; Senapathy, et al., 1990). 
One alternatively spliced eDNA molecule has been isolated, in which exon VIII was 
found to be skipped. The sizes of internal exons range from 79 to 745 nt. Three of the 
internal exons (exon II, V, and XVIII) have an exceptional size: 436, 745 and 708 nt, 
respectively; the average exon length for vertebrate internal exons being 137 nt 
(Hawkins, 1988). Intron lengths range from 85 to 19,000 nt; the average size of 
vertebrate introns being 1,127 nt (Hawkins, 1988). 
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INTRON EXON INTRON 
SP TCE ACCEP'T'OR SPLICE DONOR 
I (~65) CCCTGG ? (6 kb) 
TACAATGAATCCTATATAACGAAAA 66 501 
GGCTTATAAATTTTTTTCCTTTTAG GTAGTC II (436) CCTCAC GTGAGGTCCAGCC ( 1. 8 kb) 
TATAAAAATGTTATCAGAGTGCAAA 502 622 
ATAGACAATTTATCTTATTTTTCAG GTCATG III (121) AATAAG GTGATTCAGAATA ( 2.1 kb) 
CAATAAATCACTTCATTGCTGTTTT 623 731 
CTGTCTTCTATATTTACCATTCAAG GAACAA IV (109) ATGCAG GTGAGGATGCTAG (4 kb) 
CCCTCGGAAAGTTTCATGCTAGTGG 732 1476 
CAAAGCATTGCTATTGTTCTTTCAG AGCCGG v (745) GTTAAG GTCGGTCTGTGGG (19 kb) 
TCTGTCTTGTGATCAAAATAATGGA 1477 1605 
AATGTGATTTTTATTTTCATGGTAG GAGATG VI (129) TTTTAA GTATGTACCATAT (5 kb) 
TATCCACCATTTGCCATTTTCTCTT 1606 1764 
TTCTTGTTGGTGTTTGTTGTCATAG GTACCA VII (159) TTACAG GCAAGTGCTCCTC ( 7. 5 kb) 
TCTTTCATGGTT 1765 1900 
GTTTTCTTCTTGCGTTTGGATGCAG GTTTGA VIII (136) AAAAAG GTAACACAATATT (9 kb) 
GGTGTCACTTCTTATTT~ 1901 2071 
£TTTACCATTTTATTGTGGTCTCAG GAGAAA IX (171) AAACAG GTATGACCTCTTT (0.5 kb) 
GATTGCTAAAAGGTAAATTTAATAA 2072 2241! 
~GGTGCTTCCTTTCCTCAAATAG TTTCGC X (177) GTACAG GTAAAATATTAGG (3.5 kb) 
TTCCTTAAACATATATAGTAAT 2249 2365 
GTTCCCTTCTCTGCTCTTATTAAAG GTCAAA XI (117) GAACAG GTCTGTAAATCCA (2 kb) 
GTTAATTTTTTTTTTGAAATTATAG 2366 2461 
TTTCCTTGTTTTTCCCGGTTCGTAG GTCTTA XII (96) ATGCAG GTCAGCTAAAAAA (2 kb) 
TTACTTTACATGGGGTCATCTGAGT 2402 2677 
GTACATGTACTCTTTCTTACGACAG ATTTTC XIII (216) AGGCAG GTGAGTGCACAGA ( 0 • 5 kb) 
CTGGGAATGTGTATTTGCTTTGCAA 2678 2788 
~CTCCTATCCCCCACCTCCAAACAG ATGCTG XIV (111) AATGAG GTAACATGTGAAT ( 0. 4 kb) 
TGTAACTGGTCTTAAGTGTGTGTGC 2789 2908 
TCAGTGTTGTGTGTCTTACCTCTAG GACACA XV (120) ACGCAG GTTTGTTTTTATT (0.4 kb) 
GTCATTGGGAAGGATTCTCGTTG 2909 3003 
AGAGGTCTCTCTCTCTCTGTTGCAG GCCCGG XVI (95) CCACCG GTCAGTGCACACA ( 1. 1 kb) 
TAGGTAGAGCTACACATTGTTTTAT 3004 3149 
ACCAGCTTATCTTTTATTTTTTTAG ACAAAT XVII (146) TTGCAG GTATTACATAAAA (85 bp) 
TTGCACAAGATGATACAATATA~ 3150 3857 
TTAGTGGTGTTTTTCCTCTTTACAG GAACTG XVIII (708) AATCAG GTAACCATTTGAT (8.5 kb) 
TTTCTTGCATACAGAGTGAAATATC 3858 4062 
ACTTTGCTATTTCTTTTCTTGCTAG TTGGCG XIX (205) AAAAAA GTAAGAGATTGCT (0.8 kb) 
AAGTCTCAAAAGCAAACATTTAATC 4063 4141 
TACTGTGATGCTTTTCCTTTTTTAG GAGTAG XX (79) TGCCAG GTAATATAGATAA (1.2 kb) 
GGCATAAACTAGAAATTAAATATAT 4142 
gaQTATAGTGGTCTTCTTTTTATAG GATGGC XXI (573 I 2.5 kb) 3'poly(A) 
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Figure 4. Schematic depiction of the postulated functional domains as encoded by different exons. 
The shaded area represents the ORF; encoded domains are indicated above the exons. Intron length 
is given in kb. The postulated functional domains (froelstra, et al., 1992b) encoded by the different 
exons are indicated: A, acidic amino acid stretch; S, putative nuclear location signal followed by a 
postulated casein kinase II phosphorylation site; the helicase signatures are numbered I to VI; N, 
putative nucleotide binding fold. The interrupted box added to ex on XXI indicates the 3 • end of the 
longest ERCC6 mRNA, produced by alternative poly-adenylation. 
ERCC6 gene expression and alternative poly-adenylation 
Northern blot analysis of human poly(A)+ RNA demonstrated the presence of 
two ERCC6 transcripts of approximately 5 and 7 kb in length, both expressed at a 
very low level (Figure 5). To examine the structure of the long ERCC6 mRNA, 
various eDNA libraries were screened for the presence of clones with extra sequences 
not found in the 4.7 kb eDNA. One of the isolated (partial) cDNAs had a 3' 
untranslated region extending 2 kb more 3' as the mentioned 4.7 kb construct. It 
contained a poly(A)tail, preceded by the common polyadenylation signal AATAAA 
(Birnstiel, et al., 1985; Wickens, 1990)_ The total length of the isolated eDNA then 
becomes ±6.7 kb, probably reflecting the longest mRNA. Sequence analysis and 
restriction enzyme digests showed the 3' untranslated region to be colinear with the 
genome. This suggests the 2 mRNA products to be the result of alternative 
polyadenylation (Figure 1). 
Analysis of mouse tissues revealed the presence of elevated (though still very 
low) levels of ERCC6 mRNA in brain and testis; in most other tissues transcription 
was below detection level (Figure 5). Also in mouse two transcripts are identified, 
Figure 3. Structural organization of the ERCC6 gene. The nucleotide sequence of each intron-exon 
junction is shown~ with the exception of the splice donor of exon I. The vertical lines represent 
intron-exon borders. The splice donor of exon VII has a GC dinucleotide (indicated in bold) at the 
position of the canonical GT. All other acceptor and donor sires are in reasonable accordance with 
the consensus sequence (Py),NCAG/G and (C,A)AG/GTPuAGT (Senapathy, et al .• 1990). The 
nucleotides at the borders of each exon are numbered as reported previously (froelstra, et al., 1992b). 
The size of introns and exons are given between parenthesis (in bp, if not indicated otherwise). 
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Figure 5. Expression of the ERCC6 gene. 
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A: Northern blot analysis of 5 p.g poly(Aj+ mRNA from HeLa cells, hybridized with a "P-Iabeled 
ERCC6 eDNA fragment extending from nt 1662- 3746 (middle probe). B: Northern blot analysis of 
5 p.g poly(A)• mRNA from HeLa cells and STl, a secondary repair proficienttransformant ofUV61, 
containing the human ERCC6 gene (froelstra, et al., 1990). The blot is hybridized with a strand-
specific probe (''P-labeled transcribed strand, TS) spanning nt 16 to 1667 from the ERCC6 eDNA. 
A radioactively labeled non-transcribed strand did not recognize any transcript (result not shown). C: 
Northern blot analysis of 20 p.g of total RNA from different mouse tissues. The probe used is similar 
to that in A. 
suggesting that the alternative polyadenylation is conserved. Remarkably, the larger 
transcript is the most abundant in mouse brain, whereas in testis the smaller mRNA 
is the more frequently occurring one (Figure 5). 
In human RNA, a third transcript of 3.5 kb is detected, with probes in the 5' 
1.7 kb of the gene. A probe from nt 1662 to 3746 did not detect this short transcript. 
Both a probe covering the first 350 bp of the eDNA (exon I and part of exon II) and 
one spanning nt 1020 to 1667 (part of exon V, exon VI and 60 nt of exon VII) 
recognize this short transcript, suggesting that at least sequences from exon I or H as 
well as exon V or VI (and maybe the 60 nt of exon VII) should be present. The 
transcript is detected in both total and poly A+ RNA. Hybridizations with strand-
specific probes, as shown in Figure 5, have excluded the possibility of an overlapping 
antisense gene: the transcript appears to be produced from the same strand as the two 
longer ERCC6 mRNAs. Since we have been unable to identify ERCC6 transcripts in 
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mouse tissues with a 5' probe, it is unclear whether the 3.5 kb transcript is conserved 
through evolution. 
DISCUSSION 
The ERCC6 gene product, which is predicted to be a nuclear DNA helicase, 
has recently been shown to be involved in the human DNA repair disorder Cockayne's 
syndrome (Troelstra, et a!., 1992b). In this paper, the expression and structural 
organization of the ERCC6 gene are reported. 
Two lowly expressed ERCC6 mRNA molecules of 5 and 7 kb have been 
identified by Northern blot analysis of human poly(A)+ RNA (Figure 5). Two types 
of cDNAs have been isolated, varying in their 3' end by differential polyadenylation. 
The second polyadenylation site, accompanied by the common polyadenylation signal 
AATAAA, is present 2 kb downstream of the first one that contains the less preferred 
signal A TT AAA (Bimstiel, et a!., 1985; Wickens, 1990). Alternative polyadenylation 
occurs in many genes, including another human NER gene ERCCJ (Van Duin, et al., 
1987). It is unclear though, whether this has any regulatory function. In this respect, 
it is interesting to note that often the alternative polyadenylation is evolutionarily 
conserved, as it is- presumably- for ERCC6. We noted differential expression of the 
two transcripts in mouse brain and testis (Figure 5). It is unknown whether the 
elevated expression of the longest ERCC6 mRNA in brain is related to the (severe) 
progressive neurological degeneration in CS patients. Also the function of the (human) 
3.5 kb transcript encompassing only the 5' region of the ERCC6 eDNA is unresolved. 
Hybridization with strand-specific probes ruled out the possibility of an overlapping 
antisense gene. An overlapping gene in sense direction seems unlikely, since it should 
then have (parts) of at least 2 exons (exons I or II and V, VI or VII) in common with 
the ERCC6 gene. A third possibility is that the 3.5 kb transcript is the result of a 
(strong) transcriptional stop due to the presence of an attenuation site. The attenuation 
site should then be within or 3' of exon V, which is approximately 15 kb (or more) 
from the transcriptional start site. Normally, attenuation takes place within a few 
hundred bp from the transcription initiation site, although there is one example of a 
termination site z2 kb from the start (c-myb; Watson, 1988). If, for the ERCC6 gene, 
the stop site is 3' of exon V, it could be within the 19 kb long intron V. Cross-
hybridization of unique human sequences from this intron to rodent DNA suggested 
the presence of 2 conserved regions within intron XIX (unpublished observations). It 
is possible that a second gene is located within this large intron, with transcription 
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termination sequences that can be recognized by RNA polymerase complexes 
transcribing the ERCC6 gene. Splicing of this prematurely terminated transcript might 
result in the observed 3.5 kb mRNA. A more conclusive statement concerning the role 
of this short (truncated) ERCC6 transcript should, however, await further research, 
particularly by the isolation of corresponding cDNAs. So far, no such cDNAs have 
been isolated, despite the screening of several eDNA libraries. 
The ERCC6 locus is 82 - 90 kb in length, and harbors at least 21 exons. The 
presence of a CpG-island within intron I (Figure 1) suggests that there is no 
unidentified exon more 5' (containing extra 5' untranslated sequences not present in 
the eDNA), although we cannot completely exclude this possibility. It is interesting 
to note that also ERCC2 and ERCC3 have CpG-islands within the first intron (Weber, 
et al., 1990; Weeda, et al., 1991). The putatively identified functional domains in the 
ERCC6 eDNA sequence are - with one exception - dispersed over separate exons. It 
has been proposed that modern eukaryotic genes may have been assembled from a 
limited number of ancestral exons encoding separate functional domains (Dorit, et al., 
1990). Within ERCC6, only helicase domain VI is split by intron XV (see Figure 4). 
Interruption of helicase domains by introns has been noted before: yeast RNA helicase 
p68 contains one intron in domain V (Iggo, et al., 1991), which is positionally 
conserved (between human, Saccharomyces cerevisiae, and Schizosaccharomyces 
pombe); within the ERCC3 gene (encoding a putative DNA helicase) both domain l 
and V are interrupted (W eeda, et al., !991). 
In one of the isolated ERCC6 cDNAs exon VUI was found to be skipped. 
Although we cannot completely exclude the possibility that a mRNA molecule without 
exon VIII has any functional potential, it seems unlikely. The exon skipping results 
in a frarneshift; consequently, the mRNA only encodes a very short protein. 
Presumably, this unconventionally spliced mRNA is the result of an erroneous splice 
event, rather than the product of a mechanism that creates an alternative, functional 
ERCC6 protein. 
All splice sites, with the exception of the splice donor at the 3' end of exon 
VII, are in reasonable accordance with the consensus sequences (Py).CAG I G and 
(C,A)AG I GTPuAGT for donor and acceptor, respectively (Senapathy, et al., 1990, 
see Figure 3). In the splice donor of intron VII, the "invariable" GT dinucleotide is 
replaced by GC. "GC" instead of "GT" splice donors are very rare. Recently, Jackson 
(Jackson, 1991) compared 26 "GC" splice donors from the literature, and noted that 
as a group they have a better "overall' match to the (CIA)AGIGTAAGT consensus 
than the regular "GT" donors. To assess the validity of this finding and to make 
conclusions statistically more significant, we have screened various data bases for 
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Table I. Summary of GC-splice donor sequences. 
Gene 
Human cytochrome P~4SO 
Hamster a:A·crystall in 
House czA-crystallin 
Mole rat a:A-crystallin 
Chicken <tO-globin 
Duck afl-globin 
Chicken myosin heavy chain 
Rat heme oxygenase 
Soybean nodul in-24 
Human factor XII 
Pig growth hormone 
Human acetylcholine receptor 
Rat pyruvate kinase 
Human superoxide disrotase-1 
Mouse superoxide disrotase-1 
Human pr-othronbin 
Human factor VI I 
Human erythrocyte a-spectrin 
Rat D2a receptor 
Earthworm hemGglobin chain c 
Minute virus of mice 
Human a-glucosidase 
Bovine aspartyl protease 
Mouse APRT 
Hamster APRT 
Human APRT 
Neurospora qa repressor 
Human argininosuccinat:e lyase 
Mouse TRP-1 
Murine fifth complement {CS) 
Hlnlln platelet GP Ilb (exon V) 
1\I.J'IIan platelet GP lib (exon VIII) 
Human keratin 18 
Mouse RNA polymerase (exon VII) 
Mouse RNA polymerase cexon XIII) 
E. typhina TUB-S 
Rat ESP·1 
HSV-1 LAT 
Hunan C3 
Hunan DNA ligase I 
H1..111an ERCC3 
Hunan ERCC6 
Sequence c~lementary. to U1 snRNA 
Sequence 
Exon Intron 
CACTAAG 
CATCAAG 
CGTCAAG 
CATCAAG 
TTTCAAG 
CTTcAAG' 
GCTGCA'G 
TCGACAG 
AAAGA'GG 
AGGA.£c_§ 
GCTGCAG 
CCGCAAG 
CACCCAG 
GCAGAAG 
GCAGAAG 
TGTGCTG 
GCTGCAG 
CATTCAG 
AATACA'G 
TCACgA 
TTTACAG 
CACCAAG 
TGGCGAG 
ATCGCA'G 
ATCGCAG 
ATCGCAG 
gEig~~ 
GTGGAAG 
ACGGGCT 
CACTCAG 
ACTACA'G 
CGAAGAG 
CTATAA'G 
crcc'CA'G 
CAAC'GAG 
CTATciG 
CAAGAAG 
TACCCA'G 
ACGcA'iG 
TATTAAG 
ATTACAG 
GCAAGCCCACA 
GeiAGTTACAT 
GCAAGTTACAT 
GCAAGTTTCGT 
GCAAGCAAAGG 
GCAAGCGGGGA 
GCAAGTGTCTG 
GCAAGCGACTA 
GCAAGTTAATT 
Q!.;GAGTACCCG 
~GCCCC 
GCAAGGACCCT 
§QT§!.GCTAT 
~GGCTGG 
GCAAGGCCCGG 
GCAAGTCTGTG 
Q!;GG§.GTCGCT 
§fM§!TCAA 
~CTGGC 
GCAAGTCTCCC 
GCCTGAAATC 
GCAAGA 
GCAAGTCCAG 
Q!.;GAGTGGCCT 
gGAGTGGCCA 
Qf.GillGCCAG 
~C§!.CTGTA 
GCAAGACATCA 
GCAAGTAA 
GCAAGTGGT 
GCGAGTAGGGA 
G'CAAGAAATCC 
GCAAGCAGGGG 
GCAT§!AAATA 
GCAAGATGCTT 
GCAAGTCTTCA 
GCAAGAATGCT 
GCATGTGTCCC 
GcAAGT 
GCAAGT 
GCAAGTGACAG 
GCAAGTGCTCC 
CAG GTAAGT 
Reference 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Takenaka, et al., 1989) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Kotula, et at., 1991) 
(O'Malley, et al., 1990) 
(Jackson, 1991 and references therein) 
(Jongeneel, et al., 1986) 
(Hoefsloot, et al., 1990) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Abramson, et al., 1991) 
(Jackson, 1991 and references therein) 
(Haviland, et al., 1991) 
(Keidenreich, et at., 1990) 
(Heidenreich, et al., 1990) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Jackson, 1991 and references therein) 
(Byrd, et al., 1990) 
(Girotti, et al., 1992) 
(Spivack, et at., 1991) 
{Barnun, et al., 1989) 
(Noguiez, et al., 1992) 
(Weeda, et al., 1991) 
(This paper) 
(Rosbash and Seraphin, 1991) 
additional "GC" splice donors, and extended the list to a total of 42 (fable I). The 
comparison presented in Table II clearly confirms and strengthens the observation 
made by Jackson: "GC" splice sequences display as a whole at all (remaining) 
positions a substantially higher level of complementarity to the Ul snRNA than the 
group of "GT" donors. Particularly the G residue at position +5 seems invariant, 
whereas the "G" at -1 is almost invariant. Most sites have 6-8 bases matching Ul 
snRNA (6 sites have 8 matches, 21 sites have 7 matches, 12 sites have 6 matches, the 
remaining 3 sites only have 5 bases matching to Ul snRNA). Apparently, the 
mismatch in base pairing with Ul snRNA caused by the GT to GC alteration needs 
to be compensated by a better match of the rest of the sequence, in order to permit the 
assembly of a functional spliceosome. 
Three of the internal ERCC6 exons (exons without either a cap site or a 
polyadenylation signal) are exceptionally large: 436, 708, and 745 nt (exons II, XVIII, 
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Table n. Nucleotide percentages at GC-type compared to GT-type splice donors. 
Consensus 
GT 
G 
A 
T 
c 
G 
A 
T 
c 
-1 ~ -2 
CIA A 
-3 1 
G G 
100 
G 
100 
2 
T 
100 
c 
100 
3 
A!G 
35 
3 
3 
A 
14.3 
2.4 
4 
A 
9 
9.5 
2.4 
5 6 
G T 
6 16 
T 
9.5 
14.3 
11.9 
Significance of increased complementarity to Ul snRNA in GC splice donor sites 
(shaded boxes) 
p-values <0.1 <0.001 - -
(ns)' 
' Data taken from reference (Senapathy, et al., 1990). 
Percentages are based on 3724 different splice donors. 
'Data from this work and reference (Jackson, 1991). 
Percentages are based on 42 different splice donors. 
' ns = not significantly different. 
<0.001 <0.05 <0.01 <0.1 
(ns)' 
and V respectively). Out of 1305 internal vertebrate exons examined by Hawkins, only 7 
exceed 550 nt; the average length being 137 nt (Hawkins, 1988). A conceivable explanation 
for the scarcity of large internal exons, as proposed by Robberson and colleagues 
(Robberson, et al., 1990) is based on the idea that, in order to stably form a spliceosome, 
factors bound at the 5' and 3' border of an exon need to "communicate". The interaction 
between the different factors might become less stable if the exon length exceeds a certain 
limit. In vitro splicing experiments demonstrated splicing of an intron followed by a large 
exon ( > 300 nt) to be less efficient than splicing of the same intron preceding a small exon 
98 
( <300 nt; Robberson, eta!., 1990). Whether this is true in vivo too, is unknown. If so, it 
might (partly) explain the low expression level of the ERCC6 gene. 
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Chapter VII 
General discussion 

General considerations 
Over the past few years, many eukaryotic nucleotide excision repair (NER) 
deficient mutants have been characterized, and a number of genes (and gene products) 
have been isolated and studied to considerable detail (Friedberg, 1988; Hoeijmakers 
and Bootsma, 1990; Hoeijmakers, 1991, for reviews). These studies have provided 
many answers, but simultaneously raised new questions. The work described in this 
thesis focusses on the isolation and characterization of the ERCC6 gene. Mutations in 
that gene were found to be responsible for the most common form of the autosomal 
recessive disease Cockayne's syndrome (CS): CS-B. The defect in preferential repair 
of active DNA sequences in CS cells implies that the ERCC6 protein is essential for 
this subpathway of NER. It is as yet unknown, though, how the protein couples repair 
to transcription, how a deficiency in this gene product results in the observed 
neurological degeneration specific for CS and why the absence of a functional ERCC6 
protein does not lead to enhanced carcinogenesis within CS-B patients. In this chapter 
these- and other- issues are discussed, and translated into putative molecular models. 
Cockayne's syndrome 
CS is a rare, autosomal recessive DNA repair disorder, clinically characterised 
by a growth defect, progressive neurological degeneration, calcification in the brain, 
ocular lesions (e.g. cataracts, progressive retinal pigmentary degeneration), and sun 
(UV) sensitivity of the skin. Three clinical subtypes of Cockayne's syndrome have 
been described, which differ in the time of onset and severity of the disease (see also 
Chapter II). The subtypes are being referred to as mild (late onset form), CS I 
(clinical symptoms become apparent within the first year after birth), and CS II, the 
most severe form (Nance and Berry, 1992). At the cellular level, two 
complementation groups are distinguished within "classical" (i.e. without XP 
symptoms) CS patients (Tanaka, et al., 1981; Lehmann, 1982). CS group A so far 
contains two patients, one defined clinically as CS I, the other having the mild form 
of the disease. CS-B, the most common subtype of the disease, comprises patients who 
are clinically defined as CS I. Apparently, the clinical heterogeneity does not coincide 
with the genetic heterogeneity as defined by the complementation groups. A hallmark 
of CS cells from group A as well as group B is the absence of preferential (fast) repair 
of UV-induced CPD in active genes, whereas the slow and less efficient repair of 
inactive chromatin (overall genome repair) is unaffected (Venema, et al., 1990a). This 
implies the defective protein in each group to function (specifically) in repair of active 
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genes. 
The molecular defect underlying the repair deficiency of CS group B has been 
unravelled; patients within this group carry a defective ERCC6 gene. The gene defect 
in CS-A patients is as yet unknown. Chapter V of this thesis describes the mutations 
present in the ERCC6 alleles of patient CSlAN (group B, a clinical report of this 
female patient is found in (Schmickel, eta!., 1977)). Both alleles carry deleterious 
mutations, resulting in two - presumably - non-functional proteins (see Figure 3B in 
Chapter V). This finding suggests cells from unassigned, more severely affected CS 
cases reported to be unlikely candidates for group B. The assignment of these severely 
affected patients to any of the existing - or possibly new - complementation groups 
will have to await further complementation analysis. Individuals with a mild form of 
the disease - such as patient GM2965 in CS group A - most likely have mutations that 
only partially affect the function of the responsible gene. A patient with such a mild, 
late-onset form of the disease that should possibly be assigned to group B is described 
by Fryns et al. (1991). This patient carries an interstitial deletion of chromosome 
region IOqll-21, including the ERCC6 gene (Fryns, et a!., 1991, B. Smit and A. 
Hagemeijer, personal communication). Presumably, the other ERCC6 allele harbours 
a less severe mutation. 
Several patients have been described that exhibit a combination of clinical 
features of both CS and XP (Robbins, et al., 1974; Lafforet and Dupuy, 1978; Jaeken, 
et al., 1989). These patients have been assigned to XP group B (also designated CS-C; 
now containing 3 individuals), XP-D (1 XP/CS case), and XP-G (2 XP/CS 
individuals) (Robbins, et a!., 1974; Lehmann, 1982; Vermeulen, et a!., 1991; 
Vermenlen, et al., 1992, and Vermeulen, manuscript in preparation). They suffer 
from the neurological abnormalities characteristic for CS as well as the pigmentation 
abnormalities normally seen in the skin of XP patients. The skin tumors often found 
in XP patients were present in two cases only (XPllBE from XP group Band XP-CS-
2 from XP-D). The absence of tumors in the two XP/CS individuals in XP group G 
might be related to the young age of both patients (who died at age 2.5 and 6, 
respectively). The absence of tumor formation in the two other- much older- XPICS 
patients (assigned to XP-B) is as yet unexplained. Lehmann and Norris (Lehmann and 
Norris, 1989) have proposed a model in which the XP repair defect by itself is thought 
to be insufficient to trigger tumorigenesis and an additional deficiency in immune 
response is essential to result in the cancer prone XP phenotype. So far, however, 
there is no definite proof for this idea. The XP- and XP/CS-mouse models that are 
currently being developed (by gene replacement in mouse embryonic stem cells, G. 
Weeda, I. Danker, M. Hoogeveen, and J. de Wit, personal communication) might 
shed light on the difference in tumor susceptibility. At the cellular level, XP/CS 
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patients have - in contrast to "classical" CS - a severely reduced UV -induced DNA 
repair synthesis (unscheduled DNA synthesis) (Robbins, eta!., 1974; Jaeken, eta!., 
1989; Vermeulen, eta!., 1991; Vermeulen, eta!., 1992 and Vermeulen, manuscript 
in preparation). In several XP/CS cell lines UV-induced RNA synthesis recovery has 
been examined, and found to be inhibited (Lehmann, 1982; Jaeken, et a!., 1989; 
Vermeulen, eta!., 1992 and Vermeulen, manuscript in preparation), indicating that 
besides a defect in overall genome repair (reduction of UDS) also preferential repair 
of active genes is deficient (so similar to what has been found for e.g. XP group A). 
Cockayne's syndrome: mutation induction and tmnorigenesis 
Although CS patients are - like XP - photosensitive, other cutaneous symptoms 
associated with XP (pigmentation abnormalities and the elevated risk for developing 
skin tumors) are absent (Lehmann, 1987; Nance and Berry, 1992). Studies on UV-
induced mutability in CS cells appeared to be difficult because of the premature 
senescence intrinsic to CS cells (Lehmann, 1987). The few data available, however, 
indicate an elevated mutation induction in cultured CS cells, albeit less pronounced 
than in XP (Arlett and Harcourt, 1982). Although preferential repair has a profound 
effect on cell survival, it is - in human cells - expected to contribute ouly slightly to 
the process of mutagenesis. First of all, preferential repair is directed towards the 
transcribed strand (Mellon, et a!., 1987), thus of little influence on mutations 
originating from lesions in the nontranscribed strand. Secondly, the removal of (6-4) 
photoproducts (besides CPD the most frequently UV -induced lesion) is fast (Mitchell 
and Nairn, 1989 for a review), and ouly slightly influenced by preferential repair of 
active genes (Thomas, eta!., 1989; Link Jr., eta!., 1992). Finally the slower, in CS 
seemingly unaffected, "overall genome" repair might in the end remove most of the 
lesions from the nontranscribed as well as many from the transcribed strand. 
Especially in this respect use of in vitro cultured cells (fastly growing) could differ 
from the in vivo situation in the patient (where many cells are growing more slowly). 
The contribution of preferential repair to mutagenesis could be exaggerated in the 
relatively fast growing cultured cells. The inefficient "overall genome" repair, which 
in vivo might be enough to - finally - remove many lesions from both the 
nontranscribed and the transcribed strand of active genes, could be too slow to achieve 
the same in the fastly growing cultured cells. This hypothesis would explain the lack 
of tumorigenesis in CS patients on the one hand as well as the (slightly) elevated level 
of mutagenesis reported in cultured CS cells (Arlett and Harcourt, 1982) on the other 
hand. 
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Neurological. degeneration in XP, CS, and XP/CS patients 
Progressive neurological degeneration is a characteristic of all CS, XP/CS, and 
some XP patients. XP patients with neurological disease have been reported in groups 
A, B(=XP/CS), D, and G (Robbins, 1988). Within the relatively large group C, one 
patient was reported to have neurological complications (Robbins, 1989); generally, 
XP-C patients do not suffer from neurological degeneration. The finding of Venema 
and coworkers that XP-C cells are specifically disturbed in repair of inactive 
sequences, while retaining the ability to repair the transcribed strand of active genes 
(Venema, et al., 1990b; Venema, et al., 1991) -thus being the "biochemical antipole" 
of CS-A and CS-B - prompted them to speculate neurological disease to be correlated 
with the absence of preferential repair (Venema, et al., 1990a). This assumption is 
sustained by the fact that neuronal cells are transcriptionally active, and transcribe a 
larger fraction of their genome compared to other cells. It does not, however, explain 
the mysterious phenomenon that the histopathological findings with respect to the 
progressive degeneration is reported to differ between CS on one, and XP on the other 
hand. In CS patients, primary demyelination is said to lead to the severe neurological 
symptoms (Grunnet, et al., 1983; Ohnishi, et al., 1987; Patton, et al., 1989; Sasaki, 
et al., 1992), whereas in XP they seem to be due to an axonal degeneration (Robbins, 
1988 for a review; Robbins, et al., 1991). This suggests that in CS patients the myelin 
forming glia cells are the primary target, whereas in XP the axons are the more 
sensitive cell type. Furthermore, CS patients differ - neurologically - from those 
suffering from XP in that multiple calcifications are found in brains of CS patients. 
XP/CS patients appear to exhibit the neurological disease of CS rather than that of XP 
(Robbins, et al., 1974; Lafforet and Dupuy, 1978; Jaeken, et al., 1989). In XP, the 
(slow) accumulation of lesions throughout the genome will lead to a general 
deterioration of cell function and finally cell death, possibly resulting in the XP-like 
axonal degeneration. In CS cells the - still functional - "overall genome" repair 
pathway would be able to repair part of the lesions, thereby postponing cell death. 
This might explain why CS patients do not have the neuronal degeneration specific for 
XP patients. The mechanism responsible for the CS-Iike demyelination, however, 
remains unexplained. 
In CS cells, preferential repair of (the transcribed strand of) active genes is 
strongly affected, whereas "overall genome" repair appears normal (Venema, eta!., 
1990a; Venema, 1991). The defective proteins (ERCC6 for CS-B, still unknown for 
CS-A) are therefore hypothesized to somehow couple repair to the process of 
transcription. One of the ways in which this could be achieved is by recognition or 
displacement of a RNA polymerase complex stalled at a DNA lesion - as hypothesized 
for the ERCC6 protein in Chapter V. If not recognized and removed, the RNA 
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polymerase and all pursuing transcription complexes might remain bound at the 
template strand. "Trapping" of RNA polymerase complexes could - hypothetically -
disturb repair and transcription of this particular gene, as well as possibly overall 
transcription levels. Especially non-dividing cells such as present in the nervous 
system - in which there is no replication complex that might efficiently remove 
blocked RNA polymerase complexes from their template strand - would then be prone 
to deterioration of overall transcription levels. 
Myelinating glia cells (Schwann cells and oligodendrocytes) have received 
considerable attention during the past decade, since demyelination is the primary cause 
of diseases like Multiple Sclerosis, and several immune-mediated demyelinating 
diseases. In mouse models, evidence has been obtained that the production of the 
myelin sheath is strongly determined by the amount of mRNA encoding myelin basic 
protein (MBP). The correction of the phenotype of mice carrying different mutations 
in the MBP gene by introduction of the normal MBP gene in fertilized oocytes was 
dependent on the transcription level of the transgene: only mice homozygous for the 
introduced MBP gene showed a normal phenotype (Popko, eta!., 1987; Readhead, et 
al., 1987). This suggests the myelination process to be - at least in part- critically 
dependent on transcription levels. It is unlikely, although not excluded, that the 
dependence on transcription levels is due to an inhibiting effect of the mutated protein 
present. The results were obtained in two different mouse strains, shiverer (Readhead, 
et a!., 1987) and mid (Popko, et al., 1987). Shiverer mice are homozygous for a 
deletion removing the entire MBP gene with the exception of the promotor and the 
first exon (Roach, et al., 1985). In mid mice, a complicated duplication and inversion 
of part of the gene - resulting in the production of normal as well as antisense 
transcripts - is thought to be the cause. The strongly reduced. amount of MBP protein 
detected in mid mice is ascribed to the formation of duplex MRNA molecules (Okano, 
et al., 1991). It seems therefore possible that if in CS the presence of DNA lesions in 
transcribed genes has a severe effect on overall transcription levels, this could 
specifically effect myelin synthesis by glia cells (and thereby result in the progressive 
demyelination of CS patients). 
In XP group A - in which many patients have severe neurological abnormalities 
- cells are thought to be defective in one of the (early) excision repair steps common 
to both preferential and overall genome repair (Shivji, et al., 1992). Although this 
obviously leads to accumulation of DNA lesions in the genome- possibly resulting in 
the XP-like neuronal degeneration - the (still functional) proteins specific for the 
preferential repair pathway might be able to recycle the stalled RNA polymerase 
complexes without inducing DNA repair. This would at least allow transcription of 
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undamaged genes, ensuring production and maintenance of e.g. the myelin sheath. 
XPICS patients have the cutaneous abnormalities typical for XP, but a CS-like 
neurodegeneration. At the cellular level, both a reduced level of UDS (unscheduled 
DNA synthesis) and a defect in recovery ofUV-induced RNA synthesis inhibition are 
present, suggestive of a defect in preferential as well as "overall genome" repair 
(similar to e.g. XP-A). In the above described hypothesis, the proteins affected in the 
different XP/CS complementation groups (XP-B/CS-C, XP-D, and XP-G) might 
perform a dual role: besides their functioning in the actual repair of the lesion, they 
could be involved in recognition and/ or removal of stalled RNA polymerase 
complexes. If such a protein is defective, the neurological consequences might be 
determined maiuly by the most direct effect: the negative influence of the stalled RNA 
polymerase complexes on overall transcription levels; thereby "masking" the XP-like 
neuroual degeneration due to accumulation oflesions throughout the genome. In XP-D 
patients that have been described having a XP-like neurological degeneration (Johnson 
and Squires, 1992), the affected protein (ERCC2) should then be mutated such that 
the ability to recognize and/or remove (together with other proteins) stalled RNA 
polymerase complexes is retained, but the actual repair function is lost. Alternatively, 
in this hypothesis, the protein affected in each XP/CS complementation group could 
have a role outside the NER, in the RNA transcription process. Subtle mutations in 
these proteins might then lead to a deterioration of transcription levels, leading to the 
CS-like neurological impairment. For ERCC2 and ERCC3 (XP-D and XP-B resp.) 
vital functions outside the excision repair process have been suggested (on the basis 
of- unknown - vital functions of their yeast homologs; Higgins, et a!., 1983; 
Naumovski and Friedberg, 1983; Gulyas and Donahue, 1992; Park, eta!., 1992). 
It seems reasonable to assume that there is a common defect in CS and XP/CS 
patients, which results in the demyelination and discriminates them - clinically - from 
XP. Whether this common defect is indeed, as hypothesized, a decrease in 
transcriptional activity remains to be determined. At present, the above model is 
highly speculative; there is no evidence to sustain the proposed reduction in overall 
transcription levels. Other possibilities, such as differences in the nature of DNA 
lesions in different cell types (due to differences in cell metabolism), or disturbance 
of cell-cell interactions (between the neuron and the surrounding glia cells) can be 
envisaged, too. 
Characterization of genes and gene products involved in (preferential) NER 
The isolation and characterization of genes and gene products involved in the 
enkaryotic excision repair process has contributed considerably to our insight into the 
molecular mechanisms of NER. We are now able to assign putative functions to 
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several individual proteins, based on either in vitro activities or the predicted amino 
acid sequence of the protein in question. Nevertheless the issue as to how the different 
proteins cooperate and function in the recognition and removal of DNA damage is far 
from understood and remains subject to speculation. 
Genes involved spec!ficolly in preferentiol NER 
The NER system is divided in two subpathways: the fast, preferential repair of 
active genes, and the slower "overall genome" repair (Link Jr., et a!., 1991 for a 
review). Although many gene products are shared by both repair pathways, at least 
one gene- ERCC6- can be pinpointed to be specifically involved in preferential repair 
only (see Chapter V). The predicted amino acid sequence of this protein (described 
in Chapter V) suggests it to be a nuclear DNA (or RNA) helicase. In Chapter V 
several possible functions for the ERCC6 protein are described: I) Probably, a RNA 
polymerase complex that is stalled at a DNA lesion within an actively transcribed gene 
will sterically hinder access of repair enzymes to the lesion, and should therefore be 
removed before repair can be accomplished (Selby and Sancar, 1990). ERCC6 might 
function herein - either by forcing the polymerase complex passed the lesion, pushing 
it backwards, or completely dissociating it from the DNA template. 2) Alternatively, 
the protein could be involved in recognition of a stalled RNA polymerase complex, 
thereby directing the excision complex to actively transcribed genes. At present, we 
have no clues as to discriminate between these or even other possible functions of the 
ERCC6 protein. 
A second gene product functioning in preferential gene repair is encoded by the 
CS-A correcting (CSAC) gene: the phenotype of CS-A patients as well as the repair 
characteristics of CS-A cells are very much alike CS-B (Venema, et al., !990a). A 
more conclusive statement concerning the function of the CSAC protein has to await 
isolation and characterization of the CSAC gene and gene product. 
Genes involved in preferentiol and "overall genome" repair 
Mutations in either the ERCCJ, ERCC2, ERCC3, ERCC4, ERCC5, XPAC or 
XPGC gene seem to abolish repair of inactive as well as active genes. Rodent mutants 
from complementation groups 1, 2, 3, 4 and 5 as well as XP-A cells are deficient in 
the incision step of the NER reaction. Cells from XP-G patients have a severely 
reduced repair DNA synthesis (UDS). Within the human counterparts of rodent groups 
2 and 3 - XP-D and XP-B resp. - patients are found that exhibit the neurological 
degeneration normally found in CS, but the cellular characteristics specific for XP 
(Vermeulen, et al., 1991 and Vermeulen, manuscript in preparation). Similar patients 
1!3 
have been assigned to XP group G (Vermeulen, et al., 1992). Above, models are 
hypothesized, in which the proteins affected (ERCC2, ERCC3, and the not yet isolated 
XPGC) have a dual role; one in repair of a lesion irrespective of its location in the 
genome, the other in retaining normal levels of transcription (possibly through "tum-
over" of stalled RNA polymerase complexes). For both ERCC2 and ERCC3 yeast 
homologs have been isolated and characterized (Weber, et al., 1990; Gulyas and 
Donahue, 1992; Park, eta!., 1992). The gene product of the ERCC2 yeast homolog 
RAD3 has been investigated to considerable detail. The protein is demonstrated to be 
a DNA-DNA and DNA-RNA helicase (Sung, et al., 1987; Bailly, et al., 1991; 
Naegeli, et al., 1992). RAD3, and by implication its human homologue ERCC2, has 
been postulated to function in scanning the DNA for the presence of damage. It was 
suggested that the protein scans both inactive and actively transcribed sequences for 
the presence of DNA damage, by use of its DNA-DNA and DNA-RNA unwinding 
capacity respectively (Bailly, et al., 1991; Naegeli, et al., 1992). The protein would 
then encounter RNA polymerase complexes that are stalled at a DNA lesion. It might 
thus be involved in the recognition of damage as well as the recognition and 
displacement of a stalled RNA polymerase complex. Based on the phenotype of a 
specific rad3 mutant: rad3 Arg-48, an alternative model has been proposed. The rad3 
Arg-48 mutant carries a defective RAD3 gene, encoding a protein in which the 
invariable lysine within the A TP-binding fold (helicase signature I) is replaced by 
arginine. Rad3 Arg-48 cells retain the ability to incise DNA upon UV -irradiation 
(although less efficient then wt), but are disturbed in the removal of pyrimidine 
dimers. Therefore, the RAD3 protein was suggested to function in a post-incision step, 
and to be essential for strand displacement and/or turn-over of the incision complex 
(cf. UvrD; Sung, et al., 1988). Conform with this postulated strand displacement or 
complex tum-over, the RAD3 (and by implication ERCC2) protein might utilize its 
DNA-RNA unwinding activity for tum-over of a stalled RNA polymerase complex. 
If so, the protein might act together or in complex with the ERCC6 gene product. 
Among the rodent group 2 mutants (which carry mutations in ERCC2, the human 
homolog of RAD3) a cell line (V-Hl) has been reported that has similar characteristics 
as the yeast rad3 Arg-48 mutant: no CPD removal, but intermediate levels of incision. 
This mutant appeared to exhibit intermediate repair of (6-4) photoproducts, thus 
explaining the intermediate levels of incision (Mitchell, et al., 1989). For the rad3 
Arg-48 yeast mutant repair of (6-4) photoproducts has not been investigated. For both 
the rodent and the yeast mutant, the protein might be affected such that CPD can not 
be recognized anymore, whereas the more helix disturbing (6-4) photoproducts still 
are recognized. This would suggest that the proteins (RAD3 and its human homolog 
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ERCC2) are directly or indirectly involved in damage recognition. Whether the protein 
in the in vivo NER process actually has one (or all) of the above mentioned or other 
functions awaits further research. Besides the important role in excision repair, RAD3 
has another- as yet unidentified - function that is essential for yeast viability (Higgins, 
eta!., 1983; Naumovski and Friedberg, 1983). The high degree of homology between 
RAD3 and its human homologue prompted the idea that probably also ERCC2 has 
such a vital function distinct from its involvement in repair. If so, this might provide 
an explanation for the surprising TID phenotype seen in some XP group D patients 
(described in Chapter II). TTD might be the result of mutations affecting, but not 
abolishing, the vital function of the protein. 
The sequence of the ERCC3 gene revealed the presence of seven motifs 
conserved between different helicases, suggesting that also this protein possesses 
unwinding activity (Weeda, et a!., 1990b). Several lines of evidence suggest the 
ERCC3 protein to have a role equivalent or complementary to that ofERCC2 (Weeda, 
eta!., l990b). The rodent mutants from cg 2 and 3 have comparable sensitivities; both 
XP group B (ERCC3) and XP-D (ERCC2) encompass XP/CS patients; both genes 
have yeast homologues with a similar (high) degree of identity and similarity ("" 50 
and 70 % resp.) and both yeast proteins have a (presumed) helicase function and are 
essential for yeast viability. It has been suggested that ERCC3 might act in the same 
process as ERCC2 (whatever that process might be), but exhibiting a helicase activity 
of a different polarity (RAD3 possesses a 5' to 3' unwinding capacity). Alternatively, 
the proteins might function as a hetero-dimer (or multimer). The vital function of the 
yeast ERCC3 protein is, as for the RAD3 protein, unknown. Recently, a search for 
suppressor mutations relieving translation blockage from a MRNA containing an 
artificial hairpin in the 5' untranslated region (UTR) resulted in the isolation of four 
genes, designated SSLI-4. Surprisingly, sequence analysis of one of these genes - SSL2 
- revealed it to be the Saccharomyces cerevisiae equivalent of ERCC3 (Gulyas and 
Donahue, 1992). Apparently, the mutated SSL2 protein permits translation from a 
MRNA containing a hairpin that normally blocks protein synthesis. Possibly, this is 
achieved through unwinding of the stable hairpin, or by stripping bound proteins from 
the 5' UTR containing this unusually stable hairpin. The vital function of SSL2 (and 
presumably its human homologue ERCC3) might therefore be related to the translation 
(initiation) process. Alternatively, the protein might actually be involved in 
transcription. As a result of the mutation it might for instance remain bound to the 
hairpin-region, thus preventing its formation and permitting translation. The 
involvement in transcription would be more conform the idea postulated above 
concerning the demyelination reported in both CS and XP/CS. 
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Future directions 
In the past decade, considerable effort has been devoted to the isolation and 
characterization of genes involved in mammalian excision repair. The results have 
provided several key steps towards unravelling the molecular mechanism of 
mammalian nucleotide excision repair. At least seven genes are cloned (Westerveld, 
et al., 1984; Weber, et al., 1988; Tanaka, et al., 1989; Mudgett and Macinnes, 1990; 
Weeda, et al., 1990a; Legerski and Peterson, 1992 and Chapter Ill), and characterized 
to some extent. The primary structure of the encoded proteins as well as the phenotype 
of corrected rodent mutant cell lines or an associated human repair disorder have 
provided clues to putative functions. Undoubtedly, in the near future several of the 
postulated activities will be sustained by biochemical evidence. Moreover, insight into 
interactions between different components of the excision repair machinery can now 
be obtained (Bailly, eta!., 1992; Bardwell, eta!., !992). Even specific steps in which 
single proteins are involved can be deduced with help of the - recently developed - in 
vitro repair assay based on cell-free extracts (Wood, et al., 1988; Shivji, eta!., !992). 
The isolation and characterization of the ERCC6 gene has provided a primary 
sequence that strongly suggests the protein to be a nuclear DNA (or RNA) helicase. 
The work has now come to a stage that will require protein analysis. Overexpression 
and purification of (parts of) the ERCC6 protein might provide biochemical 
information sustaining the prediction of a DNA (or RNA) unwinding activity. 
Thereby, antibodies raised against ERCC6 will be essential in providing insight into 
possible complexes in which the protein might exist in vivo. 
The region spanning the different helicase signatures in ERCC6 is highly 
homologous to similar parts of several other putative helicases functioning in DNA 
repair (RAD5, RAD16, RAD54), transcriptional regulation (SNF2, MOT!, brahma), 
preservation of chromosome stability (lodestar), or unknown processes (FUN30, 
STH!) (see Chapter V). The functional significance of the homology between this 
group of presumed DNA helicases could be assessed by mutational analysis of the 
ERCC6 gene and subsequent transfection to either rodent mutant cell line UV61 or a 
cell line of CS group B. Alternatively, the helicase regions could be interchanged 
between one of the yeast genes in this group and a yeast homologue of ERCC6 could 
be performed; to test the repair capacity of the hybrid protein, though, an ERCC6 
deficient yeast mutant should be available. Recently, a new member of the above 
mentioned "helicase" subfamily has been isolated from yeast (A. van Goo!, personal 
communication). The entire helicase region exhibits an extremely high degree of 
homology to the similar region ofthe human ERCC6 protein (the homology to human 
ERCC6 exceeds that to other family members). Whether this gene is indeed "the" 
1!6 
yeast homolog of ERCC6 remains to be elucidated. It will be interesting to determine 
the degree of UV-sensitivity of an ERCC6 (and thus preferential repair) deficient 
mutant. The E. coli mutant mfd, deficient in strand-specific repair of active genes, has 
a near normal UV-sensitivity (George and Witkin, 1974). The fact that no ERCC6 
deficient yeast mutant has been isolated yet suggests it to be only marginally UV-
sensitive, although other options (e.g. lethality of mutations in the gene) cannot be 
excluded. 
Mutations in the ERCC6 gene have been demonstrated to be responsible for the 
repair defect in cells from CS patients. ln one clinically severely affected patient 
deleterious mutations are present in both ERCC6 alleles. A CS patient with relatively 
mild clinical symptoms has been described, carrying an interstitial deletion of 
chromosome 10, region qll-21 including the ERCC6 gene (Fryns, et al., 1991, B. 
Smit and A. Hagemeijer, personal communication). Mutational analysis of the second. 
still present ERCC6 allele of this patient will provide information on a mutation that 
most likely only partially inhibits the normal function of the protein. 
ln this thesis, several models concerning ERCC6 activity in preferential repair 
of (the transcribed strand of) active genes are discussed. There is, however, no clue 
as to confirm or reject one of the hypotheses. Whether ERCC6 is involved in the 
recognition and/or replacement of a stalled RNA polymerase - one of the models 
proposed - is clearly an important point. An in vitro assay, that could measure repair 
in an actively transcribed plasmid - which is as yet not available - might shed some 
light on this issue. If a stalled RNA polymerase is to be recognized and/or removed 
before repair of the lesion can be accomplished, repair of these lesions in an extract 
that is deficient in this recognition/replacement (possibly CS) would be negatively 
influenced by transcription. A similar assay has been described for preferential repair 
in E. coli (Selby and Sancar, 1990; Selby and Sancar, 1991). 
To study in more detail the in vivo function of ERCC6 in processes such as 
mutagenesis, tumorigenesis, and neurodegeneration, a mouse model would be very 
informative. By ERCC6 gene replacement in mouse embryonic stem cells, a CS-B 
mouse can be generated; the results obtained by mutational analysis of a CS-B patient 
(see Chapter V) suggest that construction of a mouse model in which both copies of 
the ERCC6 gene are deprived of any function is feasible. The construction of different 
repair-deficient mouse models will undoubtedly result in valuable information on 
various issues. The effect of the absence of preferential repair on mutagenesis and 
tumorigenesis can be investigated in more detail, e.g. after the administration of 
carcinogens, after UV exposure or in CS mice that carry an activated oncogene in 
their genome. A mouse model for CS will permit accurate determination of damage 
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in neuronal tissues. The results with respect to mutagenesis, tumorigenesis and 
neurodegeneration can be compared between XP, XPICS, and CS mice. Moreover, 
XP!CS mice could be compared to "double mutant" mice carrying mutations in both 
alleles of a XP gene (e.g. XPAC) as well as in both alleles of a CS gene (e.g. 
ERCC6). 
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Samenvatting 

Summary 
The genetic information of an organism is constantly subject to the introduction 
of mutations by environmental agents, faulty DNA metabolism or instability intrinsic 
to the DNA itself. To protect cells from a deleterious accumulation of alterations, 
various DNA repair mechanisms have evolved. The nucleotide excision repair (NER) 
process is one of the most versatile repair systems. It is able to remove a broad range 
of different DNA lesions, such as bulky chemical adducts, DNA cross links, and UV-
induced lesions (cyclobutane pyrimidine dimers, (6-4) photoproducts, thymine 
glycols). 
The importance of the NER process is illustrated by the classical DNA repair 
disorder xeroderma pigmentosum (XP). Due to a NER defect XP patients are 
extremely sun(UV)sensitive, they have pigmentation abnormalities in sunexposed areas 
and have a highly elevated (± 2000x) risk for the formation of skin tumors. 
Sometimes patients also suffer from progressive neurological degeneration. Patients 
with the hereditary repair disorder Cockayne's syndrome (CS) are, as XP patients, 
sun(UV)sensitive, but have no elevated risk for the formation of skin tumors. Other 
clinical characteristics of CS are cachectic dwarfism, retinal abnormalities and 
progressive neurological degeneration. CS cells perform - in contrast to XP cells -
apparently normal repair of UV -induced pyrimidine dimers from the genome overalL 
They are, however, unable to recover their RNA synthesis after UV exposure. 
Recently, the repair defect in CS has been pinpointed to a subpathway of NER that 
primarily focusses on the preferential repair oflesions from (the transcribed strand of) 
active genes. This ingenious repair system normally permits cells to quickly resume 
transcription that was blocked by lesions in the template. Consequently, it has a major 
impact on the cellular resistance to UV and some other genotoxic agents. 
To obtain a more detailed understanding of the molecular mechanism of the 
eukaryotic NER process, isolation and characterization of genes and gene products 
involved is indispensable. The work described in this thesis focusses on the isolation 
and characterization of the gene that corrects the NER defect of a UV -sensitive 
Chinese hamster ovary (CHO) mutant. The mutant, UV6l, is a representative of 
complementation group 6 of the laboratory induced, NER-deficient rodent cell lines. 
It is only moderately UV -sensitive in comparison with mutant cell lines from groups 
1 to 5, and harbors a partial deficiency in the repair of cyclobutane pyrimidine dimers 
but permits apparently normal repair of (6-4) photoproducts. The correcting gene, 
designated ERCC6, has been isolated through DNA-mediated transfection of UV61. 
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As described in Chapter Ill, the gene appeared to have a - for transfection cloning -
respectable size of close to 100 kb, explaining the extremely low yield at which 
genomic repair-corrected transformants were obtained. The isolation of a revertant that 
has amplified an endogenous, mutated CHO ERCC6 allele suggests that the UV61 
mutation is leaky and can be overcome by gene amplification. This hypothesis is 
sustained by the recent observation ofLommel and Hanawalt (Mutat. Res. 255 (1991), 
183-191) that UV61 is only partly disturbed in repair of cyclobutane pyrimidine 
dimers from the transcribed strand of the active DHFR locus. 
In Chapter IV, we localize theERCC6 gene on chromosome 10, region q11-21. 
Almost simultaneously, Fryns et al. (Am. J. Med. Genet. 40 (1991), 343-344) 
reported a CS patient with a late onset form of the disease, carrying an interstitial 
deletion of the long arm of chromosome 10 (del(lO)(ql 1.23-q2L2)). This prompted 
us to transfect the ERCC6 gene to CS cells from both complementation groups A and 
B. As reported in Chapter V, the repair defect of CS group B cells is corrected upon 
introduction of the ERCC6 gene, implying the ERCC6 protein to function in 
preferential repair of (the transcribed strand of) active genes. Thereby it indicates 
UV61 and other representatives of rodent group 6 to be the rodent equivalent of CS 
group B. The gene is spread over 21 exons and produces two lowly expressed, 
differentially polyadenylated mRNAs (Chapter VJ). It encodes a protein of 1493 amino 
acids that contains seven motifs conserved among different DNA and RNA helicases. 
The region encompassing these helicase signatures exhibits a high degree of homology 
(± 30% identity and 50-60% similarity at the amino acid level) to a number of other 
postnlated helicases functioning in DNA repair, preservation of chromosome stability, 
transcription regulation, and other yet unknown processes, constituting a gene family. 
Mutation analysis of RNA and DNA of a CS-B patient revealed the presence of 
deleterious mutations in both alleles, presumably resulting in the production of non-
functional proteins. This suggests that the ERCC6 protein is not essential for cell 
viability and specific for the preferential repair of active genes. 
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Sam en vatting 
De erfelijke informatie van een organisme wordt voortdurend bloot gesteld aan 
de mutagene effecten van omgevings factoren, onnauwkeurigheden in het DNA 
metabolisme of instabiliteit van het DNA zelf. Om de eel te beschermen tegen de 
desastreuze accumulatie van veranderingen, zijn verschillende DNA herstel 
mechanismen ontstaan. Het nucleotide excisie reparatie (NER) mechanisme is een van 
de meest veelzijdige herstel systemen. Het is in staat een grote verscheidenheid aan 
lesies te verwijderen, zoals lesies veroorzaakt door diverse chemische agentia en 
UV(zonlicht)-geinduceerde lesies (cyclobutaan pyrimidine dimeren, (6-4) 
fotoprodukten, thymine glycolen). 
Het belang van het NER proces blijkt uit de fenotypische gevolgen van de 
erfelijke afwijking xeroderma pigmentosum (XP), het klassieke voorbee!d van een 
DNA herstel defect. Als gevolg van een niet of slecht functionerend NER zijn XP 
patienten extreem gevoelig voor zon(UV)Iicht. Aan de zon blootgestelde delen van de 
huid vertonen een abnormale pigmentatie, en de patienten hebben een sterk verhoogde 
(± 2000x) kans op het ontstaan van hnid tumoren. De ziekte gaat soms gepaard met 
progressieve neurologische degeneratie. Patienten met de erfelijke ziekte Cockayne's 
syndroom (CS) zijn - evenals XP patienten - overgevoelig voor zonlicht, maar hebben 
geen verhoogde kans op het ontstaan van huid tumoren. De ziekte wordt verder 
gekenmerkt door ernstige groeistoornissen en een progressieve neurologische 
degeneratie. Ce!len van deze patienten zijn UV(zon)-gevoelig. De verwijdering van 
UV-geinduceerde pyrimidine dimeren, wanneer gemeten in het "totale genoom", is-
in tegenstelling tot XP - normaal. Recentelijk is gebleken dat het herstel defect in CS 
zich beperkt tot een onderdeel van het NER systeem dat zich primair rich! op de 
preferentiele verwijdering van lesies uit (de getranscribeerde streng van) actieve 
genen. Dit ingenieuze herstel mechanisme stelt de eel in staat om het transcriptie 
proces, dat geblokkeerd was door lesies in de getranscribeerde streng, snel te 
hervatten. Als gevolg daarvan draagt dit systeem in belangrijke mate bij aan de 
resistentie van cellen voor verschillende genotoxische agentia. 
Een beter inzicht in het moleculaire mechanisme van het eukaryote NER proces 
is mogelijk door iso!atie en karakterisering van betrokken genen en gen produkten. Dit 
proefschrift beschrijft de isolatie en karakterisering van een humaan gen, dat het NER 
defect van een UV -gevoelige chinese hamster ovarium (CHO) mutant cellijn 
corrigeert. De mutant cellijn, UV61, behoort tot complementatie groep 6 van de NER-
deficiente knaagdier cellijnen. UV61 is slechts matig UV-gevoelig en heeft een partieel 
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defect in het herstel van cyclobutaan pyrimidine dimeren. Herstel van (6-4) 
fotoprodukten, daarentegen, verloopt normaal. Het corrigerende gen, ERCC6, is 
geisoleerd door middel van DNA transfectie naar UV61. Het gen heeft een - voor 
transfectie clonering respectabele - grootte van bijna 100 kb; dit verklaart de !age 
frequentie waarmee herstel-proficiente transformanten werden geisoleerd (Hoofdstuk 
Ill). De isolatie van een revertant met een geamplificeerd, endogeen gemuteerd CHO 
ERCC6 allel suggereert dat het geproduceerde eiwit nog gedeeltelijk kan functioneren. 
Deze hypothese wordt ondersteund door de recente bevinding van Lamme! en 
Hanawalt (Mutat. Res. 255 (1991), 183-191) dat UV61 s!echts gedeelte!ijk gestoord 
is in het herstel van cyclobutaan pyrimidine dimeren in de getranscribeerde streng van 
het actieve DHFR gen. 
ERCC6 is gelokaliseerd op chromosoom 10, regio qll-21 (Hoofdstuk IV). In 
een publikatie van Fryns et al. (Am. J. Med. Genet. 40 (1991), 343-344) word! een 
CS patient gerapporteerd met een interstitiele deletie in de lange arm van chromosoom 
10 (del(10)(qll.23-q21.2)). Dit heeft ons ertoe gebracht het ERCC6 gen te 
transfecteren naar CS cellen van de beide complementatie groepen A en B. Zoals 
beschreven in Hoofdstuk V, kan ERCC6 inderdaad het herstel defect van CS groep B 
cellen corrigeren. Dit suggereert dat het ERCC6 eiwit betrokken is bij het 
preferentiele herstel van (de getranscribeerde streng van) actieve genen. Daarbij 
betekent het dat UV61 en andere knaagdier groep 6 mutanten het knaagdier equivalent 
vormen van CS groep B. Het ERCC6 gen is verdee1d in 21 exonen en expresseert 
twee, altematief gepo1yadeny1eerde, mRNAs (Hoofdstuk VI). Beide - niet frequent 
voorkomende- mRNAs coderen voor een eiwit van 1493 amino zuren (Hoofdstuk 11). 
Dit eiwit bevat zeven sequentie motieven die geconserveerd zijn tussen verschillende 
DNA en RNA helicases. De "helicase-regio" vertoont een hoge mate van homologie 
met een aantal andere veronderstelde helicases (±30% identiek en 50-60% 
vergelijkbaar op amino zuur niveau). De eiwitten gecodeerd door deze genfamilie zijn 
betrokken in DNA herstel, behoud van chromosoom stabiliteit, transcriptie regulatie 
en andere nog onbekende processen. Mutatie analyse bij een CS-B patient heeft de 
aanwezigheid van emstige mutaties in beide ERCC6 allelen aangetoond; het is 
aannemelijk dat beide allelen coderen voor niet-functionele eiwitten. Dit suggereert dat 
bet ERCC6 eiwit niet essentieel is voor !evensvatbaarheid en waarschijnlijk specifiek 
betrokken is bij preferentieel herstel van getranscribeerde genen. 
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Nawoord 
Het mage duidelijk zijn dat het tot stand komen van dit boekje geen verdienste is van 
mij aileen. Een woord van dank aan a! diegenen die in de afgelopen jaren hebben 
meegewerkt, meegedacht of hun belangstelling hebben getoond is dan ook op zijn 
plaats. Enkelen wil ik met name noemen. 
Allereerst mijn promotor Professor Bootsma, zonder wiens vertrouwen in mij dit 
proefschrift nooit verschenen was. Het is verbluffend hoe U het "managen" van een-
nag steeds groeiende - groep weet te combineren met een grate interesse voor wat er 
achter de lab-tafel gebeurt. Een betere promotor had ik me niet kunnen wensen! 
Zander de bezielende Ieiding van Jan Hoeijmakers zou "Repair" niet zijn wat het nu 
is. Beste Jan, ik heb in de afgelopen jaren ontzettend vee! van je geleerd. Jouw 
onvoorstelbare en nooit afnemende enthousiasme voor alles wat naar wetenschap ruikt 
is, vooral in "mindere" tijden, een belangrijke steun geweest. Ik ben er trots op dat 
ik oak na bet voltooien van dit boekwerk met jouw club kan blijven samenwerken. 
De clonering van ERCC6 is begonnen met een ongelooflijke hoeveelheid transfectie 
werk, hetgeen voor bet belangrijkste dee! op conto kwam van Andries (Professor) 
Westerveld, Hanny Odijk en Jan de Wit. Zander jullie geen ERCC6! Andries, bedankt · 
dat je mijn manuscript hebt willen doorworstelen en hebt voorzien van waardevol 
commentaar. Oak Professor van Zeeland en Professor Niermeyer hebben die taak op 
zich willen nemen: vee! dank voor aile goede suggesties. Jan en Hanny, jullie stonden 
mij aan bet begin van mijn AIO-carriere terzijde in bet kweekhok; ik ben blij dat jullie 
me aan bet einde van mijn AIO-periode als paranimfen terzijde staan. 
In mijn eerste "repair jaren" heb ik vele vragen op jou afgevuurd, Marcel (van Duin). 
Het heeft me altijd verbaast dat je voor vrijwel alles een oplossing had. 
Kokie (Marcel Koken), ik mis je aansporende, vee! gehoorde kreet "is bet nou nog 
niet af'' nu a! (wanneer is dat boekje vanjou eigenlijk klaar?). Gelukkig is Parijs niet 
bet andere eind van de wereld, voor goede adviezen weet ik je nog steeds te vinden. 
Koos, ook jouw hnlp - op velerlei fronten (computer, artikelen, verhalen, etc.) - heb 
ik enorm gewaardeerd. Ik zal in mijn (radiobiologische) toekomst nog wei vaker een 
beroep op jouw kennis doen! 
Sjozef, jij bent voor een ieder die af en toe een computer aanraakt van onschatbare 
waarde! Er is niemand die zoveel domme vragen met zoveel geduld "a Ia minute" 
oplost. Behalve het oplossen van vragen deed je overigens vee! meer: figuur 4B in 
hoofdstuk V zal ik niet Iicht vergeten! 
Bij bet praktische werk heb ik vee! hulp gekregen van studenten. Patricia, Martha, 
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Emmy, Gerben, en Wout, bedankt voor aile inzet en - niet te vergeten - de resultaten. 
Alain, ik ben blij dat je ons op het juiste moment bent komen versterken. Ik wacht 
met spanning op bet volgende ERCC6 boekje! 
Wim, bedankt voor de vele discussies - zowel over de proeven (lang !eve bet agressie-
papier!) als anderszins. Zonder jouw aanwezigheid zou de groep (voor mij) een heel 
andere zijn. 
Ruud en Peer, ik beb dankbaar gebruik gemaakt van jullie computer programma. 
Zonder dat had het vinden van de ERCC6 helicase domeinen stukken meer tijd in 
beslag genomen. Peer, de stress ijsjes en andere "afkoelende middelen" hebben bet 
lab-leven in elk gevallevendig gebouden! 
Dan zijn er nog a! die mensen wiens naam nooit boven een van onze artikelen prijkt, 
maar die desainiettemin van groot belang zijn voor de afdeling. Ons lab zou niet 
draaien zonder de afdeling fotografie. Mirko, zeker jij bebt een boel tijd aan dit boelge 
gespendeerd. Reuze bedankt! Ook de "meiden van de keuken" zijn niet weg te denken. 
Jopie, Elly en Joke jullie goede humeur is benijdenswaardig en aanstekelijk! Rita en 
Jeanette ("bet" secretariaat), vee! dank voor aile gezelligheid en a! die "regel-
dinge\ies". Ook Rein, Mieke en Piet, heel hartelijk dank: bestellingen, reparaties, etc. 
etc., bet gaat allemaal schijnbaar vanzelf...! 
Zoals velen heb ook ik een boel aan (scboon)familie te danken. Bedankt voor aile 
belangstelling en sorry voor aile keren dat ik "moest" werken. Pappa en mamma, bet 
is prettig om te weten dater mensen zijn die echt aitijd voor je klaar staan. Bedankt 
voor aile goede raad, de "peptalk", en nog vee! meer. Mam, zonder jou waren (o.a.) 
de ramen nu zo vies geweest dat we geen luxaflex meer nodig zouden bebben. 
En tenslotte het thnisfront. Wil(bert), jouw begrip voor mijn werktijden, je schouder 
bij (o.a.) mislukte proeven, je oprechte interesse in mijn "werk", en a! die andere 
"(ldeine) dingen die het doen" waren- en zijn- heel belangrijk! 
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